This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Burn and corrosion of wrist and hand
ST19_BURN_CORROSION_WRIST_HAND
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519870 |
1. Apply sex-specific ruleNone |
519870 |
2. Check conditionsNone |
519870 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
1612 |
4. Check minimum number of eventsNone |
1612 |
5. Include endpointsNone |
1612 |
6. Filter based on genotype QC (FinnGen only) |
1537 |
Control definitions (FinnGen only)
- Control exclude
- CD2_BENIGN_FEMALE_GEN_OTH
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- T2[0-5]
- Name in latin
- Combustiones et corrosiones carpi/manus
Similar endpoints
↥List of similar endpoints to
Burn and corrosion of wrist and hand
based on the number of shared cases.
Similar with more cases:
- Burns and corrosions of external body surface, specified by site
- Burns and corrosions
- Injury, poisoning and certain other consequences of external causes
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1537 | 708 | 829 |
| Unadjusted period prevalence (%) | 0.32 | 0.25 | 0.38 |
| Median age at first event (years) | 44.68 | 41.77 | 47.17 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1612
- Matched controls
- 16120
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
T23.1
ICD-10 Finland
Burn of first degree of wrist and hand
374.6
307.7
396
14
T23.2
ICD-10 Finland
Burn of second degree of wrist and hand
690.9
307.7
894
29
X18
ICD-10 Finland
Contact with other hot metals
200.4
307.7
194
11
X12
ICD-10 Finland
Contact with other hot fluids
107.8
307.7
292
33
T23.0
ICD-10 Finland
Burn of unspecified degree of wrist and hand
368.4
307.7
324
11
S14
ICPC
Burn/scald
19.7
307.7
408
273
T23.3
ICD-10 Finland
Burn of third degree of wrist and hand
1953.0
176.3
168
*
QCD00
NOMESCO Finland
Dressing of major burn of upper limb
215.4
135.0
138
7
T20.2
ICD-10 Finland
Burn of second degree of head and neck
46.9
129.2
76
17
QCB10
NOMESCO Finland
Major dressing of wound of skin of upper limb
10.6
117.2
133
136
QCD20
NOMESCO Finland
Excision of burn of upper limb and coverage
210.1
114.2
117
6
T22.2
ICD-10 Finland
Burn of second degree of shoulder and upper limb, except wrist and hand
23.7
106.5
77
34
ZZA00
NOMESCO Finland
Split skin graft
9.0
91.0
116
138
SPAT1148
SPAT
Treatment of chronic ulcer or burn
3.8
79.2
284
869
X59
ICD-10 Finland
Exposure to unspecified factor
2.9
78.3
492
2110
T21.2
ICD-10 Finland
Burn of second degree of trunk
21.1
77.9
59
29
T20.1
ICD-10 Finland
Burn of first degree of head and neck
42.1
74.5
45
11
T24.2
ICD-10 Finland
Burn of second degree of hip and lower limb, except ankle and foot
21.9
68.5
51
24
X04
ICD-10 Finland
Exposure to ignition of highly flammable material
631.7
62.2
61
*
TQW10
NOMESCO Finland
Exchange of bandage for burn
84.7
58.4
65
8
X19
ICD-10 Finland
Contact with other and unspecified heat and hot substances
105.6
56.2
61
6
X58
ICD-10 Finland
Exposure to other specified factors
2.6
55.7
392
1745
X14
ICD-10 Finland
Contact with hot air and gases
171.9
48.1
50
*
R4120
NOMESCO Finland
Occupational therapy
3.5
46.3
173
536
T31.0
ICD-10 Finland
Burns involving less than 10% of body surface
73.5
44.2
50
7
X09
ICD-10 Finland
Exposure to unspecified smoke, fire and flames
57.3
42.6
50
9
W92
ICD-10 Finland
Exposure to excessive heat of man-made origin
54.9
40.7
48
9
QCD10
NOMESCO Finland
Debridement of burn of upper limb
+∞
38.7
37
*
X03
ICD-10 Finland
Exposure to controlled fire, not in building or structure
173.5
32.8
34
*
QDD00
NOMESCO Finland
Dressing of major burn of lower limb
36.3
30.7
39
11
T20.0
ICD-10 Finland
Burn of unspecified degree of head and neck
36.3
30.7
39
11
T29.2
ICD-10 Finland
Burns of multiple regions, no more than second-degree burns mentioned
67.3
29.0
33
5
QBD00
NOMESCO Finland
Dressing of major burn of trunk
43.3
27.8
34
8
W86
ICD-10 Finland
Exposure to other specified electric current
8.0
26.5
36
46
S18
ICPC
Laceration/cut
1.8
26.2
737
5227
T36
ICD-10 Finland
Poisoning by systemic antibiotics
3.1
25.9
116
399
QBD20
NOMESCO Finland
Excision of burn of trunk and coverage
49.2
24.3
29
6
N02AX02
ATC
tramadol; systemic, rectal
1.7
23.8
635
4405
T23.4
ICD-10 Finland
Corrosion of unspecified degree of wrist and hand
+∞
23.0
22
*
QAD00
NOMESCO Finland
Dressing of major burn of head or neck
233.2
22.7
23
*
X00
ICD-10 Finland
Exposure to uncontrolled fire in building or structure
29.5
21.9
29
10
J01DB01
ATC
cefalexin; oral
1.9
21.9
1339
11550
N07BB01
ATC
disulfiram; oral
2.9
21.3
105
381
N02BE01
ATC
paracetamol; systemic, rectal
2.0
21.0
1381
12080
T21.1
ICD-10 Finland
Burn of first degree of trunk
24.6
20.9
29
12
T95.2
ICD-10 Finland
Sequelae of burn, corrosion and frostbite of upper limb
77.8
20.7
23
*
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.7
20.3
462
3036
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
2.4
20.2
143
622
S06.0
ICD-10 Finland
Concussion
2.1
19.8
215
1114
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
4.1
19.6
54
135
X06
ICD-10 Finland
Exposure to ignition or melting of other clothing and apparel
106.4
19.6
21
*
T22.0
ICD-10 Finland
Burn of unspecified degree of shoulder and upper limb, except wrist and hand
20.3
19.1
28
14
W22
ICD-10 Finland
Striking against or struck by other object(s)
2.2
19.0
162
763
T22.1
ICD-10 Finland
Burn of first degree of shoulder and upper limb, except wrist and hand
28.2
18.7
25
9
T23
ICD-10 Finland
Burn and corrosion of wrist and hand
44.5
18.3
22
5
T21.0
ICD-10 Finland
Burn of unspecified degree of trunk
33.3
18.0
23
7
X01
ICD-10 Finland
Exposure to uncontrolled fire, not in building or structure
181.9
17.5
18
*
P15
ICPC
Chronic alcohol abuse
3.0
17.4
79
274
AA1AD
NOMESCO Finland
CT of head and brain
1.7
17.2
377
2436
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.8
17.2
311
1904
N05AH04
ATC
quetiapine; oral
1.8
17.2
330
2056
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
2.1
17.1
179
913
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
2.9
17.0
82
294
T31.1
ICD-10 Finland
Burns involving 10-19% of body surface
50.6
17.0
20
*
Y94.0
ICD-10 Finland
Accident at home
4.3
16.7
43
102
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.8
16.7
84
308
SPAT1149
SPAT
Suture or treatment of traumatic wound
2.1
16.5
179
925
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.6
16.2
641
4782
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
4.2
16.1
43
105
T24.0
ICD-10 Finland
Burn of unspecified degree of hip and lower limb, except ankle and foot
26.6
15.6
21
8
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.8
15.5
291
1795
N02AJ06
ATC
codeine and paracetamol; systemic
1.5
15.5
674
5122
M79.6
ICD-10 Finland
Pain in limb
1.5
15.3
659
4994
QDD20
NOMESCO Finland
Excision of burn of lower limb and coverage
17.9
15.2
23
13
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.7
15.1
377
2512
QCE25
NOMESCO Finland
Excision and repair of scar of upper limb caused by burn
57.2
14.8
17
*
T24.1
ICD-10 Finland
Burn of first degree of hip and lower limb, except ankle and foot
25.3
14.7
20
8
T22.3
ICD-10 Finland
Burn of third degree of shoulder and upper limb, except wrist and hand
42.9
14.1
17
*
M01AB05
ATC
diclofenac; systemic, rectal
1.5
13.8
963
8006
X76
ICD-10 Finland
Intentional self-harm by smoke, fire and flames
53.8
13.8
16
*
F10.20
ICD-10 Finland
Alcohol dependence currently independent
3.3
13.7
51
157
T29.3
ICD-10 Finland
Burns of multiple regions, at least one burn of third degree mentioned
75.8
13.6
15
*
S61.0
ICD-10 Finland
Open wound of finger(s) without damage to nail
1.9
13.5
186
1042
J01FF01
ATC
clindamycin; systemic
1.6
13.3
387
2666
L12
ICPC
Hand/finger symptom/complaint
1.7
13.2
292
1879
M03BC01
ATC
orphenadrine (citrate); systemic
1.6
13.2
342
2292
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.7
12.8
242
1491
Z42.3
ICD-10 Finland
Follow-up care involving plastic surgery of upper extremity
70.4
12.6
14
*
J01DA01
ATC
[U] cefalexin
1.5
12.6
887
7330
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.6
12.5
328
2200
T23.6
ICD-10 Finland
Corrosion of second degree of wrist and hand
+∞
12.5
12
*
ZZA40
NOMESCO Finland
Graft of synthetic skin substitute
131.0
12.4
13
*
T23.7
ICD-10 Finland
Corrosion of third degree of wrist and hand
131.0
12.4
13
*
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.5
12.3
732
5846
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
4.3
12.2
31
73
M54.5
ICD-10 Finland
Low back pain
1.5
12.2
562
4268
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
3.0
11.9
53
182
QCB05
NOMESCO Finland
Revision of wound of skin of upper limb
4.9
11.9
26
54
QBD10
NOMESCO Finland
Debridement of burn of trunk
65.4
11.6
13
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.5
11.6
552
4208
W19
ICD-10 Finland
Unspecified fall
1.9
11.3
160
903
N05AA02
ATC
levomepromazine; systemic
2.5
11.2
69
281
F10.09
ICD-10 Finland
Alcohol intoxication UNS
3.1
11.2
47
156
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
3.4
11.1
40
121
R05
ICPC
Cough
1.5
11.1
380
2703
T21.3
ICD-10 Finland
Burn of third degree of trunk
28.2
10.7
14
5
F10.24
ICD-10 Finland
Alcohol depence active use
3.3
10.7
40
124
N06AB10
ATC
escitalopram; oral
1.5
10.6
342
2400
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.4
10.6
851
7109
N05BA04
ATC
oxazepam; oral
1.5
10.5
354
2504
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
4.0
10.5
29
73
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.4
10.5
623
4929
M01AE03
ATC
ketoprofen; systemic, rectal
1.5
10.4
455
3396
N06AX11
ATC
mirtazapine; oral
1.5
10.4
482
3640
T74.1
ICD-10 Finland
Physical abuse
2.9
10.4
48
169
S97
ICPC
Chronic ulcer skin
2.3
10.3
82
375
M01AH05
ATC
etoricoxib; oral
1.4
10.3
912
7732
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.5
10.2
393
2859
M25.5
ICD-10 Finland
Pain in joint
1.5
10.2
494
3759
NA1AD
NOMESCO Finland
Cervical spine CT examination
2.2
10.1
80
366
SPAT1255
SPAT
Intravenous administration of medicine
2.2
10.0
88
421
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
3.9
9.9
28
72
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
3.0
9.8
43
147
F10.25
ICD-10 Finland
Alcohol dependence continuous use
3.1
9.8
39
126
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.7
9.8
187
1153
J01AA02
ATC
doxycycline; systemic
1.4
9.8
1067
9341
SPAT1254
SPAT
Administration of medicine
1.7
9.7
211
1345
QXD00
NOMESCO Finland
Exchange of dressing for burn, unspecified location
55.3
9.7
11
*
B18.2
ICD-10 Finland
Chronic viral hepatitis C
3.4
9.6
34
102
N03AX16
ATC
[U] pregabalin
1.5
9.5
288
1987
NDQ20
NOMESCO Finland
Amputation of finger
10.1
9.5
18
18
SAA01
NOMESCO Finland
Simple examination of mouth
1.4
9.4
1172
10461
T29.0
ICD-10 Finland
Burns of multiple regions, unspecified degree
100.6
9.4
10
*
W40
ICD-10 Finland
Explosion of other materials
30.2
9.4
12
*
A46
ICD-10 Finland
Erysipelas
1.7
9.4
188
1174
WX290
NOMESCO Finland
Other blockage of nerve
1.4
9.3
819
6883
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.0
9.3
101
522
S40.0
ICD-10 Finland
Contusion of shoulder and upper arm
2.1
9.3
84
406
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.7
9.2
194
1227
QC6S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in hand
13.8
9.2
15
11
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.4
9.2
465
3556
A02BC02
ATC
pantoprazole; systemic
1.4
9.1
924
7937
Y04.8
ICD-10 Finland
Assault by bodily force by other known person
5.0
9.1
19
38
QCE20
NOMESCO Finland
Excision and repair of scar or web of skin of upper limb
15.7
9.0
14
9
QAD20
NOMESCO Finland
Excision of burn of head or neck and coverage
36.9
9.0
11
*
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
1.6
9.0
198
1267
L08
ICPC
Shoulder symptom/complaint
1.5
9.0
315
2243
R56.8
ICD-10 Finland
Other and unspecified convulsions
2.1
8.9
87
433
N05BA01
ATC
diazepam; systemic, rectal
1.7
8.9
167
1025
ZXE10
NOMESCO Finland
More than one and less than three hours
1.4
8.8
452
3458
S69.9
ICD-10 Finland
Unspecified injury of wrist and hand
2.9
8.8
41
145
S61.9
ICD-10 Finland
Open wound of wrist and hand, part unspecified
2.3
8.8
63
276
ACC53
NOMESCO Finland
Release of ulnar nerve
3.5
8.8
30
88
D11
ICPC
Diarrhoea
1.6
8.8
201
1298
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.8
8.7
136
791
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.7
8.7
160
975
WX408
NOMESCO Finland
General anesthesy, balanced
1.5
8.7
360
2647
Y94.8
ICD-10 Finland
Other leisure activity accident
2.5
8.7
51
204
QCB10, ,
SPAT
4.0
8.6
24
61
F10.31
ICD-10 Finland
Withdrawal symptoms caused by alcohol with seizures
4.6
8.6
20
44
S20.2
ICD-10 Finland
Contusion of thorax
2.0
8.6
87
439
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.6
8.6
186
1185
R51.80
ICD-10 Finland
Headache
1.5
8.5
256
1761
SPAT1265
SPAT
Breathalyser
3.8
8.5
25
66
M01AE01
ATC
ibuprofen; systemic, rectal
1.6
8.5
1416
13205
Y96.0
ICD-10 Finland
Work-related condition
3.2
8.5
32
100
M03BX02
ATC
tizanidine; oral
1.4
8.5
893
7678
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.5
8.5
347
2545
R50.9
ICD-10 Finland
Fever, unspecified
1.6
8.5
239
1622
K02.1
ICD-10 Finland
Caries of dentine
1.4
8.5
966
8413
M94.0
ICD-10 Finland
Chondrocostal junction syndrome [Tietze]
3.0
8.4
37
127
T25.2
ICD-10 Finland
Burn of second degree of ankle and foot
8.6
8.3
17
20
R02
ICPC
Shortness of breath/dyspnoea
1.6
8.3
176
1115
ZXD05
NOMESCO Finland
Urgent procedure
1.4
8.2
411
3126
R42
ICD-10 Finland
Dizziness and giddiness
1.5
8.2
271
1903
P29
ICPC
Psychological sympt/compl other
1.7
8.2
152
930
R83
ICPC
Respiratory infection other
1.4
8.2
457
3544
T30.0
ICD-10 Finland
Burn of unspecified body region, unspecified degree
11.8
8.1
14
12
S01.0
ICD-10 Finland
Open wound of scalp
1.8
8.1
113
637
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.7
8.0
147
897
D01
ICPC
Abdominal pain/cramps general
1.6
8.0
201
1329
WX110
NOMESCO Finland
Infiltration anesthesia
1.4
7.9
1133
10169
SPAT1283
SPAT
Restricted health certificate
1.5
7.9
313
2280
N05CF01
ATC
zopiclone; oral
1.4
7.9
379
2861
P01
ICPC
Feeling anxious/nervous/tense
1.5
7.9
254
1774
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.5
7.8
308
2238
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
1.6
7.7
203
1355
F41.09
ICD-10 Finland
UNS Panic Syndrome
2.2
7.7
60
274
M54.2
ICD-10 Finland
Cervicalgia
1.8
7.6
122
717
TNX32
NOMESCO Finland
Custom moulded splint, unspecified region
2.0
7.5
75
377
S22.3
ICD-10 Finland
Fracture of rib
1.8
7.5
108
614
WX200
NOMESCO Finland
Interscalenous plexus blockade
2.8
7.4
36
131
T24.3
ICD-10 Finland
Burn of third degree of hip and lower limb, except ankle and foot
13.4
7.4
12
9
N03AX12
ATC
[U] gabapentin; oral
1.6
7.4
200
1344
Z3231
NOMESCO Finland
Registered nurse
1.4
7.3
374
2847
S93.4
ICD-10 Finland
Sprain and strain of ankle
1.5
7.3
205
1387
WZC00, ,
SPAT
1.5
7.3
224
1546
ZXA00
NOMESCO Finland
Right side
1.5
7.3
295
2154
R07.4
ICD-10 Finland
Chest pain, unspecified
1.4
7.3
351
2647
QCB00
NOMESCO Finland
Suture of skin of upper limb
2.9
7.2
32
111
QDD10
NOMESCO Finland
Debridement of burn of lower limb
30.1
7.1
9
*
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.5
7.1
241
1697
F43.1
ICD-10 Finland
Post-traumatic stress disorder
2.2
7.1
55
250
S13.4
ICD-10 Finland
Sprain and strain of cervical spine
2.0
7.1
75
386
Z00.0
ICD-10 Finland
General medical examination
1.5
7.0
276
2002
L17
ICPC
Foot/toe symptom/complaint
1.4
7.0
420
3282
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.4
7.0
374
2867
T50.9
ICD-10 Finland
Poisoning: Other and unspecified drugs, medicaments and biological substances
7.0
7.0
16
23
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
3.0
6.9
29
97
N03AX09
ATC
lamotrigine; oral
1.9
6.9
87
474
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
2.9
6.9
31
108
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.6
6.8
182
1217
SPAT1260
SPAT
Consultation of another employee
1.5
6.8
219
1527
Z29
ICPC
Social problem NOS
2.5
6.8
40
161
Z53.2
ICD-10 Finland
Procedure not carried out because of patient's decision for other and unspecified reasons
2.7
6.8
34
126
X84
ICD-10 Finland
Intentional self-harm by unspecified means
6.1
6.8
17
28
T30.2
ICD-10 Finland
Burn of second degree, body region unspecified
40.2
6.8
8
*
ZXE00
NOMESCO Finland
One hour or less
1.3
6.7
516
4187
T20.3
ICD-10 Finland
Burn of third degree of head and neck
22.6
6.7
9
*
W85
ICD-10 Finland
Exposure to electric transmission lines
22.6
6.7
9
*
N05AF03
ATC
chlorprothixene; systemic
2.4
6.6
42
175
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
1.9
6.6
86
474
N30.0
ICD-10 Finland
Acute cystitis
1.5
6.6
202
1393
G57.3
ICD-10 Finland
Lesion of lateral popliteal nerve
3.2
6.6
25
79
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
2.3
6.6
47
207
SPAT1263
SPAT
Sampling
1.3
6.5
572
4727
S80.0
ICD-10 Finland
Contusion of knee
1.7
6.5
119
726
S63.6
ICD-10 Finland
Sprain and strain of finger(s)
2.0
6.5
72
377
ZZA10
NOMESCO Finland
Split skin allograft
70.1
6.4
7
*
M01AE02
ATC
naproxen; oral, rectal
1.3
6.4
828
7211
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.5
6.4
177
1194
R74
ICPC
Upper respiratory infection acute
1.3
6.4
565
4672
R03AC02
ATC
salbutamol; inhalant
1.3
6.4
794
6880
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
2.1
6.3
58
283
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.6
6.3
148
962
SGB10
NOMESCO Finland
Root filling of tooth with one root canal
1.6
6.3
165
1100
N05AH03
ATC
olanzapine; systemic
1.7
6.3
109
655
T95.1
ICD-10 Finland
Sequelae of burn, corrosion and frostbite of trunk
+∞
6.3
6
*
F43.9
ICD-10 Finland
Reaction to severe stress, unspecified
2.2
6.2
51
238
S29
ICPC
Skin symptom/complaint other
1.4
6.2
271
2002
EBA00
NOMESCO Finland
Extraction of tooth
1.3
6.2
573
4763
Z50.1
ICD-10 Finland
Other physical therapy
2.0
6.2
64
327
B35.3
ICD-10 Finland
Tinea pedis
1.9
6.1
70
370
L03
ICPC
Low back symptom/complaint
1.3
6.1
411
3260
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
2.2
6.1
51
240
G56.0
ICD-10 Finland
Carpal tunnel syndrome
1.5
6.1
176
1198
ZXD10
NOMESCO Finland
Scheduled procedure
1.3
6.1
464
3750
SFA30
NOMESCO Finland
Three-surface restoration
1.3
6.1
589
4924
N02BF02
ATC
pregabalin; oral
1.8
6.1
89
510
R06.4
ICD-10 Finland
Hyperventilation
2.9
6.1
27
94
G83.4
ICD-10 Finland
Cauda equina syndrome
8.6
6.1
12
14
X78
ICD-10 Finland
Intentional self-harm by sharp object
3.4
6.0
21
63
TimeCodeWAS
↥TODO / Current known limitations:
- Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
- Legend / how to read the glyphs.
- Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
- Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
- Download CSV.
- No filters and sorters.
- Limited amount of endpoints (~400) having TimeCodeWAS data.
- Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Emergency Room Visit
ER [9203]
ER [9203]
6.3e-01
7.9e-01
1.8e+00
7.9e+00
2.3e+00
8.5e-01
7.2e-01
cases:45.98%
controls:31.30%
cases:21.50%
controls:11.02%
cases:7.42%
controls:1.29%
cases:57.33%
controls:0.05%
cases:11.77%
controls:1.31%
cases:21.28%
controls:10.33%
cases:43.58%
controls:27.31%
709
4824
833
10589
333
1705
1216
13770
115
200
1434
15275
888
8
661
15467
182
203
1364
15242
316
1549
1169
13446
580
3656
751
9730
Emergency Medicine
93 [38004510]
93 [38004510]
4.7e-01
6.3e-01
1.5e+00
7.2e+00
2.0e+00
6.1e-01
6.4e-01
cases:17.06%
controls:11.38%
cases:11.23%
controls:6.29%
cases:3.10%
controls:0.72%
cases:30.08%
controls:0.03%
cases:5.69%
controls:0.81%
cases:11.04%
controls:6.34%
cases:31.03%
controls:19.14%
263
1754
1279
13659
174
973
1375
14502
48
111
1501
15364
466
5
1083
15470
88
125
1458
15320
164
950
1321
14045
413
2562
918
10824
Exposure to unspecified factor
X59 [45756412]
X59 [45756412]
7.7e-01
1.2e+00
2.8e+00
1.0e+50
3.8e+00
1.8e+00
9.9e-01
cases:4.47%
controls:2.13%
cases:2.07%
controls:0.63%
cases:0.77%
controls:0.05%
cases:8.07%
controls:0.00%
cases:3.49%
controls:0.08%
cases:4.38%
controls:0.73%
cases:6.69%
controls:2.59%
69
328
1473
15085
32
98
1517
15377
12
7
1537
15468
125
0
1424
15475
54
13
1492
15432
65
110
1420
14885
89
347
1242
13039
Plastic And Reconstructive Surgery
24 [38004467]
24 [38004467]
1.5e-01
5.7e-01
2.5e+00
—
4.8e+00
2.6e+00
1.0e+00
cases:2.66%
controls:2.30%
cases:1.48%
controls:0.85%
cases:1.94%
controls:0.17%
—
—
cases:16.69%
controls:0.16%
cases:10.57%
controls:0.85%
cases:6.24%
controls:2.29%
41
355
1501
15058
23
131
1526
15344
30
26
1519
15449
—
258
25
1288
15420
157
128
1328
14867
83
306
1248
13080
Inpatient Hospital
21 [8717]
21 [8717]
2.9e-01
3.7e-01
1.1e+00
6.0e+00
2.0e+00
5.8e-01
5.0e-01
cases:33.46%
controls:27.27%
cases:12.98%
controls:9.36%
cases:3.62%
controls:1.25%
cases:14.72%
controls:0.05%
cases:7.96%
controls:1.16%
cases:13.80%
controls:8.23%
cases:29.38%
controls:20.14%
516
4203
1026
11210
201
1449
1348
14026
56
193
1493
15282
228
7
1321
15468
123
179
1423
15266
205
1234
1280
13761
391
2696
940
10690
Exposure to other specified factors
X58 [45756411]
X58 [45756411]
7.9e-01
1.1e+00
2.4e+00
1.0e+50
3.7e+00
1.5e+00
7.6e-01
cases:3.37%
controls:1.56%
cases:1.61%
controls:0.54%
cases:0.77%
controls:0.07%
cases:8.33%
controls:0.00%
cases:2.85%
controls:0.07%
cases:2.29%
controls:0.53%
cases:4.58%
controls:2.20%
52
241
1490
15172
25
84
1524
15391
12
11
1537
15464
129
0
1420
15475
44
11
1502
15434
34
80
1451
14915
61
294
1270
13092
Person encountering health services in unspecified circumstances
Z76.9 [45609967]
Z76.9 [45609967]
1.1e+00
1.4e+00
2.9e+00
—
2.3e+00
1.5e+00
7.0e-01
cases:2.27%
controls:0.74%
cases:1.10%
controls:0.26%
cases:0.58%
controls:0.03%
—
—
cases:0.45%
controls:0.05%
cases:0.94%
controls:0.21%
cases:2.18%
controls:1.10%
35
114
1507
15299
17
41
1532
15434
9
5
1540
15470
—
7
7
1539
15438
14
31
1471
14964
29
147
1302
13239
Burn/scald
S14 [2002000979]
S14 [2002000979]
1.4e+00
2.9e+00
—
1.0e+50
1.0e+50
3.9e+00
1.7e+00
cases:0.97%
controls:0.23%
cases:0.84%
controls:0.05%
—
—
cases:2.97%
controls:0.00%
cases:18.69%
controls:0.00%
cases:2.83%
controls:0.06%
cases:1.58%
controls:0.29%
15
36
1527
15377
13
7
1536
15468
—
46
0
1503
15475
289
0
1257
15445
42
9
1443
14986
21
39
1310
13347
codeine and paracetamol
N02AJ06 [1123647]
N02AJ06 [1123647]
4.5e-01
5.5e-01
1.0e+00
4.3e+00
2.0e+00
6.6e-01
5.6e-01
cases:17.96%
controls:12.20%
cases:7.81%
controls:4.65%
cases:2.00%
controls:0.73%
cases:2.32%
controls:0.03%
cases:5.05%
controls:0.73%
cases:7.88%
controls:4.22%
cases:19.83%
controls:12.39%
277
1881
1265
13532
121
719
1428
14756
31
113
1518
15362
36
5
1513
15470
78
113
1468
15332
117
633
1368
14362
264
1659
1067
11727
Treatment of chronic ulcer or burn
SPAT1148 [2001700249]
SPAT1148 [2001700249]
4.5e-01
9.8e-01
2.4e+00
—
4.6e+00
1.5e+00
4.6e-01
cases:1.69%
controls:1.08%
cases:1.23%
controls:0.47%
cases:1.10%
controls:0.10%
—
—
cases:9.70%
controls:0.11%
cases:2.09%
controls:0.48%
cases:1.95%
controls:1.25%
26
167
1516
15246
19
72
1530
15403
17
16
1532
15459
—
150
17
1396
15428
31
72
1454
14923
26
167
1305
13219
Outpatient Hospital
22 [8756]
22 [8756]
2.2e-01
3.3e-01
7.2e-01
4.8e+00
2.0e+00
5.9e-01
4.7e-01
cases:24.25%
controls:20.40%
cases:8.46%
controls:6.24%
cases:1.74%
controls:0.86%
cases:6.39%
controls:0.06%
cases:5.24%
controls:0.72%
cases:9.43%
controls:5.47%
cases:21.11%
controls:14.31%
374
3144
1168
12269
131
965
1418
14510
27
133
1522
15342
99
9
1450
15466
81
111
1465
15334
140
820
1345
14175
281
1916
1050
11470
ibuprofen
R02AX02 [1588667]
R02AX02 [1588667]
2.9e-01
3.4e-01
9.3e-01
4.4e+00
1.9e+00
5.3e-01
4.9e-01
cases:41.96%
controls:35.17%
cases:20.98%
controls:15.96%
cases:4.78%
controls:1.95%
cases:4.13%
controls:0.05%
cases:12.68%
controls:2.04%
cases:23.16%
controls:15.10%
cases:49.66%
controls:37.56%
647
5420
895
9993
325
2470
1224
13005
74
301
1475
15174
64
8
1485
15467
196
315
1350
15130
344
2264
1141
12731
661
5028
670
8358
ibuprofen; oral, parenteral, rectal
M01AE01 [21603967]
M01AE01 [21603967]
2.9e-01
3.4e-01
9.3e-01
4.4e+00
1.9e+00
5.3e-01
4.9e-01
cases:41.96%
controls:35.17%
cases:20.98%
controls:15.96%
cases:4.78%
controls:1.95%
cases:4.13%
controls:0.05%
cases:12.68%
controls:2.04%
cases:23.16%
controls:15.10%
cases:49.66%
controls:37.56%
647
5420
895
9993
325
2470
1224
13005
74
301
1475
15174
64
8
1485
15467
196
315
1350
15130
344
2264
1141
12731
661
5028
670
8358
General Practice
1 [38004446]
1 [38004446]
7.3e-01
1.1e+00
1.6e+00
—
2.7e+00
9.9e-01
6.3e-01
cases:19.84%
controls:10.69%
cases:10.20%
controls:3.72%
cases:2.71%
controls:0.56%
—
—
cases:6.53%
controls:0.46%
cases:10.64%
controls:4.23%
cases:19.23%
controls:11.27%
306
1648
1236
13765
158
575
1391
14900
42
86
1507
15389
—
101
71
1445
15374
158
634
1327
14361
256
1508
1075
11878
Occupational therapy
R4120 [2001310234]
R4120 [2001310234]
9.5e-01
1.2e+00
2.2e+00
—
—
3.4e+00
1.2e+00
cases:1.36%
controls:0.53%
cases:0.58%
controls:0.17%
cases:0.39%
controls:0.05%
—
—
—
—
cases:3.30%
controls:0.11%
cases:1.88%
controls:0.56%
21
82
1521
15331
9
26
1540
15449
6
7
1543
15468
—
—
49
17
1436
14978
25
75
1306
13311
General Surgery
2 [38004447]
2 [38004447]
4.6e-01
6.6e-01
1.9e+00
—
3.0e+00
1.0e+00
4.6e-01
cases:21.98%
controls:15.05%
cases:8.07%
controls:4.35%
cases:3.68%
controls:0.58%
—
—
cases:13.13%
controls:0.71%
cases:10.84%
controls:4.23%
cases:17.73%
controls:11.98%
339
2319
1203
13094
125
673
1424
14802
57
90
1492
15385
—
203
110
1343
15335
161
635
1324
14360
236
1604
1095
11782
Physiotherapist
Z3226 [2001311560]
Z3226 [2001311560]
4.9e-01
2.5e-01
1.9e+00
1.0e+50
2.9e+00
1.6e+00
1.0e+00
cases:3.37%
controls:2.09%
cases:0.71%
controls:0.56%
cases:0.52%
controls:0.08%
cases:1.36%
controls:0.00%
cases:1.88%
controls:0.10%
cases:2.22%
controls:0.46%
cases:2.63%
controls:0.99%
52
322
1490
15091
11
86
1538
15389
8
12
1541
15463
21
0
1528
15475
29
16
1517
15429
33
69
1452
14926
35
132
1296
13254
Mental and behavioural disorders due to use of alcohol, Harmful use
F10.1 [45595844]
F10.1 [45595844]
1.0e+00
1.2e+00
2.1e+00
—
—
1.6e+00
1.4e+00
cases:2.27%
controls:0.83%
cases:1.16%
controls:0.35%
cases:0.58%
controls:0.07%
—
—
—
—
cases:1.68%
controls:0.34%
cases:3.46%
controls:0.86%
35
128
1507
15285
18
54
1531
15421
9
11
1540
15464
—
—
25
51
1460
14944
46
115
1285
13271
Psychiatry
26 [38004469]
26 [38004469]
6.1e-01
7.9e-01
7.3e-01
2.4e+00
1.0e+00
8.9e-01
8.3e-01
cases:11.28%
controls:6.47%
cases:7.30%
controls:3.44%
cases:2.97%
controls:1.45%
cases:0.71%
controls:0.06%
cases:4.01%
controls:1.51%
cases:7.88%
controls:3.39%
cases:14.65%
controls:6.98%
174
997
1368
14416
113
532
1436
14943
46
224
1503
15251
11
10
1538
15465
62
233
1484
15212
117
508
1368
14487
195
935
1136
12451
Laceration/cut
S18 [2002000983]
S18 [2002000983]
4.5e-01
6.8e-01
1.6e+00
2.3e+00
2.9e+00
9.0e-01
5.9e-01
cases:8.95%
controls:5.90%
cases:4.26%
controls:2.20%
cases:1.42%
controls:0.29%
cases:0.32%
controls:0.03%
cases:5.11%
controls:0.30%
cases:4.92%
controls:2.07%
cases:12.40%
controls:7.28%
138
910
1404
14503
66
340
1483
15135
22
45
1527
15430
5
5
1544
15470
79
47
1467
15398
73
310
1412
14685
165
974
1166
12412
Hand Surgery
40 [38004480]
40 [38004480]
4.3e-01
7.2e-01
1.8e+00
—
2.5e+00
1.2e+00
5.3e-01
cases:3.50%
controls:2.31%
cases:1.81%
controls:0.89%
cases:0.77%
controls:0.13%
—
—
cases:1.55%
controls:0.13%
cases:2.76%
controls:0.86%
cases:5.11%
controls:3.09%
54
356
1488
15057
28
137
1521
15338
12
20
1537
15455
—
24
20
1522
15425
41
129
1444
14866
68
413
1263
12973
Supplier / Service Provider
OMOP5117446 [33004]
OMOP5117446 [33004]
-6.9e-01
-8.0e-01
-9.7e-01
—
2.3e+00
2.6e+00
3.0e+00
cases:15.37%
controls:26.49%
cases:4.26%
controls:8.98%
cases:0.32%
controls:0.85%
—
—
cases:0.52%
controls:0.05%
cases:4.98%
controls:0.41%
cases:15.10%
controls:0.84%
237
4083
1305
11330
66
1390
1483
14085
5
131
1544
15344
—
8
8
1538
15437
74
61
1411
14934
201
113
1130
13273
paracetamol; oral, parenteral, rectal
N02BE01 [21604344]
N02BE01 [21604344]
3.7e-01
4.3e-01
3.8e-01
2.8e+00
1.7e+00
6.2e-01
5.3e-01
cases:35.34%
controls:27.39%
cases:20.01%
controls:13.98%
cases:3.42%
controls:2.37%
cases:2.00%
controls:0.13%
cases:10.22%
controls:2.13%
cases:23.16%
controls:13.95%
cases:46.73%
controls:33.95%
545
4222
997
11191
310
2163
1239
13312
53
367
1496
15108
31
20
1518
15455
158
329
1388
15116
344
2092
1141
12903
622
4545
709
8841
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
1988-5 [3020460]
1.9e-01
2.6e-01
7.6e-01
3.2e+00
1.2e+00
4.3e-01
4.5e-01
cases:27.95%
controls:24.36%
cases:19.24%
controls:15.49%
cases:5.68%
controls:2.75%
cases:4.78%
controls:0.21%
cases:8.93%
controls:2.86%
cases:21.82%
controls:15.42%
cases:46.73%
controls:35.87%
431
3755
1111
11658
298
2397
1251
13078
88
426
1461
15049
74
32
1475
15443
138
441
1408
15004
324
2312
1161
12683
622
4801
709
8585
Medical doctor
Z2221 [2001311556]
Z2221 [2001311556]
1.5e-01
2.8e-01
1.4e+00
—
2.8e+00
1.1e+00
8.4e-01
cases:4.73%
controls:4.09%
cases:1.61%
controls:1.23%
cases:0.71%
controls:0.17%
—
—
cases:1.81%
controls:0.11%
cases:2.96%
controls:1.03%
cases:4.58%
controls:2.04%
73
631
1469
14782
25
190
1524
15285
11
26
1538
15449
—
28
17
1518
15428
44
154
1441
14841
61
273
1270
13113
Poisoning by systemic antibiotics
T36 [45756588]
T36 [45756588]
1.2e+00
1.5e+00
—
—
—
1.7e+00
1.7e+00
cases:1.82%
controls:0.55%
cases:0.97%
controls:0.21%
—
—
—
—
—
—
cases:1.08%
controls:0.21%
cases:2.55%
controls:0.49%
28
85
1514
15328
15
33
1534
15442
—
—
—
16
31
1469
14964
34
65
1297
13321
cefalexin; oral
J01DB01 [21602870]
J01DB01 [21602870]
3.7e-01
4.4e-01
1.6e+00
—
2.6e+00
5.5e-01
5.0e-01
cases:35.73%
controls:27.76%
cases:13.23%
controls:8.94%
cases:4.97%
controls:1.01%
—
—
cases:12.29%
controls:1.08%
cases:13.67%
controls:8.39%
cases:37.34%
controls:26.52%
551
4278
991
11135
205
1383
1344
14092
77
156
1472
15319
—
190
167
1356
15278
203
1258
1282
13737
497
3550
834
9836
Outpatient Visit
OP [9202]
OP [9202]
1.8e-01
1.4e-01
4.3e-01
3.1e+00
1.5e+00
3.9e-01
3.6e-01
cases:69.46%
controls:65.58%
cases:47.77%
controls:44.27%
cases:14.33%
controls:9.80%
cases:9.36%
controls:0.45%
cases:32.86%
controls:9.60%
cases:53.80%
controls:44.10%
cases:79.19%
controls:72.72%
1071
10108
471
5305
740
6851
809
8624
222
1517
1327
13958
145
69
1404
15406
508
1483
1038
13962
799
6613
686
8382
1054
9734
277
3652
Internal Medicine
11 [38004456]
11 [38004456]
2.1e-01
1.0e-01
8.0e-01
3.5e+00
7.6e-01
3.7e-01
4.4e-01
cases:21.21%
controls:17.90%
cases:8.97%
controls:8.16%
cases:2.71%
controls:1.24%
cases:1.61%
controls:0.05%
cases:2.52%
controls:1.20%
cases:10.77%
controls:7.69%
cases:23.82%
controls:16.79%
327
2759
1215
12654
139
1263
1410
14212
42
192
1507
15283
25
8
1524
15467
39
185
1507
15260
160
1153
1325
13842
317
2247
1014
11139
Other specified counselling
Z71.8 [45581061]
Z71.8 [45581061]
3.2e-01
5.0e-01
1.4e+00
2.5e+00
1.9e+00
4.1e-01
2.7e-01
cases:4.86%
controls:3.59%
cases:3.10%
controls:1.91%
cases:0.84%
controls:0.21%
cases:0.39%
controls:0.03%
cases:1.29%
controls:0.19%
cases:2.96%
controls:1.99%
cases:8.94%
controls:6.95%
75
553
1467
14860
48
295
1501
15180
13
33
1536
15442
6
5
1543
15470
20
29
1526
15416
44
298
1441
14697
119
930
1212
12456
Bacteria identified in Skin by Aerobe culture
620-5 [3007853]
620-5 [3007853]
1.4e-01
1.1e+00
2.1e+00
1.0e+50
2.6e+00
8.0e-01
4.3e-01
cases:2.01%
controls:1.75%
cases:1.74%
controls:0.60%
cases:0.58%
controls:0.07%
cases:0.45%
controls:0.00%
cases:1.62%
controls:0.12%
cases:1.41%
controls:0.64%
cases:3.53%
controls:2.32%
31
270
1511
15143
27
93
1522
15382
9
11
1540
15464
7
0
1542
15475
25
19
1521
15426
21
96
1464
14899
47
310
1284
13076
clindamycin; oral, parenteral
J01FF01 [21602985]
J01FF01 [21602985]
6.5e-01
6.1e-01
1.6e+00
—
2.8e+00
3.9e-01
6.8e-01
cases:5.06%
controls:2.72%
cases:1.42%
controls:0.78%
cases:0.52%
controls:0.10%
—
—
cases:1.29%
controls:0.08%
cases:1.14%
controls:0.78%
cases:5.86%
controls:3.07%
78
419
1464
14994
22
120
1527
15355
8
16
1541
15459
—
20
12
1526
15433
17
117
1468
14878
78
411
1253
12975
disulfiram; oral
N07BB01 [21604821]
N07BB01 [21604821]
1.4e+00
1.5e+00
—
—
—
1.4e+00
1.4e+00
cases:2.08%
controls:0.51%
cases:0.84%
controls:0.19%
—
—
—
—
—
—
cases:1.01%
controls:0.25%
cases:2.18%
controls:0.56%
32
78
1510
15335
13
29
1536
15446
—
—
—
15
37
1470
14958
29
75
1302
13311
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
62238-1 [40764999]
1.7e-01
2.8e-01
6.5e-01
3.2e+00
9.2e-01
2.7e-01
3.4e-01
cases:20.82%
controls:18.08%
cases:17.69%
controls:13.93%
cases:5.16%
controls:2.75%
cases:2.71%
controls:0.11%
cases:6.79%
controls:2.82%
cases:18.45%
controls:14.70%
cases:38.77%
controls:31.10%
321
2787
1221
12626
274
2156
1275
13319
80
426
1469
15049
42
17
1507
15458
105
436
1441
15009
274
2205
1211
12790
516
4163
815
9223
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
2951-2 [3019550]
1.5e-01
2.3e-01
4.7e-01
3.3e+00
1.1e+00
2.7e-01
2.9e-01
cases:27.04%
controls:24.28%
cases:20.98%
controls:17.45%
cases:5.04%
controls:3.20%
cases:4.20%
controls:0.17%
cases:8.02%
controls:2.95%
cases:22.49%
controls:18.07%
cases:44.63%
controls:37.66%
417
3742
1125
11671
325
2700
1224
12775
78
495
1471
14980
65
26
1484
15449
124
456
1422
14989
334
2710
1151
12285
594
5041
737
8345
Mixed anxiety and depressive disorder
F41.2 [45566845]
F41.2 [45566845]
7.4e-01
9.9e-01
—
—
2.0e+00
9.8e-01
7.6e-01
cases:2.40%
controls:1.15%
cases:1.36%
controls:0.51%
—
—
—
—
cases:0.71%
controls:0.10%
cases:1.48%
controls:0.56%
cases:3.98%
controls:1.90%
37
178
1505
15235
21
79
1528
15396
—
—
11
15
1535
15430
22
84
1463
14911
53
255
1278
13131
quetiapine; oral
N05AH04 [21604544]
N05AH04 [21604544]
7.7e-01
8.6e-01
1.2e+00
—
8.8e-01
9.4e-01
8.2e-01
cases:6.55%
controls:3.14%
cases:4.71%
controls:2.05%
cases:1.68%
controls:0.51%
—
—
cases:1.36%
controls:0.57%
cases:4.85%
controls:1.96%
cases:8.64%
controls:4.01%
101
484
1441
14929
73
317
1476
15158
26
79
1523
15396
—
21
88
1525
15357
72
294
1413
14701
115
537
1216
12849
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
N02AX02 [21604298]
5.5e-01
4.3e-01
1.0e+00
—
2.2e+00
6.5e-01
7.3e-01
cases:9.99%
controls:6.01%
cases:3.68%
controls:2.42%
cases:1.55%
controls:0.55%
—
—
cases:4.14%
controls:0.45%
cases:4.38%
controls:2.33%
cases:12.32%
controls:6.33%
154
927
1388
14486
57
375
1492
15100
24
85
1525
15390
—
64
70
1482
15375
65
350
1420
14645
164
847
1167
12539
Orthopedic Surgery
20 [38004465]
20 [38004465]
5.1e-01
5.0e-01
1.1e+00
—
1.9e+00
7.2e-01
5.3e-01
cases:17.64%
controls:11.43%
cases:7.04%
controls:4.38%
cases:1.81%
controls:0.62%
—
—
cases:5.05%
controls:0.82%
cases:8.48%
controls:4.30%
cases:20.59%
controls:13.25%
272
1761
1270
13652
109
678
1440
14797
28
96
1521
15379
—
78
126
1468
15319
126
645
1359
14350
274
1773
1057
11613
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
2823-3 [3023103]
1.6e-01
2.2e-01
4.4e-01
3.2e+00
1.0e+00
2.5e-01
2.8e-01
cases:27.50%
controls:24.38%
cases:20.98%
controls:17.62%
cases:5.04%
controls:3.30%
cases:4.13%
controls:0.18%
cases:8.15%
controls:3.08%
cases:22.49%
controls:18.37%
cases:44.63%
controls:37.90%
424
3757
1118
11656
325
2727
1224
12748
78
510
1471
14965
64
28
1485
15447
126
476
1420
14969
334
2754
1151
12241
594
5073
737
8313
Hand/finger symptom/complaint
L12 [2002000636]
L12 [2002000636]
5.3e-01
8.9e-01
1.7e+00
—
2.5e+00
9.7e-01
7.6e-01
cases:2.79%
controls:1.67%
cases:1.42%
controls:0.59%
cases:0.45%
controls:0.08%
—
—
cases:0.71%
controls:0.06%
cases:1.75%
controls:0.67%
cases:4.58%
controls:2.20%
43
257
1499
15156
22
91
1527
15384
7
13
1542
15462
—
11
9
1535
15436
26
101
1459
14894
61
295
1270
13091
Alcohol-related acute intoxication uncomplicated
F10.00 [2000501668]
F10.00 [2000501668]
1.5e+00
2.0e+00
—
—
—
2.1e+00
1.4e+00
cases:0.65%
controls:0.14%
cases:0.32%
controls:0.05%
—
—
—
—
—
—
cases:0.74%
controls:0.09%
cases:0.98%
controls:0.23%
10
22
1532
15391
5
7
1544
15468
—
—
—
11
14
1474
14981
13
31
1318
13355
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
14682-9 [3020564]
1.2e-01
2.2e-01
5.5e-01
3.0e+00
7.8e-01
2.2e-01
2.3e-01
cases:29.96%
controls:27.55%
cases:24.98%
controls:21.05%
cases:7.17%
controls:4.26%
cases:4.13%
controls:0.21%
cases:8.60%
controls:4.12%
cases:25.93%
controls:21.85%
cases:49.21%
controls:43.44%
462
4247
1080
11166
387
3257
1162
12218
111
660
1438
14815
64
33
1485
15442
133
637
1413
14808
385
3277
1100
11718
655
5815
676
7571
Case Management Agency
251B00000X [38004193]
251B00000X [38004193]
9.6e-02
1.5e-01
4.0e-01
3.6e+00
9.9e-01
1.7e-01
1.4e-01
cases:61.15%
controls:58.86%
cases:55.97%
controls:52.36%
cases:28.21%
controls:20.85%
cases:31.18%
controls:1.25%
cases:42.11%
controls:21.20%
cases:58.05%
controls:53.86%
cases:74.38%
controls:71.62%
943
9072
599
6341
867
8103
682
7372
437
3226
1112
12249
483
193
1066
15282
651
3274
895
12171
862
8077
623
6918
990
9587
341
3799
Fall on same level from slipping, tripping and stumbling
W01 [45756243]
W01 [45756243]
6.1e-01
1.0e+00
9.2e-01
—
1.6e+00
9.1e-01
6.3e-01
cases:5.77%
controls:3.22%
cases:2.65%
controls:0.96%
cases:0.39%
controls:0.16%
—
—
cases:0.65%
controls:0.13%
cases:2.69%
controls:1.10%
cases:6.76%
controls:3.71%
89
497
1453
14916
41
149
1508
15326
6
24
1543
15451
—
10
20
1536
15425
40
165
1445
14830
90
497
1241
12889
Normoblasts [#/volume] in Blood
715-3 [3021589]
715-3 [3021589]
1.6e-01
2.9e-01
3.4e-01
3.0e+00
8.6e-01
4.0e-01
4.1e-01
cases:8.56%
controls:7.37%
cases:7.30%
controls:5.55%
cases:1.81%
controls:1.29%
cases:0.77%
controls:0.04%
cases:2.98%
controls:1.28%
cases:8.42%
controls:5.80%
cases:16.53%
controls:11.61%
132
1136
1410
14277
113
859
1436
14616
28
200
1521
15275
12
6
1537
15469
46
198
1500
15247
125
870
1360
14125
220
1554
1111
11832
chlorprothixene; oral, parenteral
N05AF03 [21604533]
N05AF03 [21604533]
1.3e+00
1.9e+00
—
—
—
1.5e+00
1.3e+00
cases:1.04%
controls:0.28%
cases:0.77%
controls:0.12%
—
—
—
—
—
—
cases:0.54%
controls:0.13%
cases:0.90%
controls:0.24%
16
43
1526
15370
12
18
1537
15457
—
—
—
8
19
1477
14976
12
32
1319
13354
temazepam; oral
N05CD07 [21604642]
N05CD07 [21604642]
5.8e-01
9.2e-01
9.8e-01
—
1.2e+00
9.1e-01
8.9e-01
cases:4.09%
controls:2.34%
cases:2.91%
controls:1.18%
cases:0.77%
controls:0.29%
—
—
cases:0.84%
controls:0.25%
cases:2.90%
controls:1.18%
cases:5.33%
controls:2.26%
63
360
1479
15053
45
182
1504
15293
12
45
1537
15430
—
13
38
1533
15407
43
177
1442
14818
71
302
1260
13084
Chronic alcohol abuse
P15 [2002000811]
P15 [2002000811]
1.3e+00
8.8e-01
—
—
—
1.6e+00
1.5e+00
cases:1.23%
controls:0.33%
cases:0.39%
controls:0.16%
—
—
—
—
—
—
cases:0.88%
controls:0.17%
cases:1.95%
controls:0.43%
19
51
1523
15362
6
25
1543
15450
—
—
—
13
26
1472
14969
26
57
1305
13329
Platelets [#/volume] in Blood
26515-7 [3007461]
26515-7 [3007461]
7.1e-02
1.4e-01
5.1e-01
2.7e+00
7.2e-01
2.2e-01
2.2e-01
cases:33.59%
controls:32.04%
cases:28.15%
controls:25.34%
cases:8.91%
controls:5.53%
cases:4.71%
controls:0.32%
cases:10.54%
controls:5.41%
cases:30.98%
controls:26.42%
cases:54.70%
controls:49.13%
518
4938
1024
10475
436
3922
1113
11553
138
855
1411
14620
73
49
1476
15426
163
835
1383
14610
460
3961
1025
11034
728
6577
603
6809
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
30428-7 [3024731]
6.7e-02
1.4e-01
5.1e-01
2.7e+00
7.3e-01
2.3e-01
2.2e-01
cases:33.66%
controls:32.17%
cases:28.08%
controls:25.42%
cases:8.91%
controls:5.56%
cases:4.71%
controls:0.32%
cases:10.61%
controls:5.41%
cases:31.11%
controls:26.48%
cases:54.77%
controls:49.28%
519
4958
1023
10455
435
3933
1114
11542
138
860
1411
14615
73
49
1476
15426
164
836
1382
14609
462
3970
1023
11025
729
6597
602
6789
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
26453-1 [3026361]
6.7e-02
1.4e-01
5.1e-01
2.7e+00
7.3e-01
2.2e-01
2.2e-01
cases:33.66%
controls:32.17%
cases:28.15%
controls:25.43%
cases:8.91%
controls:5.56%
cases:4.71%
controls:0.32%
cases:10.61%
controls:5.42%
cases:31.11%
controls:26.51%
cases:54.85%
controls:49.31%
519
4958
1023
10455
436
3935
1113
11540
138
861
1411
14614
73
49
1476
15426
164
837
1382
14608
462
3975
1023
11020
730
6600
601
6786
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
718-7 [3000963]
6.5e-02
1.4e-01
5.1e-01
2.7e+00
7.3e-01
2.3e-01
2.2e-01
cases:33.72%
controls:32.28%
cases:28.15%
controls:25.48%
cases:8.91%
controls:5.56%
cases:4.71%
controls:0.32%
cases:10.61%
controls:5.43%
cases:31.25%
controls:26.56%
cases:54.85%
controls:49.37%
520
4975
1022
10438
436
3943
1113
11532
138
861
1411
14614
73
49
1476
15426
164
839
1382
14606
464
3983
1021
11012
730
6609
601
6777
MCH [Entitic mass]
28539-5 [3035941]
28539-5 [3035941]
6.9e-02
1.4e-01
5.0e-01
2.7e+00
7.3e-01
2.3e-01
2.2e-01
cases:33.66%
controls:32.14%
cases:28.08%
controls:25.41%
cases:8.84%
controls:5.56%
cases:4.71%
controls:0.32%
cases:10.61%
controls:5.42%
cases:31.11%
controls:26.45%
cases:54.85%
controls:49.26%
519
4953
1023
10460
435
3932
1114
11543
137
860
1412
14615
73
49
1476
15426
164
837
1382
14608
462
3966
1023
11029
730
6594
601
6792
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
20570-8 [3009542]
6.7e-02
1.4e-01
5.0e-01
2.7e+00
7.3e-01
2.3e-01
2.2e-01
cases:33.66%
controls:32.17%
cases:28.15%
controls:25.42%
cases:8.91%
controls:5.58%
cases:4.71%
controls:0.32%
cases:10.61%
controls:5.42%
cases:31.11%
controls:26.50%
cases:54.77%
controls:49.31%
519
4959
1023
10454
436
3933
1113
11542
138
863
1411
14612
73
49
1476
15426
164
837
1382
14608
462
3973
1023
11022
729
6601
602
6785
INR in Blood by Coagulation assay
34714-6 [3032080]
34714-6 [3032080]
3.7e-01
1.5e-01
4.7e-01
2.9e+00
6.3e-01
6.2e-01
5.1e-01
cases:9.27%
controls:6.59%
cases:4.33%
controls:3.74%
cases:1.55%
controls:0.97%
cases:1.42%
controls:0.08%
cases:1.88%
controls:1.00%
cases:6.20%
controls:3.41%
cases:14.12%
controls:9.02%
143
1016
1399
14397
67
578
1482
14897
24
150
1525
15325
22
12
1527
15463
29
155
1517
15290
92
512
1393
14483
188
1208
1143
12178
Leukocytes [#/volume] in Blood
26464-8 [3010813]
26464-8 [3010813]
7.1e-02
1.4e-01
5.1e-01
2.7e+00
7.2e-01
2.3e-01
2.2e-01
cases:33.79%
controls:32.22%
cases:28.21%
controls:25.47%
cases:8.91%
controls:5.57%
cases:4.71%
controls:0.32%
cases:10.61%
controls:5.46%
cases:31.25%
controls:26.54%
cases:54.85%
controls:49.37%
521
4966
1021
10447
437
3941
1112
11534
138
862
1411
14613
73
49
1476
15426
164
843
1382
14602
464
3980
1021
11015
730
6608
601
6778
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
X69 [45585661]
X69 [45585661]
1.2e+00
1.3e+00
—
—
—
1.6e+00
1.5e+00
cases:1.49%
controls:0.43%
cases:0.65%
controls:0.18%
—
—
—
—
—
—
cases:0.67%
controls:0.14%
cases:1.58%
controls:0.34%
23
67
1519
15346
10
28
1539
15447
—
—
—
10
21
1475
14974
21
46
1310
13340
Essential (primary) hypertension
I10 [45591453]
I10 [45591453]
1.7e-02
3.2e-01
5.3e-01
3.5e+00
8.2e-01
3.2e-01
2.0e-01
cases:10.12%
controls:9.97%
cases:6.71%
controls:4.95%
cases:1.55%
controls:0.92%
cases:1.29%
controls:0.04%
cases:2.01%
controls:0.89%
cases:7.54%
controls:5.60%
cases:17.21%
controls:14.49%
156
1536
1386
13877
104
766
1445
14709
24
142
1525
15333
20
6
1529
15469
31
138
1515
15307
112
839
1373
14156
229
1939
1102
11447
Bacteria identified in Blood by Culture
600-7 [3023368]
600-7 [3023368]
2.9e-01
6.8e-01
9.2e-01
—
2.4e+00
6.0e-01
6.4e-01
cases:4.09%
controls:3.09%
cases:2.84%
controls:1.46%
cases:0.45%
controls:0.18%
—
—
cases:1.42%
controls:0.14%
cases:2.56%
controls:1.41%
cases:8.56%
controls:4.71%
63
477
1479
14936
44
226
1505
15249
7
28
1542
15447
—
22
21
1524
15424
38
212
1447
14783
114
630
1217
12756
Chronic ulcer skin
S97 [2002001061]
S97 [2002001061]
3.0e-01
3.3e-01
—
—
2.2e+00
1.2e+00
9.0e-01
cases:0.45%
controls:0.34%
cases:0.32%
controls:0.23%
—
—
—
—
cases:0.39%
controls:0.05%
cases:0.81%
controls:0.24%
cases:1.43%
controls:0.58%
7
52
1535
15361
5
36
1544
15439
—
—
6
7
1540
15438
12
36
1473
14959
19
78
1312
13308
Scheduled procedure
ZXD10 [2001311387]
ZXD10 [2001311387]
4.1e-01
4.8e-01
9.2e-01
—
2.0e+00
1.1e+00
8.0e-01
cases:6.68%
controls:4.55%
cases:2.32%
controls:1.45%
cases:0.45%
controls:0.18%
—
—
cases:0.97%
controls:0.14%
cases:2.90%
controls:1.00%
cases:6.39%
controls:2.98%
103
701
1439
14712
36
225
1513
15250
7
28
1542
15447
—
15
21
1531
15424
43
150
1442
14845
85
399
1246
12987
Emergency Room and Inpatient Visit
ERIP [262]
ERIP [262]
3.4e-01
3.1e-01
1.3e+00
—
1.8e+00
6.8e-01
4.6e-01
cases:4.93%
controls:3.55%
cases:2.65%
controls:1.95%
cases:0.90%
controls:0.24%
—
—
cases:1.55%
controls:0.27%
cases:4.18%
controls:2.17%
cases:10.89%
controls:7.15%
76
547
1466
14866
41
302
1508
15173
14
37
1535
15438
—
24
42
1522
15403
62
325
1423
14670
145
957
1186
12429
UNS Panic Syndrome
F41.09 [2000501997]
F41.09 [2000501997]
1.1e+00
1.8e+00
—
—
—
—
1.4e+00
cases:0.91%
controls:0.32%
cases:0.45%
controls:0.08%
—
—
—
—
—
—
—
—
cases:1.28%
controls:0.33%
14
49
1528
15364
7
12
1542
15463
—
—
—
—
17
44
1314
13342
General anesthesia, balanced
WX408 [2001310808]
WX408 [2001310808]
3.2e-01
7.3e-01
—
1.0e+50
2.9e+00
6.8e-01
5.7e-01
cases:4.47%
controls:3.30%
cases:1.81%
controls:0.88%
—
—
cases:0.77%
controls:0.00%
cases:1.36%
controls:0.08%
cases:1.35%
controls:0.69%
cases:3.46%
controls:1.99%
69
509
1473
14904
28
136
1521
15339
—
12
0
1537
15475
21
12
1525
15433
20
103
1465
14892
46
266
1285
13120
hydroxyzine; oral, parenteral
N05BB01 [21604590]
N05BB01 [21604590]
5.9e-01
5.1e-01
—
—
2.1e+00
9.3e-01
5.5e-01
cases:3.31%
controls:1.86%
cases:1.16%
controls:0.70%
—
—
—
—
cases:0.78%
controls:0.10%
cases:1.75%
controls:0.70%
cases:3.46%
controls:2.02%
51
286
1491
15127
18
108
1531
15367
—
—
12
15
1534
15430
26
105
1459
14890
46
270
1285
13116
Abdominal pain/cramps general
D01 [2002000300]
D01 [2002000300]
8.5e-01
1.1e+00
—
—
—
1.5e+00
6.4e-01
cases:2.79%
controls:1.21%
cases:1.16%
controls:0.39%
—
—
—
—
—
—
cases:1.55%
controls:0.33%
cases:2.85%
controls:1.52%
43
186
1499
15227
18
61
1531
15414
—
—
—
23
50
1462
14945
38
204
1293
13182
Alcohol dependence periodic alcoholism
F10.26 [2000501683]
F10.26 [2000501683]
2.2e+00
—
—
—
—
—
1.9e+00
cases:0.78%
controls:0.08%
—
—
—
—
—
—
—
—
—
—
cases:0.68%
controls:0.10%
12
13
1530
15400
—
—
—
—
—
9
14
1322
13372
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
51480-2 [3031040]
1.2e-01
3.3e-01
8.7e-01
2.5e+00
7.1e-01
3.6e-01
4.0e-01
cases:13.36%
controls:12.05%
cases:8.07%
controls:5.94%
cases:1.68%
controls:0.71%
cases:0.45%
controls:0.04%
cases:1.62%
controls:0.80%
cases:8.22%
controls:5.89%
cases:22.61%
controls:16.35%
206
1857
1336
13556
125
919
1424
14556
26
110
1523
15365
7
6
1542
15469
25
124
1521
15321
122
883
1363
14112
301
2188
1030
11198
Physiotherapy
R4110 [2001310233]
R4110 [2001310233]
2.1e-01
2.0e-01
1.2e+00
1.0e+50
2.4e+00
1.0e+00
6.6e-01
cases:4.47%
controls:3.67%
cases:1.81%
controls:1.48%
cases:0.71%
controls:0.21%
cases:1.42%
controls:0.00%
cases:2.13%
controls:0.21%
cases:3.30%
controls:1.22%
cases:5.33%
controls:2.82%
69
566
1473
14847
28
229
1521
15246
11
33
1538
15442
22
0
1527
15475
33
32
1513
15413
49
183
1436
14812
71
377
1260
13009
One hour or less
ZXE00 [2001311394]
ZXE00 [2001311394]
3.2e-01
3.3e-01
—
—
2.3e+00
1.1e+00
6.9e-01
cases:6.87%
controls:5.11%
cases:2.19%
controls:1.58%
—
—
—
—
cases:1.36%
controls:0.14%
cases:3.16%
controls:1.13%
cases:6.84%
controls:3.56%
106
787
1436
14626
34
245
1515
15230
—
—
21
22
1525
15423
47
169
1438
14826
91
476
1240
12910
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]
77397-8 [46236098]
2.8e-01
3.6e-01
8.2e-01
—
2.3e+00
8.7e-01
7.8e-01
cases:3.70%
controls:2.82%
cases:2.00%
controls:1.41%
cases:0.32%
controls:0.14%
—
—
cases:1.81%
controls:0.18%
cases:2.83%
controls:1.21%
cases:7.96%
controls:3.80%
57
435
1485
14978
31
218
1518
15257
5
22
1544
15453
—
28
28
1518
15417
42
181
1443
14814
106
509
1225
12877
lamotrigine; oral
N03AX09 [21604431]
N03AX09 [21604431]
8.4e-01
9.9e-01
—
—
—
1.3e+00
8.6e-01
cases:1.75%
controls:0.77%
cases:0.97%
controls:0.36%
—
—
—
—
—
—
cases:1.21%
controls:0.35%
cases:2.10%
controls:0.90%
27
118
1515
15295
15
56
1534
15419
—
—
—
18
52
1467
14943
28
121
1303
13265
Bacteria identified in Isolate by Culture
43409-2 [3042936]
43409-2 [3042936]
-1.4e-01
5.6e-01
—
—
2.2e+00
1.1e+00
6.6e-01
cases:1.56%
controls:1.79%
cases:1.23%
controls:0.70%
—
—
—
—
cases:0.78%
controls:0.09%
cases:1.82%
controls:0.60%
cases:4.43%
controls:2.33%
24
276
1518
15137
19
109
1530
15366
—
—
12
14
1534
15431
27
90
1458
14905
59
312
1272
13074
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
34531-4 [3044640]
2.3e-01
2.1e-01
4.6e-01
—
2.4e+00
8.0e-01
7.5e-01
cases:5.51%
controls:4.44%
cases:2.58%
controls:2.09%
cases:0.39%
controls:0.25%
—
—
cases:2.20%
controls:0.21%
cases:3.77%
controls:1.73%
cases:10.67%
controls:5.32%
85
685
1457
14728
40
324
1509
15151
6
38
1543
15437
—
34
32
1512
15413
56
260
1429
14735
142
712
1189
12674
CBC panel - Blood by Automated count
58410-2 [40761511]
58410-2 [40761511]
8.1e-02
9.7e-02
3.6e-01
3.0e+00
7.5e-01
1.8e-01
2.0e-01
cases:28.66%
controls:27.03%
cases:18.66%
controls:17.23%
cases:4.45%
controls:3.16%
cases:3.36%
controls:0.18%
cases:6.21%
controls:3.04%
cases:20.61%
controls:17.78%
cases:44.33%
controls:39.35%
442
4166
1100
11247
289
2667
1260
12808
69
489
1480
14986
52
28
1497
15447
96
469
1450
14976
306
2666
1179
12329
590
5268
741
8118
Pharmacy visit
OMOP4822462 [581458]
OMOP4822462 [581458]
1.8e-01
3.1e-01
3.1e-01
2.1e+00
7.7e-01
3.6e-01
4.3e-01
cases:93.39%
controls:92.19%
cases:83.28%
controls:78.44%
cases:45.06%
controls:37.57%
cases:12.72%
controls:1.70%
cases:56.53%
controls:37.51%
cases:84.44%
controls:79.08%
cases:95.94%
controls:93.91%
1440
14209
102
1204
1290
12138
259
3337
698
5814
851
9661
197
263
1352
15212
874
5794
672
9651
1254
11858
231
3137
1277
12571
54
815
More than one and less than three hours
ZXE10 [2001311401]
ZXE10 [2001311401]
3.8e-01
3.0e-01
1.1e+00
1.0e+50
2.6e+00
4.4e-01
8.5e-01
cases:6.23%
controls:4.36%
cases:1.87%
controls:1.39%
cases:0.58%
controls:0.19%
cases:1.23%
controls:0.00%
cases:1.68%
controls:0.13%
cases:1.55%
controls:1.00%
cases:5.94%
controls:2.62%
96
672
1446
14741
29
215
1520
15260
9
30
1540
15445
19
0
1530
15475
26
20
1520
15425
23
150
1462
14845
79
351
1252
13035
Severe depressive episode with psychotic symptoms
F32.3 [45600739]
F32.3 [45600739]
6.2e-02
—
—
—
—
2.2e+00
1.6e+00
cases:0.32%
controls:0.30%
—
—
—
—
—
—
—
—
cases:0.47%
controls:0.05%
cases:0.75%
controls:0.15%
5
47
1537
15366
—
—
—
—
7
8
1478
14987
10
20
1321
13366
Buprenorphine [Presence] in Urine by Screen method
93494-3 [1001926]
93494-3 [1001926]
5.9e-01
6.4e-01
—
—
2.0e+00
1.2e+00
6.3e-01
cases:1.36%
controls:0.76%
cases:0.71%
controls:0.37%
—
—
—
—
cases:0.39%
controls:0.05%
cases:1.21%
controls:0.39%
cases:2.78%
controls:1.50%
21
117
1521
15296
11
58
1538
15417
—
—
6
8
1540
15437
18
58
1467
14937
37
201
1294
13185
Major dressing of wound of skin of upper limb
QCB10 [2001309904]
QCB10 [2001309904]
1.7e+00
1.9e+00
—
1.0e+50
—
3.8e+00
1.4e+00
cases:0.32%
controls:0.06%
cases:0.39%
controls:0.06%
—
—
cases:1.55%
controls:0.00%
—
—
cases:1.75%
controls:0.04%
cases:0.53%
controls:0.13%
5
9
1537
15404
6
9
1543
15466
—
24
0
1525
15475
—
26
6
1459
14989
7
18
1324
13368
diazepam; oral, parenteral, rectal
N05BA01 [21604566]
N05BA01 [21604566]
7.4e-01
8.0e-01
1.3e+00
—
6.6e-01
6.1e-01
9.6e-01
cases:4.60%
controls:2.25%
cases:2.45%
controls:1.12%
cases:1.23%
controls:0.35%
—
—
cases:0.65%
controls:0.34%
cases:2.09%
controls:1.14%
cases:5.11%
controls:2.02%
71
347
1471
15066
38
173
1511
15302
19
54
1530
15421
—
10
52
1536
15393
31
171
1454
14824
68
271
1263
13115
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
28540-3 [3003338]
-1.1e-02
9.6e-02
4.4e-01
2.6e+00
6.5e-01
1.4e-01
6.0e-02
cases:24.38%
controls:24.59%
cases:19.24%
controls:17.80%
cases:5.87%
controls:3.87%
cases:2.97%
controls:0.22%
cases:6.79%
controls:3.66%
cases:20.74%
controls:18.60%
cases:39.22%
controls:37.80%
376
3790
1166
11623
298
2754
1251
12721
91
599
1458
14876
46
34
1503
15441
105
565
1441
14880
308
2789
1177
12206
522
5060
809
8326
Other and unspecified convulsions
R56.8 [45602033]
R56.8 [45602033]
1.0e+00
1.5e+00
—
—
—
—
1.1e+00
cases:1.62%
controls:0.58%
cases:0.65%
controls:0.14%
—
—
—
—
—
—
—
—
cases:1.50%
controls:0.49%
25
90
1517
15323
10
22
1539
15453
—
—
—
—
20
65
1311
13321
Intentional self-harm by sharp object
X78 [45756450]
X78 [45756450]
1.7e+00
—
—
—
—
2.0e+00
2.0e+00
cases:0.52%
controls:0.10%
—
—
—
—
—
—
—
—
cases:0.34%
controls:0.05%
cases:0.60%
controls:0.08%
8
15
1534
15398
—
—
—
—
5
7
1480
14988
8
11
1323
13375
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 [3007220]
2157-6 [3007220]
3.6e-01
6.9e-01
1.2e+00
—
1.8e+00
6.5e-01
4.8e-01
cases:5.45%
controls:3.87%
cases:2.78%
controls:1.42%
cases:0.71%
controls:0.22%
—
—
cases:0.84%
controls:0.14%
cases:2.83%
controls:1.49%
cases:8.87%
controls:5.67%
84
596
1458
14817
43
219
1506
15256
11
34
1538
15441
—
13
21
1533
15424
42
224
1443
14771
118
759
1213
12627
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
30385-9 [3002385]
6.7e-02
1.2e-01
3.8e-01
2.8e+00
8.2e-01
2.1e-01
1.3e-01
cases:21.73%
controls:20.61%
cases:17.56%
controls:15.91%
cases:5.23%
controls:3.65%
cases:3.03%
controls:0.19%
cases:7.57%
controls:3.49%
cases:19.60%
controls:16.47%
cases:35.61%
controls:32.73%
335
3177
1207
12236
272
2462
1277
13013
81
565
1468
14910
47
29
1502
15446
117
539
1429
14906
291
2470
1194
12525
474
4381
857
9005
Suture or treatment of traumatic wound
SPAT1149 [2001700250]
SPAT1149 [2001700250]
3.8e-01
7.9e-01
2.1e+00
—
3.6e+00
9.5e-01
4.1e-01
cases:1.69%
controls:1.16%
cases:0.71%
controls:0.32%
cases:0.32%
controls:0.04%
—
—
cases:2.13%
controls:0.06%
cases:0.94%
controls:0.37%
cases:2.03%
controls:1.35%
26
179
1516
15234
11
50
1538
15425
5
6
1544
15469
—
33
9
1513
15436
14
55
1471
14940
27
181
1304
13205
alprazolam; oral
N05BA12 [21604577]
N05BA12 [21604577]
7.5e-01
1.1e+00
1.3e+00
—
1.1e+00
9.9e-01
7.6e-01
cases:2.27%
controls:1.09%
cases:1.61%
controls:0.54%
cases:0.58%
controls:0.16%
—
—
cases:0.45%
controls:0.16%
cases:1.35%
controls:0.51%
cases:2.10%
controls:0.99%
35
168
1507
15245
25
84
1524
15391
9
25
1540
15450
—
7
24
1539
15421
20
76
1465
14919
28
133
1303
13253
Urine methamphetamine measurement
313579004 [4198724]
313579004 [4198724]
1.6e+00
—
—
—
—
2.0e+00
1.3e+00
cases:0.58%
controls:0.12%
—
—
—
—
—
—
—
—
cases:0.40%
controls:0.05%
cases:0.68%
controls:0.19%
9
19
1533
15394
—
—
—
—
6
8
1479
14987
9
26
1322
13360
Acetaminophen [Moles/volume] in Serum or Plasma
14581-3 [3020485]
14581-3 [3020485]
1.8e+00
—
—
—
—
—
1.8e+00
cases:0.45%
controls:0.08%
—
—
—
—
—
—
—
—
—
—
cases:0.68%
controls:0.11%
7
12
1535
15401
—
—
—
—
—
9
15
1322
13371
Unspecified fall
W19 [45756257]
W19 [45756257]
8.4e-01
1.5e+00
—
1.0e+50
—
1.2e+00
5.5e-01
cases:1.88%
controls:0.82%
cases:0.97%
controls:0.23%
—
—
cases:0.32%
controls:0.00%
—
—
cases:0.88%
controls:0.26%
cases:1.65%
controls:0.96%
29
127
1513
15286
15
35
1534
15440
—
5
0
1544
15475
—
13
39
1472
14956
22
129
1309
13257
pregabalin; oral
N02BF02 [955152]
N02BF02 [955152]
4.4e-01
6.0e-01
4.8e-01
—
1.1e+00
1.1e+00
6.7e-01
cases:4.54%
controls:2.98%
cases:2.65%
controls:1.47%
cases:0.84%
controls:0.52%
—
—
cases:1.55%
controls:0.50%
cases:3.70%
controls:1.29%
cases:6.69%
controls:3.53%
70
460
1472
14953
41
228
1508
15247
13
81
1536
15394
—
24
77
1522
15368
55
193
1430
14802
89
473
1242
12913
Alcohol dependence continuous use
F10.25 [2000501682]
F10.25 [2000501682]
2.0e+00
—
—
—
—
1.8e+00
1.4e+00
cases:0.84%
controls:0.11%
—
—
—
—
—
—
—
—
cases:0.34%
controls:0.05%
cases:0.83%
controls:0.21%
13
17
1529
15396
—
—
—
—
5
8
1480
14987
11
28
1320
13358
Chronic viral hepatitis C
B18.2 [45590846]
B18.2 [45590846]
1.7e+00
1.5e+00
—
—
—
—
1.8e+00
cases:0.84%
controls:0.16%
cases:0.39%
controls:0.08%
—
—
—
—
—
—
—
—
cases:0.90%
controls:0.16%
13
25
1529
15388
6
13
1543
15462
—
—
—
—
12
21
1319
13365
Alcohol depence active use
F10.24 [2000501681]
F10.24 [2000501681]
1.7e+00
—
—
—
—
—
1.7e+00
cases:0.58%
controls:0.10%
—
—
—
—
—
—
—
—
—
—
cases:0.68%
controls:0.13%
9
16
1533
15397
—
—
—
—
—
9
17
1322
13369
Office Visit
OMOP4822458 [581477]
OMOP4822458 [581477]
1.9e-01
2.4e-01
4.8e-01
—
2.0e+00
8.9e-01
4.9e-01
cases:9.73%
controls:8.19%
cases:3.36%
controls:2.65%
cases:0.65%
controls:0.40%
—
—
cases:2.65%
controls:0.37%
cases:5.45%
controls:2.31%
cases:10.07%
controls:6.40%
150
1263
1392
14150
52
410
1497
15065
10
62
1539
15413
—
41
57
1505
15388
81
346
1404
14649
134
857
1197
12529
Sleep apnoea
G47.3 [45562094]
G47.3 [45562094]
4.4e-01
4.6e-01
5.9e-01
2.5e+00
7.8e-01
4.2e-01
4.4e-01
cases:5.25%
controls:3.44%
cases:3.42%
controls:2.20%
cases:0.84%
controls:0.47%
cases:0.39%
controls:0.03%
cases:0.97%
controls:0.45%
cases:3.43%
controls:2.28%
cases:7.51%
controls:4.96%
81
530
1461
14883
53
340
1496
15135
13
72
1536
15403
6
5
1543
15470
15
69
1531
15376
51
342
1434
14653
100
664
1231
12722
olanzapine; oral, parenteral
N05AH03 [21604543]
N05AH03 [21604543]
7.8e-01
8.4e-01
1.1e+00
—
4.1e-01
8.9e-01
8.5e-01
cases:2.20%
controls:1.03%
cases:1.87%
controls:0.81%
cases:0.58%
controls:0.19%
—
—
cases:0.52%
controls:0.34%
cases:1.95%
controls:0.81%
cases:3.23%
controls:1.40%
34
158
1508
15255
29
126
1520
15349
9
30
1540
15445
—
8
53
1538
15392
29
122
1456
14873
43
188
1288
13198
oxazepam; oral
N05BA04 [21604569]
N05BA04 [21604569]
5.9e-01
5.5e-01
8.1e-01
—
9.4e-01
5.9e-01
6.9e-01
cases:7.13%
controls:4.09%
cases:3.55%
controls:2.08%
cases:1.23%
controls:0.55%
—
—
cases:1.36%
controls:0.54%
cases:3.50%
controls:1.97%
cases:8.79%
controls:4.62%
110
630
1432
14783
55
322
1494
15153
19
85
1530
15390
—
21
83
1525
15362
52
295
1433
14700
117
618
1214
12768
Physical Medicine And Rehabilitation
25 [38004468]
25 [38004468]
2.5e-01
4.4e-01
4.4e-01
—
1.8e+00
1.1e+00
4.9e-01
cases:7.26%
controls:5.77%
cases:3.03%
controls:1.98%
cases:0.58%
controls:0.37%
—
—
cases:2.20%
controls:0.38%
cases:5.45%
controls:1.89%
cases:9.47%
controls:6.04%
112
889
1430
14524
47
306
1502
15169
9
58
1540
15417
—
34
59
1512
15386
81
283
1404
14712
126
808
1205
12578
Laboratory Visit
OMOP4822461 [32036]
OMOP4822461 [32036]
5.4e-03
1.4e-01
3.9e-01
2.2e+00
5.5e-01
1.9e-01
1.5e-01
cases:37.09%
controls:36.97%
cases:37.12%
controls:33.87%
cases:14.01%
controls:9.95%
cases:6.13%
controls:0.74%
cases:16.04%
controls:9.97%
cases:39.93%
controls:35.55%
cases:59.28%
controls:55.52%
572
5698
970
9715
575
5242
974
10233
217
1539
1332
13936
95
114
1454
15361
248
1540
1298
13905
593
5331
892
9664
789
7432
542
5954
Striking against or struck by other object(s)
W22 [45756260]
W22 [45756260]
9.9e-01
1.4e+00
—
1.0e+50
—
1.5e+00
8.2e-01
cases:1.49%
controls:0.56%
cases:0.58%
controls:0.14%
—
—
cases:1.42%
controls:0.00%
—
—
cases:0.81%
controls:0.19%
cases:1.73%
controls:0.77%
23
86
1519
15327
9
22
1540
15453
—
22
0
1527
15475
—
12
28
1473
14967
23
103
1308
13283
Emotionally unstable personality disorder, borderline condition
F60.31 [2000502023]
F60.31 [2000502023]
1.1e+00
—
—
—
—
1.6e+00
1.6e+00
cases:0.52%
controls:0.17%
—
—
—
—
—
—
—
—
cases:0.61%
controls:0.12%
cases:1.13%
controls:0.22%
8
26
1534
15387
—
—
—
—
9
18
1476
14977
15
30
1316
13356
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
890-4 [3001079]
1.5e-01
1.8e-01
4.9e-01
—
2.1e+00
6.3e-01
5.2e-01
cases:7.78%
controls:6.78%
cases:3.94%
controls:3.30%
cases:0.58%
controls:0.36%
—
—
cases:2.72%
controls:0.35%
cases:5.19%
controls:2.82%
cases:13.90%
controls:8.73%
120
1045
1422
14368
61
511
1488
14964
9
55
1540
15420
—
42
54
1504
15391
77
423
1408
14572
185
1168
1146
12218
Lumbago with sciatica
M54.4 [45553205]
M54.4 [45553205]
6.7e-01
7.4e-01
—
—
2.0e+00
6.5e-01
5.2e-01
cases:3.24%
controls:1.69%
cases:1.23%
controls:0.59%
—
—
—
—
cases:0.39%
controls:0.05%
cases:1.41%
controls:0.74%
cases:3.91%
controls:2.37%
50
261
1492
15152
19
91
1530
15384
—
—
6
8
1540
15437
21
111
1464
14884
52
317
1279
13069
Addiction caused by alcohol UNS
F10.29 [2000501684]
F10.29 [2000501684]
1.6e+00
—
—
—
—
—
1.6e+00
cases:0.71%
controls:0.15%
—
—
—
—
—
—
—
—
—
—
cases:1.05%
controls:0.21%
11
23
1531
15390
—
—
—
—
—
14
28
1317
13358
Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13317-3 [3019902]
13317-3 [3019902]
2.1e-01
2.6e-01
—
1.0e+50
3.1e+00
6.1e-01
4.4e-01
cases:1.69%
controls:1.37%
cases:0.77%
controls:0.60%
—
—
cases:0.58%
controls:0.00%
cases:1.16%
controls:0.05%
cases:1.01%
controls:0.55%
cases:2.18%
controls:1.42%
26
211
1516
15202
12
93
1537
15382
—
9
0
1540
15475
18
8
1528
15437
15
83
1470
14912
29
190
1302
13196
Pain localized to other parts of lower abdomen
R10.3 [45534426]
R10.3 [45534426]
6.4e-01
8.7e-01
—
—
7.3e-01
8.5e-01
6.9e-01
cases:5.25%
controls:2.83%
cases:2.19%
controls:0.93%
—
—
—
—
cases:0.32%
controls:0.16%
cases:2.22%
controls:0.96%
cases:6.76%
controls:3.50%
81
436
1461
14977
34
144
1515
15331
—
—
5
24
1541
15421
33
144
1452
14851
90
468
1241
12918
trazodone; oral
N06AX05 [21604734]
N06AX05 [21604734]
1.8e+00
1.6e+00
—
—
—
—
1.3e+00
cases:0.84%
controls:0.14%
cases:0.32%
controls:0.06%
—
—
—
—
—
—
—
—
cases:0.83%
controls:0.23%
13
22
1529
15391
5
10
1544
15465
—
—
—
—
11
31
1320
13355
Cervical spine CT examination
NA1AD [2001306982]
NA1AD [2001306982]
1.4e+00
—
—
—
—
1.2e+00
1.6e+00
cases:1.36%
controls:0.32%
—
—
—
—
—
—
—
—
cases:0.34%
controls:0.11%
cases:1.43%
controls:0.30%
21
50
1521
15363
—
—
—
—
5
16
1480
14979
19
40
1312
13346
Right side
ZXA00 [2001311346]
ZXA00 [2001311346]
3.2e-01
1.1e-01
—
1.0e+50
3.0e+00
8.2e-01
4.5e-01
cases:3.50%
controls:2.56%
cases:0.84%
controls:0.75%
—
—
cases:0.90%
controls:0.00%
cases:1.16%
controls:0.06%
cases:1.28%
controls:0.57%
cases:3.46%
controls:2.23%
54
395
1488
15018
13
116
1536
15359
—
14
0
1535
15475
18
9
1528
15436
19
85
1466
14910
46
298
1285
13088
ABO and Rh group [Type] in Blood
882-1 [3003694]
882-1 [3003694]
-4.8e-04
6.0e-02
7.3e-01
—
2.5e+00
5.0e-01
4.4e-01
cases:4.80%
controls:4.80%
cases:2.00%
controls:1.89%
cases:0.32%
controls:0.16%
—
—
cases:1.55%
controls:0.12%
cases:2.29%
controls:1.40%
cases:8.19%
controls:5.42%
74
740
1468
14673
31
292
1518
15183
5
24
1544
15451
—
24
19
1522
15426
34
210
1451
14785
109
725
1222
12661
Severe psychotic and other severe mental disorders
112 [2001600112]
112 [2001600112]
5.9e-01
—
—
—
—
1.8e+00
1.2e+00
cases:1.04%
controls:0.58%
—
—
—
—
—
—
—
—
cases:0.54%
controls:0.09%
cases:1.20%
controls:0.38%
16
89
1526
15324
—
—
—
—
8
13
1477
14982
16
51
1315
13335
Concussion
S06.0 [45582805]
S06.0 [45582805]
1.0e+00
1.2e+00
—
—
—
9.1e-01
7.5e-01
cases:3.11%
controls:1.15%
cases:0.90%
controls:0.27%
—
—
—
—
—
—
cases:0.74%
controls:0.30%
cases:2.85%
controls:1.37%
48
177
1494
15236
14
42
1535
15433
—
—
—
11
45
1474
14950
38
184
1293
13202
Restricted health certificate
SPAT1283 [2001700384]
SPAT1283 [2001700384]
5.4e-01
7.1e-01
1.7e+00
—
1.3e+00
4.9e-01
3.6e-01
cases:6.42%
controls:3.85%
cases:2.26%
controls:1.12%
cases:0.71%
controls:0.13%
—
—
cases:0.45%
controls:0.12%
cases:1.95%
controls:1.21%
cases:4.81%
controls:3.39%
99
594
1443
14819
35
174
1514
15301
11
20
1538
15455
—
7
19
1539
15426
29
181
1456
14814
64
454
1267
12932
Alcohol dependence currently independent
F10.20 [2000501677]
F10.20 [2000501677]
1.5e+00
1.3e+00
—
—
—
—
1.4e+00
cases:0.71%
controls:0.16%
cases:0.32%
controls:0.09%
—
—
—
—
—
—
—
—
cases:0.83%
controls:0.20%
11
25
1531
15388
5
14
1544
15461
—
—
—
—
11
27
1320
13359
Left side
ZXA05 [2001311347]
ZXA05 [2001311347]
3.6e-01
2.5e-02
—
1.0e+50
2.8e+00
5.9e-01
4.5e-01
cases:3.37%
controls:2.37%
cases:0.77%
controls:0.76%
—
—
cases:0.84%
controls:0.00%
cases:0.78%
controls:0.05%
cases:1.01%
controls:0.56%
cases:2.85%
controls:1.85%
52
365
1490
15048
12
117
1537
15358
—
13
0
1536
15475
12
7
1534
15438
15
84
1470
14911
38
247
1293
13139
Other and unspecified abdominal pain
R10.4 [45568113]
R10.4 [45568113]
4.7e-01
8.1e-01
6.9e-01
—
4.5e-01
8.3e-01
7.1e-01
cases:7.85%
controls:5.06%
cases:3.55%
controls:1.62%
cases:0.32%
controls:0.16%
—
—
cases:0.32%
controls:0.21%
cases:3.50%
controls:1.55%
cases:10.37%
controls:5.40%
121
780
1421
14633
55
250
1494
15225
5
25
1544
15450
—
5
32
1541
15413
52
233
1433
14762
138
723
1193
12663
Inpatient Visit
IP [9201]
IP [9201]
3.0e-01
2.4e-01
5.5e-01
—
2.3e+00
5.4e-01
4.7e-01
cases:5.45%
controls:4.09%
cases:2.32%
controls:1.84%
cases:0.32%
controls:0.19%
—
—
cases:1.88%
controls:0.19%
cases:3.10%
controls:1.83%
cases:8.41%
controls:5.43%
84
631
1458
14782
36
285
1513
15190
5
29
1544
15446
—
29
29
1517
15416
46
274
1439
14721
112
727
1219
12659
Ankle extensive X-ray examination
NH1BA [2001308239]
NH1BA [2001308239]
1.4e+00
—
—
—
—
—
1.4e+00
cases:0.78%
controls:0.20%
—
—
—
—
—
—
—
—
—
—
cases:0.83%
controls:0.21%
12
31
1530
15382
—
—
—
—
—
11
28
1320
13358
Major dressing of wound of skin of lower limb
QDB10 [2001309970]
QDB10 [2001309970]
1.0e+00
1.6e+00
—
—
1.0e+50
1.7e+00
9.3e-01
cases:1.04%
controls:0.37%
cases:0.45%
controls:0.09%
—
—
—
—
cases:1.10%
controls:0.00%
cases:0.61%
controls:0.11%
cases:0.90%
controls:0.36%
16
57
1526
15356
7
14
1542
15461
—
—
17
0
1529
15445
9
17
1476
14978
12
48
1319
13338
levofloxacin; inhalant, oral, parenteral
J01MA12 [21603019]
J01MA12 [21603019]
6.3e-01
-6.2e-02
—
—
2.1e+00
-3.9e-02
4.3e-01
cases:2.92%
controls:1.58%
cases:0.52%
controls:0.55%
—
—
—
—
cases:0.52%
controls:0.06%
cases:0.40%
controls:0.42%
cases:2.78%
controls:1.82%
45
244
1497
15169
8
85
1541
15390
—
—
8
10
1538
15435
6
63
1479
14932
37
244
1294
13142
Leukocytes [#/volume] in Urine
30405-5 [3018095]
30405-5 [3018095]
3.6e-01
4.6e-01
6.6e-01
—
1.1e+00
4.8e-01
3.3e-01
cases:7.07%
controls:5.04%
cases:4.52%
controls:2.89%
cases:0.65%
controls:0.34%
—
—
cases:1.16%
controls:0.40%
cases:4.78%
controls:3.03%
cases:11.65%
controls:8.65%
109
777
1433
14636
70
448
1479
15027
10
52
1539
15423
—
18
62
1528
15383
71
454
1414
14541
155
1158
1176
12228
levomepromazine; oral, parenteral
N05AA02 [21604493]
N05AA02 [21604493]
1.2e+00
9.2e-01
—
—
-1.0e+50
9.6e-01
1.4e+00
cases:1.30%
controls:0.38%
cases:0.58%
controls:0.23%
—
—
—
—
cases:0.00%
controls:0.07%
cases:0.61%
controls:0.23%
cases:1.65%
controls:0.41%
20
59
1522
15354
9
36
1540
15439
—
—
0
11
1546
15434
9
35
1476
14960
22
55
1309
13331
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
6598-7 [3019800]
4.1e-01
4.7e-01
1.0e+00
1.0e+50
1.2e+00
5.9e-01
4.4e-01
cases:7.07%
controls:4.83%
cases:3.62%
controls:2.29%
cases:0.77%
controls:0.28%
cases:0.97%
controls:0.00%
cases:0.91%
controls:0.28%
cases:4.24%
controls:2.39%
cases:11.65%
controls:7.83%
109
744
1433
14669
56
354
1493
15121
12
43
1537
15432
15
0
1534
15475
14
43
1532
15402
63
358
1422
14637
155
1048
1176
12338
Depressive episode, unspecified
F32.9 [45571760]
F32.9 [45571760]
6.2e-01
9.2e-01
1.5e+00
—
1.3e+00
5.4e-01
1.1e+00
cases:3.50%
controls:1.91%
cases:1.87%
controls:0.76%
cases:0.52%
controls:0.12%
—
—
cases:0.52%
controls:0.14%
cases:1.14%
controls:0.67%
cases:5.71%
controls:2.02%
54
294
1488
15119
29
117
1520
15358
8
18
1541
15457
—
8
21
1538
15424
17
101
1468
14894
76
271
1255
13115
Urgent procedure
ZXD05 [2001311386]
ZXD05 [2001311386]
3.2e-01
4.2e-01
1.1e+00
—
2.6e+00
2.6e-01
4.3e-01
cases:4.80%
controls:3.54%
cases:1.42%
controls:0.94%
cases:0.32%
controls:0.11%
—
—
cases:1.36%
controls:0.10%
cases:1.14%
controls:0.89%
cases:4.21%
controls:2.77%
74
546
1468
14867
22
145
1527
15330
5
17
1544
15458
—
21
16
1525
15429
17
133
1468
14862
56
371
1275
13015
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
5894-1 [3033658]
3.3e-01
4.5e-01
9.6e-01
—
1.9e+00
4.5e-01
6.8e-01
cases:5.06%
controls:3.70%
cases:3.36%
controls:2.17%
cases:0.77%
controls:0.30%
—
—
cases:1.88%
controls:0.28%
cases:2.42%
controls:1.55%
cases:8.56%
controls:4.53%
78
570
1464
14843
52
336
1497
15139
12
46
1537
15429
—
29
44
1517
15401
36
233
1449
14762
114
607
1217
12779
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
14749-6 [3013826]
1.9e-01
2.3e-01
5.0e-01
—
1.5e+00
6.1e-01
4.0e-01
cases:11.15%
controls:9.38%
cases:5.94%
controls:4.79%
cases:1.10%
controls:0.67%
—
—
cases:2.65%
controls:0.58%
cases:7.95%
controls:4.47%
cases:19.61%
controls:14.04%
172
1445
1370
13968
92
742
1457
14733
17
103
1532
15372
—
41
89
1505
15356
118
671
1367
14324
261
1879
1070
11507
Methadone [Presence] in Urine by Screen method
19550-3 [3028707]
19550-3 [3028707]
6.1e-01
8.9e-01
—
—
2.0e+00
1.5e+00
9.8e-01
cases:0.91%
controls:0.49%
cases:0.52%
controls:0.21%
—
—
—
—
cases:0.32%
controls:0.05%
cases:1.08%
controls:0.23%
cases:1.95%
controls:0.74%
14
76
1528
15337
8
33
1541
15442
—
—
5
7
1541
15438
16
35
1469
14960
26
99
1305
13287
Low back pain
M54.5 [45553207]
M54.5 [45553207]
4.7e-01
7.0e-01
1.3e+00
—
4.6e-01
7.7e-01
5.6e-01
cases:7.39%
controls:4.74%
cases:3.36%
controls:1.69%
cases:0.65%
controls:0.17%
—
—
cases:0.39%
controls:0.25%
cases:3.57%
controls:1.68%
cases:11.19%
controls:6.73%
114
730
1428
14683
52
262
1497
15213
10
27
1539
15448
—
6
38
1540
15407
53
252
1432
14743
149
901
1182
12485
Other shoulder lesions
M75.8 [45572543]
M75.8 [45572543]
8.3e-02
—
—
—
—
2.5e+00
1.1e-01
cases:0.32%
controls:0.30%
—
—
—
—
—
—
—
—
cases:0.40%
controls:0.03%
cases:0.53%
controls:0.47%
5
46
1537
15367
—
—
—
—
6
5
1479
14990
7
63
1324
13323
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
19072-8 [3016431]
1.7e-01
3.5e-01
9.0e-01
—
1.1e+00
4.4e-01
2.3e-01
cases:8.37%
controls:7.12%
cases:5.36%
controls:3.83%
cases:1.48%
controls:0.61%
—
—
cases:1.88%
controls:0.60%
cases:5.99%
controls:3.94%
cases:13.00%
controls:10.64%
129
1098
1413
14315
83
593
1466
14882
23
94
1526
15381
—
29
93
1517
15352
89
591
1396
14404
173
1424
1158
11962
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
14631-6 [3006140]
3.0e-01
3.8e-01
5.2e-01
—
7.7e-01
5.6e-01
4.8e-01
cases:10.51%
controls:8.00%
cases:6.46%
controls:4.49%
cases:1.48%
controls:0.89%
—
—
cases:1.81%
controls:0.85%
cases:7.00%
controls:4.13%
cases:17.21%
controls:11.39%
162
1233
1380
14180
100
695
1449
14780
23
137
1526
15338
—
28
131
1518
15314
104
620
1381
14375
229
1525
1102
11861
Car occupant injured in noncollision transport accident, unspecified car occupant injured in traffic accident
V48.9 [45595079]
V48.9 [45595079]
2.5e+00
—
—
—
—
—
—
cases:0.39%
controls:0.03%
—
—
—
—
—
—
—
—
—
—
—
—
6
5
1536
15408
—
—
—
—
—
—
Carboxyhemoglobin/Hemoglobin.total in Arterial blood
2030-5 [3028653]
2030-5 [3028653]
4.0e-01
—
—
—
2.5e+00
6.8e-01
3.0e-01
cases:0.84%
controls:0.56%
—
—
—
—
—
—
cases:0.39%
controls:0.03%
cases:0.54%
controls:0.27%
cases:1.43%
controls:1.06%
13
87
1529
15326
—
—
—
6
5
1540
15440
8
41
1477
14954
19
142
1312
13244
Lactate [Moles/volume] in Serum or Plasma
2524-7 [3014111]
2524-7 [3014111]
4.6e-01
2.8e-01
—
—
2.5e+00
3.7e-01
4.5e-01
cases:1.36%
controls:0.86%
cases:0.58%
controls:0.44%
—
—
—
—
cases:0.39%
controls:0.03%
cases:0.67%
controls:0.47%
cases:2.55%
controls:1.64%
21
133
1521
15280
9
68
1540
15407
—
—
6
5
1540
15440
10
70
1475
14925
34
219
1297
13167
General psychiatric examination, not elsewhere classified
Z00.4 [45605094]
Z00.4 [45605094]
6.4e-01
9.7e-01
1.2e+00
—
1.2e+00
8.2e-01
8.7e-01
cases:2.85%
controls:1.52%
cases:1.16%
controls:0.45%
cases:0.39%
controls:0.12%
—
—
cases:0.45%
controls:0.14%
cases:1.01%
controls:0.45%
cases:3.53%
controls:1.51%
44
234
1498
15179
18
69
1531
15406
6
19
1543
15456
—
7
22
1539
15423
15
67
1470
14928
47
202
1284
13184
Contusion of shoulder and upper arm
S40.0 [45563774]
S40.0 [45563774]
9.2e-01
1.4e+00
—
—
—
2.5e+00
8.2e-01
cases:0.65%
controls:0.26%
cases:0.39%
controls:0.10%
—
—
—
—
—
—
cases:0.47%
controls:0.04%
cases:1.13%
controls:0.50%
10
40
1532
15373
6
15
1543
15460
—
—
—
7
6
1478
14989
15
67
1316
13319
Emotionally unstable personality disorder, impulsive
F60.30 [2000502022]
F60.30 [2000502022]
1.1e+00
1.2e+00
—
—
1.5e+00
1.3e+00
1.4e+00
cases:0.91%
controls:0.30%
cases:0.65%
controls:0.19%
—
—
—
—
cases:0.32%
controls:0.07%
cases:0.54%
controls:0.15%
cases:1.28%
controls:0.33%
14
47
1528
15366
10
29
1539
15446
—
—
5
11
1541
15434
8
23
1477
14972
17
44
1314
13342
Withdrawal symptoms and delirium caused by alcohol without information about seizures
F10.49 [2000501690]
F10.49 [2000501690]
2.5e+00
—
—
—
—
—
—
cases:0.45%
controls:0.04%
—
—
—
—
—
—
—
—
—
—
—
—
7
6
1535
15407
—
—
—
—
—
—
Teaching
WZC30 [2001310891]
WZC30 [2001310891]
3.0e-01
3.5e-01
-1.0e+50
—
2.4e+00
5.8e-01
4.2e-01
cases:1.62%
controls:1.20%
cases:0.97%
controls:0.68%
cases:0.00%
controls:0.14%
—
—
cases:1.03%
controls:0.09%
cases:1.08%
controls:0.61%
cases:3.01%
controls:2.00%
25
185
1517
15228
15
106
1534
15369
0
21
1549
15454
—
16
14
1530
15431
16
91
1469
14904
40
268
1291
13118
Thorax X-ray examination
GD1AA [2001303617]
GD1AA [2001303617]
4.3e-01
6.8e-01
8.6e-01
—
1.1e+00
6.9e-01
6.0e-01
cases:8.63%
controls:5.78%
cases:4.52%
controls:2.34%
cases:0.52%
controls:0.22%
—
—
cases:0.78%
controls:0.27%
cases:3.70%
controls:1.89%
cases:10.59%
controls:6.08%
133
891
1409
14522
70
362
1479
15113
8
34
1541
15441
—
12
42
1534
15403
55
284
1430
14711
141
814
1190
12572
Consultation of another employee
SPAT1260 [2001700361]
SPAT1260 [2001700361]
2.2e-01
4.9e-01
—
—
1.9e+00
2.8e-01
5.3e-01
cases:2.72%
controls:2.19%
cases:1.10%
controls:0.68%
—
—
—
—
cases:0.45%
controls:0.07%
cases:0.88%
controls:0.66%
cases:3.76%
controls:2.24%
42
338
1500
15075
17
105
1532
15370
—
—
7
11
1539
15434
13
99
1472
14896
50
300
1281
13086
Upper respiratory infection acute
R74 [2002000942]
R74 [2002000942]
4.9e-01
7.8e-01
7.2e-01
—
6.7e-01
5.6e-01
5.5e-01
cases:9.01%
controls:5.75%
cases:4.58%
controls:2.15%
cases:0.45%
controls:0.22%
—
—
cases:0.52%
controls:0.27%
cases:4.44%
controls:2.59%
cases:12.85%
controls:7.81%
139
886
1403
14527
71
332
1478
15143
7
34
1542
15441
—
8
41
1538
15404
66
388
1419
14607
171
1046
1160
12340
Otolaryngology
4 [38004449]
4 [38004449]
4.8e-01
6.9e-01
7.1e-01
—
7.9e-01
6.2e-01
5.8e-01
cases:14.59%
controls:9.54%
cases:6.58%
controls:3.42%
cases:1.10%
controls:0.54%
—
—
cases:1.03%
controls:0.47%
cases:5.59%
controls:3.07%
cases:15.85%
controls:9.57%
225
1470
1317
13943
102
530
1447
14945
17
84
1532
15391
—
16
73
1530
15372
83
461
1402
14534
211
1281
1120
12105
Phosphatidylethanol [Mass/volume] in Blood
74661-0 [44816559]
74661-0 [44816559]
-2.0e-02
1.1e+00
—
—
—
1.3e+00
1.0e+00
cases:0.32%
controls:0.33%
cases:0.52%
controls:0.18%
—
—
—
—
—
—
cases:0.74%
controls:0.20%
cases:2.85%
controls:1.03%
5
51
1537
15362
8
28
1541
15447
—
—
—
11
30
1474
14965
38
138
1293
13248
citalopram; oral, parenteral
N06AB04 [21604712]
N06AB04 [21604712]
6.2e-01
5.4e-01
5.8e-02
—
1.1e+00
5.9e-01
5.9e-01
cases:4.99%
controls:2.74%
cases:2.58%
controls:1.53%
cases:0.45%
controls:0.43%
—
—
cases:0.97%
controls:0.32%
cases:2.56%
controls:1.44%
cases:4.21%
controls:2.38%
77
422
1465
14991
40
236
1509
15239
7
66
1542
15409
—
15
49
1531
15396
38
216
1447
14779
56
318
1275
13068
Methylenedioxymethamphetamine [Presence] in Urine by Screen method
19568-5 [3002148]
19568-5 [3002148]
—
—
—
—
—
2.3e+00
4.5e-01
—
—
—
—
—
—
—
—
—
—
cases:0.40%
controls:0.04%
cases:0.53%
controls:0.34%
—
—
—
—
—
6
6
1479
14989
7
45
1324
13341
Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
11259-9 [3021125]
11259-9 [3021125]
9.7e-01
—
—
—
—
-1.0e+50
2.3e+00
cases:0.32%
controls:0.12%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.03%
cases:0.83%
controls:0.08%
5
19
1537
15394
—
—
—
—
0
5
1485
14990
11
11
1320
13375
Assault by bodily force by other known person
Y04.8 [2000503711]
Y04.8 [2000503711]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.45%
controls:0.04%
—
—
—
—
—
—
6
6
1325
13380
Paranoid schizophrenia continuous
F20.00 [2000501920]
F20.00 [2000501920]
7.8e-01
1.2e+00
—
—
2.3e+00
1.4e+00
8.5e-01
cases:0.65%
controls:0.30%
cases:0.39%
controls:0.12%
—
—
—
—
cases:0.45%
controls:0.05%
cases:0.54%
controls:0.13%
cases:0.68%
controls:0.29%
10
46
1532
15367
6
19
1543
15456
—
—
7
7
1539
15438
8
20
1477
14975
9
39
1322
13347
Open wound of finger(s) without damage to nail
S61.0 [45578756]
S61.0 [45578756]
7.4e-01
1.5e+00
—
—
—
8.1e-01
3.8e-01
cases:2.01%
controls:0.97%
cases:1.23%
controls:0.26%
—
—
—
—
—
—
cases:0.54%
controls:0.24%
cases:2.18%
controls:1.49%
31
150
1511
15263
19
41
1530
15434
—
—
—
8
36
1477
14959
29
200
1302
13186
gabapentin; oral
N02BF01 [955005]
N02BF01 [955005]
4.8e-01
7.0e-01
4.2e-01
—
7.8e-01
8.9e-01
6.8e-01
cases:3.05%
controls:1.91%
cases:1.94%
controls:0.98%
cases:0.45%
controls:0.30%
—
—
cases:0.78%
controls:0.36%
cases:2.42%
controls:1.01%
cases:5.71%
controls:2.98%
47
295
1495
15118
30
151
1519
15324
7
46
1542
15429
—
12
55
1534
15390
36
151
1449
14844
76
399
1255
12987
General anaesthesia
WX402 [2001310806]
WX402 [2001310806]
5.4e-01
5.6e-01
-1.0e+50
—
2.2e+00
4.4e-01
3.3e-01
cases:2.92%
controls:1.73%
cases:1.61%
controls:0.93%
cases:0.00%
controls:0.08%
—
—
cases:0.84%
controls:0.09%
cases:1.21%
controls:0.79%
cases:3.76%
controls:2.74%
45
266
1497
15147
25
144
1524
15331
0
13
1549
15462
—
13
14
1533
15431
18
118
1467
14877
50
367
1281
13019
Bipolar affective disorder, current episode hypomanic
F31.0 [45542840]
F31.0 [45542840]
1.1e+00
—
—
—
—
—
2.2e+00
cases:0.32%
controls:0.10%
—
—
—
—
—
—
—
—
—
—
cases:0.60%
controls:0.07%
5
16
1537
15397
—
—
—
—
—
8
9
1323
13377
Recurrent depressive disorder, unspecified
F33.9 [45581458]
F33.9 [45581458]
8.9e-01
1.2e+00
-1.0e+50
—
-1.0e+50
—
9.7e-01
cases:1.10%
controls:0.45%
cases:0.77%
controls:0.23%
cases:0.00%
controls:0.03%
—
—
cases:0.00%
controls:0.06%
—
—
cases:1.58%
controls:0.61%
17
70
1525
15343
12
36
1537
15439
0
5
1549
15470
—
0
10
1546
15435
—
21
81
1310
13305
pH of Serum or Plasma
2753-2 [3018418]
2753-2 [3018418]
1.7e-01
3.4e-01
1.0e+00
—
1.1e+00
4.8e-01
5.6e-02
cases:4.67%
controls:3.96%
cases:2.84%
controls:2.04%
cases:0.90%
controls:0.32%
—
—
cases:0.84%
controls:0.27%
cases:3.23%
controls:2.03%
cases:5.94%
controls:5.63%
72
610
1470
14803
44
315
1505
15160
14
50
1535
15425
—
13
42
1533
15403
48
304
1437
14691
79
754
1252
12632
Other nail disorders
L60.8 [45581953]
L60.8 [45581953]
—
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.45%
controls:0.05%
—
—
—
—
—
—
6
7
1325
13379
Problem related to life-management difficulty, unspecified
Z73.9 [45585852]
Z73.9 [45585852]
—
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.45%
controls:0.05%
—
—
—
—
—
—
6
7
1325
13379
Breathalyser test
225622001 [4023193]
225622001 [4023193]
1.5e+00
—
—
—
—
—
2.2e+00
cases:0.45%
controls:0.10%
—
—
—
—
—
—
—
—
—
—
cases:0.45%
controls:0.05%
7
16
1535
15397
—
—
—
—
—
6
7
1325
13379
permethrin
P03AC04 [21604984]
P03AC04 [21604984]
9.7e-01
—
—
—
—
-1.0e+50
2.2e+00
cases:0.32%
controls:0.12%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.05%
cases:0.45%
controls:0.05%
5
19
1537
15394
—
—
—
—
0
8
1485
14987
6
7
1325
13379
etoricoxib; oral
M01AH05 [21603996]
M01AH05 [21603996]
4.3e-01
6.1e-01
6.0e-01
—
7.7e-01
5.6e-01
5.6e-01
cases:16.80%
controls:11.62%
cases:8.26%
controls:4.65%
cases:1.10%
controls:0.61%
—
—
cases:1.16%
controls:0.54%
cases:7.88%
controls:4.67%
cases:23.07%
controls:14.64%
259
1791
1283
13622
128
720
1421
14755
17
94
1532
15381
—
18
84
1528
15361
117
701
1368
14294
307
1960
1024
11426
Observation for suspected disease or condition, unspecified
Z03.9 [45552062]
Z03.9 [45552062]
4.3e-01
6.2e-01
—
—
2.2e+00
4.4e-01
4.6e-01
cases:3.57%
controls:2.35%
cases:1.48%
controls:0.80%
—
—
—
—
cases:0.78%
controls:0.09%
cases:1.14%
controls:0.74%
cases:4.06%
controls:2.59%
55
362
1487
15051
23
124
1526
15351
—
—
12
14
1534
15431
17
111
1468
14884
54
347
1277
13039
Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent
F19.20 [2000501891]
F19.20 [2000501891]
2.2e+00
—
—
—
—
-1.0e+50
1.8e+00
cases:0.39%
controls:0.05%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.03%
cases:0.38%
controls:0.06%
6
7
1536
15406
—
—
—
—
0
5
1485
14990
5
8
1326
13378
Acute stress reaction mild
F43.00 [2000501998]
F43.00 [2000501998]
—
2.2e+00
—
—
—
-1.0e+50
—
—
—
cases:0.39%
controls:0.05%
—
—
—
—
—
—
cases:0.00%
controls:0.03%
—
—
—
6
7
1543
15468
—
—
—
0
5
1485
14990
—
Pain localized to upper abdomen
R10.1 [45568111]
R10.1 [45568111]
6.8e-01
6.2e-01
—
—
—
8.9e-01
5.7e-01
cases:3.11%
controls:1.60%
cases:1.16%
controls:0.63%
—
—
—
—
—
—
cases:1.21%
controls:0.50%
cases:3.91%
controls:2.25%
48
247
1494
15166
18
97
1531
15378
—
—
—
18
75
1467
14920
52
301
1279
13085
Centromere Ab [Units/volume] in Serum
8068-9 [3038026]
8068-9 [3038026]
—
-1.0e+50
—
—
—
—
2.1e+00
—
—
cases:0.00%
controls:0.05%
—
—
—
—
—
—
—
—
cases:0.75%
controls:0.09%
—
0
8
1549
15467
—
—
—
—
10
12
1321
13374
Withdrawal symptoms caused by alcohol uncomplicated
F10.30 [2000501685]
F10.30 [2000501685]
2.1e+00
—
—
—
—
—
—
cases:0.65%
controls:0.08%
—
—
—
—
—
—
—
—
—
—
—
—
10
12
1532
15401
—
—
—
—
—
—
Gas panel - Venous blood
24339-4 [3000991]
24339-4 [3000991]
5.6e-01
1.4e-01
—
—
2.1e+00
5.6e-01
3.4e-01
cases:1.75%
controls:1.01%
cases:0.65%
controls:0.56%
—
—
—
—
cases:0.65%
controls:0.08%
cases:1.01%
controls:0.58%
cases:2.25%
controls:1.61%
27
155
1515
15258
10
87
1539
15388
—
—
10
12
1536
15433
15
87
1470
14908
30
216
1301
13170
Fall on same level involving ice and snow
W00 [45756242]
W00 [45756242]
5.6e-01
9.7e-01
—
—
—
1.4e+00
7.4e-01
cases:1.75%
controls:1.01%
cases:0.65%
controls:0.25%
—
—
—
—
—
—
cases:0.88%
controls:0.23%
cases:2.33%
controls:1.13%
27
156
1515
15257
10
38
1539
15437
—
—
—
13
34
1472
14961
31
151
1300
13235
Examination and observation following alleged rape and seduction
Z04.4 [45605100]
Z04.4 [45605100]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.60%
controls:0.07%
—
—
—
—
—
—
8
10
1323
13376
Asthma, unspecified
J45.9 [45562456]
J45.9 [45562456]
5.5e-01
9.7e-01
1.2e+00
—
6.9e-01
5.4e-01
5.6e-01
cases:3.70%
controls:2.16%
cases:2.32%
controls:0.90%
cases:0.65%
controls:0.20%
—
—
cases:0.32%
controls:0.16%
cases:1.75%
controls:1.03%
cases:5.03%
controls:2.95%
57
333
1485
15080
36
139
1513
15336
10
31
1539
15444
—
5
25
1541
15420
26
154
1459
14841
67
395
1264
12991
ketoprofen; oral, parenteral, rectal
M01AE03 [21603969]
M01AE03 [21603969]
3.5e-01
3.2e-01
—
—
2.1e+00
3.0e-01
4.3e-01
cases:6.29%
controls:4.53%
cases:1.61%
controls:1.18%
—
—
—
—
cases:0.97%
controls:0.12%
cases:1.55%
controls:1.15%
cases:4.43%
controls:2.92%
97
698
1445
14715
25
183
1524
15292
—
—
15
19
1531
15426
23
172
1462
14823
59
391
1272
12995
Ethanol [Moles/volume] in Serum or Plasma
14719-9 [3020191]
14719-9 [3020191]
2.1e+00
—
—
—
—
—
4.1e-01
cases:0.71%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
cases:0.45%
controls:0.30%
11
14
1531
15399
—
—
—
—
—
6
40
1325
13346
Adverse effects in the therapeutic use of other and unspecified vaccines and biological substances
Y59 [45756621]
Y59 [45756621]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.53%
controls:0.07%
—
—
—
—
—
—
7
9
1324
13377
Dorsalgia, unspecified
M54.9 [45538791]
M54.9 [45538791]
9.9e-01
8.4e-01
—
—
—
7.6e-01
1.1e+00
cases:2.46%
controls:0.93%
cases:0.77%
controls:0.34%
—
—
—
—
—
—
cases:0.74%
controls:0.35%
cases:3.38%
controls:1.20%
38
143
1504
15270
12
52
1537
15423
—
—
—
11
52
1474
14943
45
160
1286
13226
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
X44 [45756400]
X44 [45756400]
1.1e+00
—
—
—
—
2.3e+00
2.1e+00
cases:0.58%
controls:0.19%
—
—
—
—
—
—
—
—
cases:0.34%
controls:0.03%
cases:0.75%
controls:0.10%
9
29
1533
15384
—
—
—
—
5
5
1480
14990
10
13
1321
13373
pantoprazole; oral, parenteral
A02BC02 [21600097]
A02BC02 [21600097]
4.6e-01
5.3e-01
3.7e-01
—
4.5e-01
4.7e-01
5.9e-01
cases:18.55%
controls:12.54%
cases:10.85%
controls:6.69%
cases:2.13%
controls:1.49%
—
—
cases:2.20%
controls:1.41%
cases:10.51%
controls:6.86%
cases:24.42%
controls:15.14%
286
1933
1256
13480
168
1036
1381
14439
33
230
1516
15245
—
34
218
1512
15227
156
1028
1329
13967
325
2027
1006
11359
Other enthesopathies of lower limb, excluding foot
M76.8 [45577349]
M76.8 [45577349]
—
—
—
—
—
2.0e+00
9.2e-01
—
—
—
—
—
—
—
—
—
—
cases:0.40%
controls:0.05%
cases:0.38%
controls:0.15%
—
—
—
—
—
6
8
1479
14987
5
20
1326
13366
Alcohol dependence currently abstinent, but staying in restrictive environment
F10.21 [2000501678]
F10.21 [2000501678]
1.8e+00
—
—
—
—
—
2.0e+00
cases:0.32%
controls:0.05%
—
—
—
—
—
—
—
—
—
—
cases:0.68%
controls:0.09%
5
8
1537
15405
—
—
—
—
—
9
12
1322
13374
10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
48348-7 [3048469]
48348-7 [3048469]
—
-1.0e+50
—
—
—
—
2.0e+00
—
—
cases:0.00%
controls:0.03%
—
—
—
—
—
—
—
—
cases:0.45%
controls:0.06%
—
0
5
1549
15470
—
—
—
—
6
8
1325
13378
Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder
F10.9 [45557158]
F10.9 [45557158]
2.0e+00
—
—
—
—
—
—
cases:0.39%
controls:0.05%
—
—
—
—
—
—
—
—
—
—
—
—
6
8
1536
15405
—
—
—
—
—
—
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
51483-6 [3030467]
4.0e-01
3.6e-01
8.0e-01
—
1.2e+00
4.7e-01
4.4e-01
cases:5.51%
controls:3.75%
cases:2.91%
controls:2.04%
cases:0.52%
controls:0.23%
—
—
cases:0.84%
controls:0.27%
cases:3.10%
controls:1.97%
cases:8.56%
controls:5.71%
85
578
1457
14835
45
316
1504
15159
8
36
1541
15439
—
13
41
1533
15404
46
295
1439
14700
114
764
1217
12622
Rotator cuff syndrome
M75.1 [45596678]
M75.1 [45596678]
2.8e-01
7.7e-01
—
—
—
7.4e-01
4.6e-01
cases:3.44%
controls:2.63%
cases:1.87%
controls:0.87%
—
—
—
—
—
—
cases:1.89%
controls:0.91%
cases:5.26%
controls:3.38%
53
405
1489
15008
29
135
1520
15340
—
—
—
28
136
1457
14859
70
452
1261
12934
Fracture of rib
S22.3 [45573285]
S22.3 [45573285]
6.5e-01
2.0e+00
—
—
—
3.1e-01
4.1e-01
cases:0.97%
controls:0.51%
cases:0.77%
controls:0.11%
—
—
—
—
—
—
cases:0.34%
controls:0.25%
cases:1.13%
controls:0.75%
15
79
1527
15334
12
17
1537
15458
—
—
—
5
37
1480
14958
15
100
1316
13286
macrogol; oral
A06AD15 [21600575]
A06AD15 [21600575]
5.3e-01
7.1e-01
—
—
—
1.1e+00
8.4e-01
cases:1.30%
controls:0.77%
cases:0.84%
controls:0.41%
—
—
—
—
—
—
cases:1.48%
controls:0.51%
cases:2.93%
controls:1.28%
20
118
1522
15295
13
64
1536
15411
—
—
—
22
76
1463
14919
39
172
1292
13214
Alcohol use
Z72.1 [45552103]
Z72.1 [45552103]
—
—
—
—
—
—
1.9e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.60%
controls:0.09%
—
—
—
—
—
—
8
12
1323
13374
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
1995-0 [3021347]
1.7e-01
2.4e-01
8.0e-01
—
1.2e+00
4.3e-01
3.1e-01
cases:7.72%
controls:6.57%
cases:4.33%
controls:3.44%
cases:1.23%
controls:0.56%
—
—
cases:1.55%
controls:0.49%
cases:5.12%
controls:3.39%
cases:11.57%
controls:8.73%
119
1012
1423
14401
67
533
1482
14942
19
86
1530
15389
—
24
76
1522
15369
76
509
1409
14486
154
1169
1177
12217
escitalopram; oral
N06AB10 [21604718]
N06AB10 [21604718]
2.9e-01
6.1e-01
7.6e-01
—
3.9e-01
5.7e-01
7.1e-01
cases:4.99%
controls:3.77%
cases:3.55%
controls:1.96%
cases:1.29%
controls:0.61%
—
—
cases:0.97%
controls:0.66%
cases:3.64%
controls:2.09%
cases:8.04%
controls:4.14%
77
581
1465
14832
55
304
1494
15171
20
94
1529
15381
—
15
102
1531
15343
54
314
1431
14681
107
554
1224
12832
prednisolone; oral, parenteral
H02AB06 [21602734]
H02AB06 [21602734]
4.4e-01
4.8e-01
5.9e-01
—
3.7e-01
4.4e-01
5.2e-01
cases:12.00%
controls:8.05%
cases:5.29%
controls:3.35%
cases:1.03%
controls:0.58%
—
—
cases:0.84%
controls:0.58%
cases:5.25%
controls:3.46%
cases:14.05%
controls:8.87%
185
1241
1357
14172
82
519
1467
14956
16
89
1533
15386
—
13
90
1533
15355
78
519
1407
14476
187
1187
1144
12199
prednisolone
A07EA01 [21600653]
A07EA01 [21600653]
4.4e-01
4.7e-01
5.9e-01
—
3.7e-01
4.3e-01
5.3e-01
cases:12.06%
controls:8.08%
cases:5.29%
controls:3.39%
cases:1.03%
controls:0.58%
—
—
cases:0.84%
controls:0.58%
cases:5.25%
controls:3.47%
cases:14.20%
controls:8.90%
186
1246
1356
14167
82
524
1467
14951
16
89
1533
15386
—
13
90
1533
15355
78
521
1407
14474
189
1192
1142
12194
Cough
R05 [2002000886]
R05 [2002000886]
6.9e-01
7.2e-01
—
—
1.2e+00
5.9e-01
4.5e-01
cases:5.77%
controls:2.98%
cases:1.94%
controls:0.95%
—
—
—
—
cases:0.32%
controls:0.10%
cases:1.89%
controls:1.05%
cases:5.63%
controls:3.67%
89
460
1453
14953
30
147
1519
15328
—
—
5
15
1541
15430
28
158
1457
14837
75
491
1256
12895
Fear of respiratory disease other
R27 [2002000896]
R27 [2002000896]
—
—
—
—
—
—
1.9e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.53%
controls:0.08%
—
—
—
—
—
—
7
11
1324
13375
Psychological sympt/compl other
P29 [2002000823]
P29 [2002000823]
5.4e-01
1.2e+00
1.8e+00
—
1.7e+00
7.1e-01
6.7e-01
cases:1.62%
controls:0.95%
cases:0.90%
controls:0.28%
cases:0.39%
controls:0.06%
—
—
cases:0.32%
controls:0.06%
cases:0.74%
controls:0.37%
cases:2.93%
controls:1.52%
25
146
1517
15267
14
43
1535
15432
6
10
1543
15465
—
5
9
1541
15436
11
55
1474
14940
39
204
1292
13182
Drugs identified in Urine by Screen method Nominal
12286-1 [3011288]
12286-1 [3011288]
5.0e-01
4.3e-01
—
—
—
1.1e+00
7.6e-01
cases:1.10%
controls:0.67%
cases:0.52%
controls:0.34%
—
—
—
—
—
—
cases:1.14%
controls:0.39%
cases:2.93%
controls:1.39%
17
104
1525
15309
8
52
1541
15423
—
—
—
17
59
1468
14936
39
186
1292
13200
Preventive oral care by dental hygienist
SCF02 [2001310319]
SCF02 [2001310319]
2.2e-01
—
—
—
—
—
1.8e+00
cases:0.32%
controls:0.26%
—
—
—
—
—
—
—
—
—
—
cases:0.60%
controls:0.10%
5
40
1537
15373
—
—
—
—
—
8
13
1323
13373
Interscalenous plexus blockade
WX200 [2001310777]
WX200 [2001310777]
1.8e+00
-1.0e+50
—
—
—
—
1.6e+00
cases:0.71%
controls:0.12%
cases:0.00%
controls:0.05%
—
—
—
—
—
—
—
—
cases:0.60%
controls:0.13%
11
18
1531
15395
0
8
1549
15467
—
—
—
—
8
17
1323
13369
Pulmonary Disease
29 [38004472]
29 [38004472]
4.6e-01
4.4e-01
7.1e-01
—
6.9e-01
4.8e-01
4.4e-01
cases:9.73%
controls:6.36%
cases:5.16%
controls:3.40%
cases:1.42%
controls:0.70%
—
—
cases:1.10%
controls:0.56%
cases:4.92%
controls:3.10%
cases:10.89%
controls:7.32%
150
981
1392
14432
80
526
1469
14949
22
109
1527
15366
—
17
86
1529
15359
73
465
1412
14530
145
980
1186
12406
Acute bronchitis, unspecified
J20.9 [45562445]
J20.9 [45562445]
1.2e+00
7.6e-01
—
—
—
3.7e-01
6.1e-01
cases:5.32%
controls:1.66%
cases:1.23%
controls:0.58%
—
—
—
—
—
—
cases:1.08%
controls:0.75%
cases:4.28%
controls:2.38%
82
256
1460
15157
19
89
1530
15386
—
—
—
16
112
1469
14883
57
318
1274
13068
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
6768-6 [3035995]
2.3e-01
2.9e-01
6.5e-01
1.7e+00
4.7e-01
4.4e-01
4.1e-01
cases:17.57%
controls:14.48%
cases:11.56%
controls:8.92%
cases:3.16%
controls:1.67%
cases:0.39%
controls:0.07%
cases:2.72%
controls:1.71%
cases:13.40%
controls:9.04%
cases:28.70%
controls:21.00%
271
2232
1271
13181
179
1380
1370
14095
49
259
1500
15216
6
11
1543
15464
42
264
1504
15181
199
1355
1286
13640
382
2811
949
10575
Guidance concerning treatment of rash and skin
SPAT1156 [2001700257]
SPAT1156 [2001700257]
2.0e-01
-8.4e-02
—
—
1.8e+00
6.4e-01
3.7e-01
cases:1.62%
controls:1.34%
cases:0.45%
controls:0.49%
—
—
—
—
cases:0.58%
controls:0.10%
cases:1.01%
controls:0.53%
cases:1.88%
controls:1.31%
25
206
1517
15207
7
76
1542
15399
—
—
9
15
1537
15430
15
80
1470
14915
25
175
1306
13211
Gestational diabetes
W85 [2002001276]
W85 [2002001276]
2.9e-01
—
—
—
—
1.8e+00
4.4e-01
cases:0.52%
controls:0.39%
—
—
—
—
—
—
—
—
cases:0.67%
controls:0.11%
cases:0.75%
controls:0.49%
8
60
1534
15353
—
—
—
—
10
17
1475
14978
10
65
1321
13321
Infiltration anesthesia
WX110 [2001310767]
WX110 [2001310767]
2.6e-01
3.5e-01
4.3e-01
1.8e+00
7.4e-01
3.1e-01
4.3e-01
cases:22.44%
controls:18.17%
cases:9.94%
controls:7.20%
cases:1.74%
controls:1.14%
cases:0.39%
controls:0.06%
cases:1.88%
controls:0.91%
cases:9.36%
controls:7.07%
cases:29.75%
controls:21.57%
346
2801
1196
12612
154
1114
1395
14361
27
176
1522
15299
6
10
1543
15465
29
140
1517
15305
139
1060
1346
13935
396
2887
935
10499
Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
53019-6 [3041423]
53019-6 [3041423]
—
-1.0e+50
—
—
—
—
1.8e+00
—
—
cases:0.00%
controls:0.05%
—
—
—
—
—
—
—
—
cases:0.75%
controls:0.13%
—
0
8
1549
15467
—
—
—
—
10
17
1321
13369
Vomiting
D10 [2002000309]
D10 [2002000309]
7.7e-01
9.0e-01
—
—
-1.0e+50
7.3e-01
1.0e+00
cases:1.69%
controls:0.79%
cases:0.71%
controls:0.29%
—
—
—
—
cases:0.00%
controls:0.05%
cases:0.47%
controls:0.23%
cases:1.80%
controls:0.66%
26
121
1516
15292
11
45
1538
15430
—
—
0
7
1546
15438
7
34
1478
14961
24
89
1307
13297
Choriogonadotropin [Units/volume] in Serum or Plasma
19080-1 [3018171]
19080-1 [3018171]
5.7e-01
7.9e-01
—
—
—
1.1e+00
6.9e-01
cases:2.01%
controls:1.14%
cases:0.84%
controls:0.38%
—
—
—
—
—
—
cases:1.14%
controls:0.39%
cases:3.01%
controls:1.53%
31
176
1511
15237
13
59
1536
15416
—
—
—
17
58
1468
14937
40
205
1291
13181
Supraventricular tachycardia
I47.1 [45567178]
I47.1 [45567178]
8.0e-01
1.2e+00
—
—
—
1.8e+00
6.5e-01
cases:0.65%
controls:0.29%
cases:0.39%
controls:0.12%
—
—
—
—
—
—
cases:0.47%
controls:0.08%
cases:0.60%
controls:0.31%
10
45
1532
15368
6
19
1543
15456
—
—
—
7
12
1478
14983
8
42
1323
13344
Other minor procedure on skin
TQW99 [2001310150]
TQW99 [2001310150]
—
—
—
1.0e+50
—
1.8e+00
4.3e-01
—
—
—
—
—
—
cases:0.32%
controls:0.00%
—
—
cases:0.47%
controls:0.08%
cases:0.53%
controls:0.34%
—
—
—
5
0
1544
15475
—
7
12
1478
14983
7
46
1324
13340
Thorax extensive CT-examination
GD1BD [2001303621]
GD1BD [2001303621]
5.3e-01
1.2e+00
—
—
—
—
1.8e+00
cases:0.52%
controls:0.30%
cases:0.32%
controls:0.10%
—
—
—
—
—
—
—
—
cases:0.53%
controls:0.09%
8
47
1534
15366
5
15
1544
15460
—
—
—
—
7
12
1324
13374
Hemoglobin [Mass/volume] in Arterial blood
30313-1 [3002173]
30313-1 [3002173]
2.3e-01
3.4e-01
—
—
1.8e+00
1.0e-01
2.0e-01
cases:1.10%
controls:0.88%
cases:0.58%
controls:0.41%
—
—
—
—
cases:0.45%
controls:0.08%
cases:0.47%
controls:0.43%
cases:1.95%
controls:1.61%
17
135
1525
15278
9
64
1540
15411
—
—
7
12
1539
15433
7
64
1478
14931
26
215
1305
13171
Oxygen saturation in Arterial blood
2708-6 [3016502]
2708-6 [3016502]
3.6e-01
3.4e-01
—
—
1.8e+00
3.1e-01
2.1e-01
cases:1.36%
controls:0.95%
cases:0.58%
controls:0.41%
—
—
—
—
cases:0.45%
controls:0.08%
cases:0.61%
controls:0.45%
cases:2.18%
controls:1.78%
21
147
1521
15266
9
64
1540
15411
—
—
7
12
1539
15433
9
67
1476
14928
29
238
1302
13148
Antenatal screening for malformation
717800004 [36713462]
717800004 [36713462]
2.4e-02
3.5e-01
1.8e+00
—
—
3.0e-01
1.6e-01
cases:2.98%
controls:2.91%
cases:1.42%
controls:1.01%
cases:0.45%
controls:0.08%
—
—
—
—
cases:1.41%
controls:1.05%
cases:3.53%
controls:3.02%
46
449
1496
14964
22
156
1527
15319
7
12
1542
15463
—
—
21
158
1464
14837
47
404
1284
12982
Sprain and strain of cervical spine
S13.4 [45573197]
S13.4 [45573197]
9.0e-01
1.8e+00
—
—
—
—
3.6e-01
cases:0.78%
controls:0.32%
cases:0.45%
controls:0.08%
—
—
—
—
—
—
—
—
cases:0.60%
controls:0.42%
12
49
1530
15364
7
12
1542
15463
—
—
—
—
8
56
1323
13330
oxycodone and naloxone; oral
N02AA55 [21604265]
N02AA55 [21604265]
1.4e-01
2.3e-01
—
—
1.7e+00
5.1e-01
4.6e-01
cases:1.62%
controls:1.41%
cases:0.77%
controls:0.61%
—
—
—
—
cases:0.78%
controls:0.14%
cases:1.08%
controls:0.65%
cases:3.08%
controls:1.96%
25
217
1517
15196
12
95
1537
15380
—
—
12
21
1534
15424
16
97
1469
14898
41
263
1290
13123
pH of Arterial blood
2744-1 [3019977]
2744-1 [3019977]
3.4e-01
2.0e-01
—
—
1.7e+00
1.9e-01
1.9e-01
cases:1.56%
controls:1.11%
cases:0.58%
controls:0.48%
—
—
—
—
cases:0.52%
controls:0.09%
cases:0.61%
controls:0.50%
cases:2.33%
controls:1.94%
24
171
1518
15242
9
74
1540
15401
—
—
8
14
1538
15431
9
75
1476
14920
31
260
1300
13126
Base excess in Arterial blood by calculation
1925-7 [3003396]
1925-7 [3003396]
3.8e-01
1.8e-01
—
—
1.7e+00
1.8e-01
1.7e-01
cases:1.62%
controls:1.12%
cases:0.58%
controls:0.48%
—
—
—
—
cases:0.52%
controls:0.09%
cases:0.61%
controls:0.51%
cases:2.33%
controls:1.97%
25
172
1517
15241
9
75
1540
15400
—
—
8
14
1538
15431
9
76
1476
14919
31
264
1300
13122
Patella X-ray examination
NG2AA [2001308078]
NG2AA [2001308078]
—
—
—
—
—
-1.0e+50
1.7e+00
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.04%
cases:0.68%
controls:0.12%
—
—
—
—
—
0
6
1485
14989
9
16
1322
13370
nitrazepam; oral
N05CD02 [21604637]
N05CD02 [21604637]
1.7e+00
—
—
—
—
—
1.6e+00
cases:0.58%
controls:0.10%
—
—
—
—
—
—
—
—
—
—
cases:0.38%
controls:0.07%
9
16
1533
15397
—
—
—
—
—
5
10
1326
13376
tizanidine; oral
M03BX02 [21604116]
M03BX02 [21604116]
3.3e-01
5.2e-01
5.0e-01
—
4.7e-01
5.8e-01
2.8e-01
cases:17.64%
controls:13.40%
cases:7.49%
controls:4.59%
cases:0.97%
controls:0.59%
—
—
cases:0.91%
controls:0.57%
cases:7.27%
controls:4.20%
cases:17.58%
controls:13.84%
272
2065
1270
13348
116
711
1433
14764
15
91
1534
15384
—
14
88
1532
15357
108
630
1377
14365
234
1853
1097
11533
Nuclear Ab [Presence] in Serum
8061-4 [3004616]
8061-4 [3004616]
6.9e-01
—
—
—
—
—
1.7e+00
cases:0.32%
controls:0.16%
—
—
—
—
—
—
—
—
—
—
cases:0.90%
controls:0.16%
5
25
1537
15388
—
—
—
—
—
12
22
1319
13364
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
24357-6 [3037467]
1.8e-01
3.2e-01
7.8e-01
1.6e+00
5.3e-01
3.3e-01
2.7e-01
cases:15.30%
controls:13.17%
cases:9.17%
controls:6.80%
cases:1.74%
controls:0.81%
cases:0.32%
controls:0.06%
cases:1.49%
controls:0.88%
cases:8.96%
controls:6.61%
cases:22.69%
controls:18.33%
236
2030
1306
13383
142
1052
1407
14423
27
125
1522
15350
5
10
1544
15465
23
136
1523
15309
133
991
1352
14004
302
2454
1029
10932
Pain in limb
M79.6 [45587063]
M79.6 [45587063]
5.3e-01
6.7e-01
6.2e-01
—
5.6e-01
3.8e-01
5.0e-01
cases:7.39%
controls:4.50%
cases:3.74%
controls:1.96%
cases:0.52%
controls:0.28%
—
—
cases:0.45%
controls:0.26%
cases:2.96%
controls:2.04%
cases:12.02%
controls:7.63%
114
693
1428
14720
58
303
1491
15172
8
43
1541
15432
—
7
40
1539
15405
44
306
1441
14689
160
1021
1171
12365
Physical abuse
T74.1 [45594864]
T74.1 [45594864]
9.8e-01
—
—
—
—
—
1.7e+00
cases:0.52%
controls:0.19%
—
—
—
—
—
—
—
—
—
—
cases:1.05%
controls:0.19%
8
30
1534
15383
—
—
—
—
—
14
26
1317
13360
Superficial injury of other parts of head
S00.8 [45563349]
S00.8 [45563349]
—
—
—
—
—
—
1.7e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.60%
controls:0.11%
—
—
—
—
—
—
8
15
1323
13371
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
Y83.9 [45547252]
Y83.9 [45547252]
—
-1.0e+50
—
—
—
—
1.7e+00
—
—
cases:0.00%
controls:0.04%
—
—
—
—
—
—
—
—
cases:0.68%
controls:0.13%
—
0
6
1549
15469
—
—
—
—
9
17
1322
13369
Pediatric Medicine
37 [38004477]
37 [38004477]
-6.5e-01
-5.5e-01
-2.6e-01
2.3e+00
7.1e-01
-2.5e-01
-9.1e-02
cases:2.27%
controls:4.24%
cases:1.16%
controls:2.00%
cases:0.39%
controls:0.50%
cases:0.45%
controls:0.05%
cases:0.84%
controls:0.41%
cases:1.21%
controls:1.55%
cases:1.65%
controls:1.81%
35
654
1507
14759
18
309
1531
15166
6
78
1543
15397
7
7
1542
15468
13
64
1533
15381
18
232
1467
14763
22
242
1309
13144
Diarrhoea
D11 [2002000310]
D11 [2002000310]
7.3e-01
5.5e-01
—
—
-1.0e+50
2.5e-01
9.2e-01
cases:2.66%
controls:1.30%
cases:0.65%
controls:0.37%
—
—
—
—
cases:0.00%
controls:0.05%
cases:0.67%
controls:0.53%
cases:3.68%
controls:1.49%
41
201
1501
15212
10
58
1539
15417
—
—
0
8
1546
15437
10
79
1475
14916
49
200
1282
13186
Infection following a procedure, not elsewhere classified
T81.4 [45575538]
T81.4 [45575538]
1.1e-01
—
-1.0e+50
—
2.0e+00
1.6e+00
3.5e-01
cases:0.97%
controls:0.88%
—
—
cases:0.00%
controls:0.05%
—
—
cases:0.32%
controls:0.05%
cases:1.14%
controls:0.23%
cases:1.28%
controls:0.90%
15
135
1527
15278
—
0
7
1549
15468
—
5
7
1541
15438
17
34
1468
14961
17
121
1314
13265
Traumatic rupture of ligament of wrist and carpus
S63.3 [45603196]
S63.3 [45603196]
—
—
—
—
—
—
1.6e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.68%
controls:0.13%
—
—
—
—
—
—
9
18
1322
13368
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
2075-0 [3014576]
2.9e-01
-1.1e-02
1.4e+00
—
1.6e+00
5.1e-01
9.5e-02
cases:1.69%
controls:1.27%
cases:0.65%
controls:0.65%
cases:0.45%
controls:0.12%
—
—
cases:0.52%
controls:0.10%
cases:1.08%
controls:0.65%
cases:2.70%
controls:2.47%
26
195
1516
15218
10
101
1539
15374
7
18
1542
15457
—
8
16
1538
15429
16
97
1469
14898
36
330
1295
13056
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]
2324-2 [3026910]
1.8e-01
3.0e-01
8.9e-01
—
5.1e-01
3.6e-01
3.6e-01
cases:15.18%
controls:12.96%
cases:8.13%
controls:6.16%
cases:1.81%
controls:0.75%
—
—
cases:1.36%
controls:0.82%
cases:8.69%
controls:6.22%
cases:26.90%
controls:20.50%
234
1997
1308
13416
126
954
1423
14521
28
116
1521
15359
—
21
127
1525
15318
129
933
1356
14062
358
2744
973
10642
Allergic urticaria
L50.0 [45581945]
L50.0 [45581945]
1.3e+00
—
—
—
—
—
1.6e+00
cases:0.52%
controls:0.14%
—
—
—
—
—
—
—
—
—
—
cases:0.90%
controls:0.19%
8
22
1534
15391
—
—
—
—
—
12
25
1319
13361
zopiclone; oral
N05CF01 [21604654]
N05CF01 [21604654]
4.2e-01
5.6e-01
4.1e-01
—
6.5e-01
4.3e-01
6.0e-01
cases:8.11%
controls:5.49%
cases:4.65%
controls:2.71%
cases:1.10%
controls:0.73%
—
—
cases:1.36%
controls:0.71%
cases:4.44%
controls:2.95%
cases:9.39%
controls:5.37%
125
846
1417
14567
72
420
1477
15055
17
113
1532
15362
—
21
110
1525
15335
66
442
1419
14553
125
719
1206
12667
Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
53017-0 [3041067]
53017-0 [3041067]
—
-1.0e+50
—
—
—
—
1.6e+00
—
—
cases:0.00%
controls:0.05%
—
—
—
—
—
—
—
—
cases:0.75%
controls:0.16%
—
0
8
1549
15467
—
—
—
—
10
21
1321
13365
haloperidol; oral, parenteral
N05AD01 [21604516]
N05AD01 [21604516]
1.6e+00
1.2e+00
—
—
—
1.4e+00
1.0e+00
cases:0.71%
controls:0.15%
cases:0.32%
controls:0.10%
—
—
—
—
—
—
cases:0.34%
controls:0.09%
cases:0.53%
controls:0.19%
11
23
1531
15390
5
15
1544
15460
—
—
—
5
13
1480
14982
7
26
1324
13360
aripiprazole; oral, parenteral
N05AX12 [21604562]
N05AX12 [21604562]
7.6e-01
4.7e-01
9.2e-01
—
-1.0e+50
3.5e-01
8.0e-01
cases:1.56%
controls:0.73%
cases:0.77%
controls:0.48%
cases:0.52%
controls:0.21%
—
—
cases:0.00%
controls:0.19%
cases:0.81%
controls:0.57%
cases:1.95%
controls:0.89%
24
113
1518
15300
12
75
1537
15400
8
32
1541
15443
—
0
29
1546
15416
12
86
1473
14909
26
119
1305
13267
Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1805-1 [3016417]
1805-1 [3016417]
8.1e-01
6.0e-01
—
—
—
5.4e-01
7.4e-01
cases:2.66%
controls:1.20%
cases:1.03%
controls:0.57%
—
—
—
—
—
—
cases:0.74%
controls:0.43%
cases:3.08%
controls:1.49%
41
185
1501
15228
16
88
1533
15387
—
—
—
11
65
1474
14930
41
200
1290
13186
Shoulder and humerus MRI examination with high intensity magnet
NB1BG [2001307231]
NB1BG [2001307231]
—
—
—
—
—
—
1.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.98%
controls:0.21%
—
—
—
—
—
—
13
28
1318
13358
Home Visit
OMOP4822459 [581476]
OMOP4822459 [581476]
1.3e-01
1.4e-01
1.6e-01
—
8.8e-01
6.5e-01
3.2e-01
cases:4.60%
controls:4.07%
cases:2.26%
controls:1.98%
cases:0.71%
controls:0.61%
—
—
cases:1.36%
controls:0.57%
cases:4.18%
controls:2.23%
cases:7.74%
controls:5.74%
71
628
1471
14785
35
306
1514
15169
11
94
1538
15381
—
21
88
1525
15357
62
334
1423
14661
103
769
1228
12617
Psychological disorders other
P99 [2002000880]
P99 [2002000880]
1.9e-01
1.3e+00
—
—
—
1.5e+00
6.4e-01
cases:0.45%
controls:0.38%
cases:0.45%
controls:0.13%
—
—
—
—
—
—
cases:0.61%
controls:0.13%
cases:0.75%
controls:0.40%
7
58
1535
15355
7
20
1542
15455
—
—
—
9
20
1476
14975
10
53
1321
13333
Pregnancy high risk
W84 [2002001275]
W84 [2002001275]
7.0e-01
1.5e+00
—
—
—
1.3e+00
2.7e-01
cases:0.71%
controls:0.36%
cases:0.65%
controls:0.14%
—
—
—
—
—
—
cases:0.47%
controls:0.13%
cases:0.68%
controls:0.52%
11
55
1531
15358
10
22
1539
15453
—
—
—
7
19
1478
14976
9
69
1322
13317
Superficial injury of scalp
S00.0 [45548998]
S00.0 [45548998]
1.0e+00
-1.0e+50
—
—
—
—
1.5e+00
cases:0.32%
controls:0.12%
cases:0.00%
controls:0.03%
—
—
—
—
—
—
—
—
cases:0.68%
controls:0.15%
5
18
1537
15395
0
5
1549
15470
—
—
—
—
9
20
1322
13366
colestyramine; oral
C10AC01 [21601876]
C10AC01 [21601876]
-1.0e+50
-1.0e+50
—
—
—
—
1.5e+00
cases:0.00%
controls:0.14%
cases:0.00%
controls:0.05%
—
—
—
—
—
—
—
—
cases:0.68%
controls:0.15%
0
22
1542
15391
0
7
1549
15468
—
—
—
—
9
20
1322
13366
Unspecified injury of ankle and foot
S99.9 [45541238]
S99.9 [45541238]
1.5e+00
—
—
—
—
—
—
cases:0.58%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
—
—
9
20
1533
15393
—
—
—
—
—
—
esomeprazole; oral, parenteral
A02BC05 [21600100]
A02BC05 [21600100]
3.3e-01
4.2e-01
3.5e-01
—
7.0e-01
6.1e-01
5.4e-01
cases:8.37%
controls:6.14%
cases:4.71%
controls:3.13%
cases:0.90%
controls:0.64%
—
—
cases:1.42%
controls:0.71%
cases:5.72%
controls:3.18%
cases:11.57%
controls:7.11%
129
947
1413
14466
73
485
1476
14990
14
99
1535
15376
—
22
110
1524
15335
85
477
1400
14518
154
952
1177
12434
CT of neck arteries
PA6AD [2001308692]
PA6AD [2001308692]
1.7e+00
-1.0e+50
—
—
—
—
1.5e+00
cases:0.39%
controls:0.07%
cases:0.00%
controls:0.05%
—
—
—
—
—
—
—
—
cases:0.98%
controls:0.22%
6
11
1536
15402
0
7
1549
15468
—
—
—
—
13
30
1318
13356
Open wound of wrist and hand, part unspecified
S61.9 [45554740]
S61.9 [45554740]
8.5e-01
1.6e+00
—
—
—
—
1.5e+00
cases:0.65%
controls:0.28%
cases:0.45%
controls:0.09%
—
—
—
—
—
—
—
—
cases:1.13%
controls:0.26%
10
43
1532
15370
7
14
1542
15461
—
—
—
—
15
35
1316
13351
Vibrio sp identified in Specimen by Organism specific culture
6581-3 [3005988]
6581-3 [3005988]
8.7e-01
—
—
—
—
—
1.5e+00
cases:0.32%
controls:0.14%
—
—
—
—
—
—
—
—
—
—
cases:0.68%
controls:0.16%
5
21
1537
15392
—
—
—
—
—
9
21
1322
13365
Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
82198-3 [21493466]
82198-3 [21493466]
8.7e-01
—
—
—
—
—
1.5e+00
cases:0.32%
controls:0.14%
—
—
—
—
—
—
—
—
—
—
cases:0.68%
controls:0.16%
5
21
1537
15392
—
—
—
—
—
9
21
1322
13365
Yersinia sp identified in Specimen by Organism specific culture
701-3 [3025468]
701-3 [3025468]
8.7e-01
—
—
—
—
—
1.5e+00
cases:0.32%
controls:0.14%
—
—
—
—
—
—
—
—
—
—
cases:0.68%
controls:0.16%
5
21
1537
15392
—
—
—
—
—
9
21
1322
13365
Remowal of suture of skin
TQW40 [2001310146]
TQW40 [2001310146]
7.4e-01
6.2e-01
—
—
—
—
1.5e+00
cases:0.91%
controls:0.43%
cases:0.32%
controls:0.17%
—
—
—
—
—
—
—
—
cases:1.65%
controls:0.39%
14
67
1528
15346
5
27
1544
15448
—
—
—
—
22
52
1309
13334
Acute upper respiratory infection, unspecified
J06.9 [45562437]
J06.9 [45562437]
4.6e-01
3.6e-01
1.6e-01
—
5.5e-01
5.0e-01
4.8e-01
cases:13.36%
controls:8.88%
cases:5.87%
controls:4.16%
cases:0.58%
controls:0.50%
—
—
cases:0.84%
controls:0.49%
cases:7.27%
controls:4.55%
cases:20.44%
controls:13.75%
206
1368
1336
14045
91
644
1458
14831
9
77
1540
15398
—
13
75
1533
15370
108
682
1377
14313
272
1841
1059
11545
Wrist symptom/complaint
L11 [2002000635]
L11 [2002000635]
2.5e-01
1.4e+00
—
—
—
6.0e-01
4.9e-01
cases:1.10%
controls:0.86%
cases:0.97%
controls:0.23%
—
—
—
—
—
—
cases:0.47%
controls:0.26%
cases:1.65%
controls:1.02%
17
133
1525
15280
15
36
1534
15439
—
—
—
7
39
1478
14956
22
136
1309
13250
Alcohol intoxication UNS
F10.09 [2000501676]
F10.09 [2000501676]
6.6e-01
—
—
—
—
1.4e+00
1.4e+00
cases:0.39%
controls:0.20%
—
—
—
—
—
—
—
—
cases:0.40%
controls:0.10%
cases:0.90%
controls:0.22%
6
31
1536
15382
—
—
—
—
6
15
1479
14980
12
29
1319
13357
Pruritus, unspecified
L29.9 [45548195]
L29.9 [45548195]
7.8e-01
-1.0e+50
—
—
—
—
1.4e+00
cases:0.32%
controls:0.15%
cases:0.00%
controls:0.05%
—
—
—
—
—
—
—
—
cases:0.90%
controls:0.22%
5
23
1537
15390
0
8
1549
15467
—
—
—
—
12
29
1319
13357
U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
59026-5 [40762119]
59026-5 [40762119]
—
-1.0e+50
—
—
—
—
1.4e+00
—
—
cases:0.00%
controls:0.09%
—
—
—
—
—
—
—
—
cases:1.05%
controls:0.25%
—
0
14
1549
15461
—
—
—
—
14
34
1317
13352
erdosteine; oral
R05CB15 [21603394]
R05CB15 [21603394]
4.2e-01
8.3e-01
—
—
—
3.6e-01
5.9e-01
cases:2.46%
controls:1.63%
cases:1.55%
controls:0.68%
—
—
—
—
—
—
cases:1.08%
controls:0.75%
cases:4.43%
controls:2.52%
38
252
1504
15161
24
105
1525
15370
—
—
—
16
113
1469
14882
59
337
1272
13049
Musculoskeletal sympt/complt other
L29 [2002000648]
L29 [2002000648]
4.4e-01
7.7e-01
—
—
—
1.4e+00
7.0e-01
cases:0.91%
controls:0.58%
cases:0.52%
controls:0.24%
—
—
—
—
—
—
cases:0.88%
controls:0.21%
cases:1.80%
controls:0.90%
14
90
1528
15323
8
37
1541
15438
—
—
—
13
32
1472
14963
24
121
1307
13265
Sprain and strain of finger(s)
S63.6 [45564454]
S63.6 [45564454]
1.4e+00
1.2e+00
—
—
—
9.8e-01
3.1e-01
cases:1.17%
controls:0.29%
cases:0.32%
controls:0.10%
—
—
—
—
—
—
cases:0.34%
controls:0.13%
cases:0.60%
controls:0.44%
18
44
1524
15369
5
15
1544
15460
—
—
—
5
19
1480
14976
8
59
1323
13327
Telehealth
OMOP5556618 [722455]
OMOP5556618 [722455]
9.5e-02
2.5e-01
5.1e-01
—
1.1e+00
2.1e-01
3.2e-01
cases:23.67%
controls:21.99%
cases:11.30%
controls:9.01%
cases:2.58%
controls:1.56%
—
—
cases:3.95%
controls:1.36%
cases:10.51%
controls:8.69%
cases:24.94%
controls:19.51%
365
3390
1177
12023
175
1394
1374
14081
40
242
1509
15233
—
61
210
1485
15235
156
1303
1329
13692
332
2611
999
10775
Remote contact by phone
ZYC01 [2001311579]
ZYC01 [2001311579]
3.4e-01
9.6e-01
—
—
—
1.4e+00
2.4e-01
cases:0.45%
controls:0.32%
cases:0.39%
controls:0.15%
—
—
—
—
—
—
cases:0.81%
controls:0.20%
cases:1.13%
controls:0.89%
7
50
1535
15363
6
23
1543
15452
—
—
—
12
30
1473
14965
15
119
1316
13267
Sprain and strain involving (fibular)(tibial) collateral ligament of knee
S83.4 [45550630]
S83.4 [45550630]
1.1e+00
—
—
—
—
—
1.4e+00
cases:0.52%
controls:0.18%
—
—
—
—
—
—
—
—
—
—
cases:1.05%
controls:0.26%
8
28
1534
15385
—
—
—
—
—
14
35
1317
13351
sertraline; oral
N06AB06 [21604714]
N06AB06 [21604714]
7.1e-01
6.8e-01
6.3e-01
—
8.6e-01
4.1e-01
5.5e-01
cases:3.18%
controls:1.58%
cases:2.07%
controls:1.05%
cases:0.58%
controls:0.31%
—
—
cases:0.58%
controls:0.25%
cases:1.55%
controls:1.03%
cases:3.31%
controls:1.94%
49
244
1493
15169
32
163
1517
15312
9
48
1540
15427
—
9
38
1537
15407
23
155
1462
14840
44
260
1287
13126
oxycodone; oral, parenteral
N02AA05 [21604260]
N02AA05 [21604260]
-1.2e-01
8.0e-02
1.1e+00
—
1.4e+00
4.4e-01
1.0e-01
cases:0.78%
controls:0.88%
cases:0.58%
controls:0.54%
cases:0.52%
controls:0.18%
—
—
cases:0.91%
controls:0.23%
cases:1.08%
controls:0.69%
cases:1.88%
controls:1.70%
12
135
1530
15278
9
83
1540
15392
8
28
1541
15447
—
14
35
1532
15410
16
104
1469
14891
25
227
1306
13159
Assessment of ability to drive and opinion
SPAT1282 [2001700383]
SPAT1282 [2001700383]
1.4e+00
—
—
—
—
—
—
cases:0.65%
controls:0.16%
—
—
—
—
—
—
—
—
—
—
—
—
10
25
1532
15388
—
—
—
—
—
—
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
30391-7 [3002582]
4.5e-01
4.9e-01
5.1e-01
—
1.0e+00
4.8e-01
4.1e-01
cases:6.74%
controls:4.39%
cases:3.87%
controls:2.40%
cases:0.52%
controls:0.31%
—
—
cases:0.84%
controls:0.31%
cases:3.84%
controls:2.40%
cases:10.22%
controls:7.01%
104
677
1438
14736
60
371
1489
15104
8
48
1541
15427
—
13
48
1533
15397
57
360
1428
14635
136
939
1195
12447
Severe depressive episode without psychotic symptoms
F32.2 [45557202]
F32.2 [45557202]
3.7e-01
9.7e-01
1.3e+00
—
1.5e+00
1.4e+00
7.1e-01
cases:1.30%
controls:0.90%
cases:0.97%
controls:0.37%
cases:0.32%
controls:0.08%
—
—
cases:0.45%
controls:0.10%
cases:1.08%
controls:0.28%
cases:1.88%
controls:0.93%
20
138
1522
15275
15
57
1534
15418
5
13
1544
15462
—
7
16
1539
15429
16
42
1469
14953
25
125
1306
13261
Open wound of other parts of foot
S91.3 [45599027]
S91.3 [45599027]
—
—
—
—
—
—
1.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.98%
controls:0.25%
—
—
—
—
—
—
13
34
1318
13352
Psychiatric monitoring contact
IGY02 [2001304322]
IGY02 [2001304322]
—
7.8e-01
—
—
—
1.3e+00
-5.4e-03
—
—
cases:0.32%
controls:0.15%
—
—
—
—
—
—
cases:0.74%
controls:0.19%
cases:0.68%
controls:0.68%
—
5
23
1544
15452
—
—
—
11
29
1474
14966
9
91
1322
13295
Cyclic citrullinated peptide Ab [Units/volume] in Serum
53027-9 [3041942]
53027-9 [3041942]
2.6e-01
8.6e-01
-1.0e+50
—
—
4.0e-01
4.8e-01
cases:3.11%
controls:2.42%
cases:1.55%
controls:0.66%
cases:0.00%
controls:0.06%
—
—
—
—
cases:1.14%
controls:0.77%
cases:4.96%
controls:3.12%
48
373
1494
15040
24
102
1525
15373
0
9
1549
15466
—
—
17
116
1468
14879
66
418
1265
12968
Pulpitis
K04.0 [45591570]
K04.0 [45591570]
1.9e-01
1.3e+00
—
—
—
3.9e-01
2.3e-01
cases:1.62%
controls:1.35%
cases:1.03%
controls:0.27%
—
—
—
—
—
—
cases:0.47%
controls:0.32%
cases:1.58%
controls:1.26%
25
208
1517
15205
16
42
1533
15433
—
—
—
7
48
1478
14947
21
168
1310
13218
Epithelial cells.non-squamous [#/volume] in Urine by Automated count
51485-1 [3030306]
51485-1 [3030306]
6.3e-01
7.1e-01
8.2e-01
—
1.0e+00
5.5e-01
3.9e-01
cases:3.24%
controls:1.75%
cases:1.81%
controls:0.90%
cases:0.32%
controls:0.14%
—
—
cases:0.39%
controls:0.14%
cases:1.89%
controls:1.09%
cases:5.41%
controls:3.74%
50
270
1492
15143
28
139
1521
15336
5
22
1544
15453
—
6
22
1540
15423
28
164
1457
14831
72
501
1259
12885
Epilepsy
G40 [45595935]
G40 [45595935]
4.2e-01
—
-1.0e+50
—
—
1.5e+00
1.3e+00
cases:0.58%
controls:0.38%
—
—
cases:0.00%
controls:0.03%
—
—
—
—
cases:0.40%
controls:0.09%
cases:0.90%
controls:0.24%
9
59
1533
15354
—
0
5
1549
15470
—
—
6
14
1479
14981
12
32
1319
13354
diclofenac; oral, parenteral, rectal
M01AB05 [21603945]
M01AB05 [21603945]
4.1e-01
4.7e-01
5.5e-01
—
5.7e-02
3.6e-01
4.4e-01
cases:19.78%
controls:14.03%
cases:7.10%
controls:4.58%
cases:0.84%
controls:0.48%
—
—
cases:0.58%
controls:0.55%
cases:6.26%
controls:4.45%
cases:19.31%
controls:13.31%
305
2162
1237
13251
110
709
1439
14766
13
75
1536
15400
—
9
85
1537
15360
93
667
1392
14328
257
1782
1074
11604
venlafaxine; oral
N06AX16 [21604745]
N06AX16 [21604745]
4.8e-01
4.3e-01
2.6e-01
—
-3.1e-01
6.0e-01
7.1e-01
cases:3.70%
controls:2.32%
cases:2.19%
controls:1.44%
cases:0.71%
controls:0.55%
—
—
cases:0.32%
controls:0.44%
cases:2.56%
controls:1.41%
cases:5.18%
controls:2.61%
57
358
1485
15055
34
223
1515
15252
11
85
1538
15390
—
5
68
1541
15377
38
212
1447
14783
69
350
1262
13036
Surface analgesia on skin or mucosa
WX105 [2001310765]
WX105 [2001310765]
4.2e-01
3.9e-01
—
—
—
1.3e+00
5.7e-01
cases:1.56%
controls:1.03%
cases:0.52%
controls:0.35%
—
—
—
—
—
—
cases:0.81%
controls:0.22%
cases:1.95%
controls:1.11%
24
159
1518
15254
8
54
1541
15421
—
—
—
12
33
1473
14962
26
149
1305
13237
Acute maxillary sinusitis
J01.0 [45601112]
J01.0 [45601112]
6.3e-01
2.7e-01
—
—
—
2.4e-01
6.7e-01
cases:5.71%
controls:3.11%
cases:1.42%
controls:1.09%
—
—
—
—
—
—
cases:1.48%
controls:1.17%
cases:7.81%
controls:4.15%
88
479
1454
14934
22
169
1527
15306
—
—
—
22
175
1463
14820
104
556
1227
12830
Constipation
D12 [2002000311]
D12 [2002000311]
1.3e+00
-1.0e+50
—
—
—
—
5.9e-01
cases:0.84%
controls:0.23%
cases:0.00%
controls:0.08%
—
—
—
—
—
—
—
—
cases:0.53%
controls:0.29%
13
36
1529
15377
0
12
1549
15463
—
—
—
—
7
39
1324
13347
salbutamol; inhalant
R03AC02 [21603256]
R03AC02 [21603256]
4.2e-01
2.8e-01
1.7e-01
—
4.0e-01
3.9e-01
4.5e-01
cases:17.96%
controls:12.54%
cases:8.07%
controls:6.22%
cases:1.23%
controls:1.04%
—
—
cases:1.68%
controls:1.13%
cases:9.49%
controls:6.61%
cases:21.56%
controls:14.91%
277
1933
1265
13480
125
963
1424
14512
19
161
1530
15314
—
26
175
1520
15270
141
991
1344
14004
287
1996
1044
11390
Chest pain, unspecified
R07.4 [45558450]
R07.4 [45558450]
5.3e-01
3.6e-01
—
—
—
6.1e-01
7.4e-01
cases:4.80%
controls:2.89%
cases:1.48%
controls:1.04%
—
—
—
—
—
—
cases:1.62%
controls:0.89%
cases:6.76%
controls:3.35%
74
446
1468
14967
23
161
1526
15314
—
—
—
24
133
1461
14862
90
448
1241
12938
Simple examination of mouth
SAA01 [2001310274]
SAA01 [2001310274]
2.9e-01
3.0e-01
9.1e-02
-1.0e+50
2.5e-01
3.5e-01
3.2e-01
cases:25.62%
controls:20.53%
cases:12.20%
controls:9.35%
cases:1.42%
controls:1.30%
cases:0.00%
controls:0.06%
cases:1.75%
controls:1.36%
cases:12.59%
controls:9.20%
cases:33.66%
controls:26.92%
395
3165
1147
12248
189
1447
1360
14028
22
201
1527
15274
0
9
1549
15466
27
210
1519
15235
187
1380
1298
13615
448
3604
883
9782
Acute apical periodontitis of pulpal origin
K04.4 [45567286]
K04.4 [45567286]
6.7e-01
6.7e-01
—
—
—
1.2e+00
5.1e-01
cases:1.69%
controls:0.87%
cases:0.52%
controls:0.26%
—
—
—
—
—
—
cases:0.88%
controls:0.25%
cases:2.33%
controls:1.41%
26
134
1516
15279
8
41
1541
15434
—
—
—
13
38
1472
14957
31
189
1300
13197
Cathetrisation of vein
TPH04 [2001309597]
TPH04 [2001309597]
6.6e-01
3.1e-01
—
—
1.0e+00
3.0e-01
5.9e-01
cases:3.83%
controls:2.02%
cases:1.36%
controls:1.00%
—
—
—
—
cases:0.32%
controls:0.12%
cases:1.14%
controls:0.85%
cases:4.43%
controls:2.52%
59
311
1483
15102
21
155
1528
15320
—
—
5
18
1541
15427
17
127
1468
14868
59
337
1272
13049
Other gastroenteritis and colitis of infectious and unspecified origin
A09 [45605189]
A09 [45605189]
6.0e-01
2.4e-01
—
—
-1.0e+50
7.4e-01
6.4e-01
cases:3.76%
controls:2.11%
cases:0.90%
controls:0.71%
—
—
—
—
cases:0.00%
controls:0.10%
cases:1.62%
controls:0.78%
cases:5.41%
controls:2.91%
58
325
1484
15088
14
110
1535
15365
—
—
0
15
1546
15430
24
117
1461
14878
72
390
1259
12996
General health counselling
SPAT1312 [2001700413]
SPAT1312 [2001700413]
3.1e-01
2.9e-01
7.6e-01
—
1.2e+00
3.9e-01
2.1e-01
cases:8.04%
controls:6.03%
cases:2.58%
controls:1.95%
cases:0.39%
controls:0.18%
—
—
cases:0.97%
controls:0.28%
cases:3.23%
controls:2.21%
cases:7.36%
controls:6.06%
124
930
1418
14483
40
302
1509
15173
6
28
1543
15447
—
15
44
1531
15401
48
331
1437
14664
98
811
1233
12575
Other blockage of nerve
WX290 [2001310792]
WX290 [2001310792]
3.4e-01
2.7e-01
-1.5e-01
—
6.8e-01
5.4e-01
3.4e-01
cases:13.75%
controls:10.21%
cases:4.52%
controls:3.50%
cases:0.32%
controls:0.37%
—
—
cases:0.91%
controls:0.46%
cases:5.86%
controls:3.49%
cases:17.28%
controls:12.91%
212
1574
1330
13839
70
541
1479
14934
5
58
1544
15417
—
14
71
1532
15374
87
523
1398
14472
230
1728
1101
11658
Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
35333-4 [3036086]
35333-4 [3036086]
—
—
—
—
—
1.2e+00
1.2e+00
—
—
—
—
—
—
—
—
—
—
cases:0.34%
controls:0.11%
cases:1.58%
controls:0.47%
—
—
—
—
—
5
16
1480
14979
21
63
1310
13323
haemophilus influenzae B and hepatitis B
J07CA08 [21601379]
J07CA08 [21601379]
-1.1e-01
-1.0e+50
—
—
-1.0e+50
—
1.2e+00
cases:0.45%
controls:0.51%
cases:0.00%
controls:0.16%
—
—
—
—
cases:0.00%
controls:0.05%
—
—
cases:1.28%
controls:0.38%
7
78
1535
15335
0
25
1549
15450
—
—
0
7
1546
15438
—
17
51
1314
13335
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
1751-7 [3024561]
1.7e-01
2.9e-01
8.8e-01
—
5.2e-01
4.1e-01
3.4e-01
cases:7.39%
controls:6.33%
cases:4.84%
controls:3.68%
cases:1.36%
controls:0.57%
—
—
cases:1.10%
controls:0.65%
cases:5.32%
controls:3.59%
cases:12.47%
controls:9.21%
114
976
1428
14437
75
570
1474
14905
21
88
1528
15387
—
17
101
1529
15344
79
539
1406
14456
166
1233
1165
12153
mirtazapine; oral
N06AX11 [21604740]
N06AX11 [21604740]
5.3e-01
2.7e-01
5.8e-01
—
-4.6e-02
3.9e-01
6.8e-01
cases:8.37%
controls:5.09%
cases:3.68%
controls:2.82%
cases:1.29%
controls:0.73%
—
—
cases:0.71%
controls:0.74%
cases:4.44%
controls:3.05%
cases:11.80%
controls:6.32%
129
785
1413
14628
57
437
1492
15038
20
113
1529
15362
—
11
115
1535
15330
66
457
1419
14538
157
846
1174
12540
Pain in joint
M25.5 [45586941]
M25.5 [45586941]
3.4e-01
6.5e-01
—
—
6.9e-01
5.7e-01
5.6e-01
cases:4.86%
controls:3.51%
cases:2.39%
controls:1.26%
—
—
—
—
cases:0.45%
controls:0.23%
cases:2.15%
controls:1.23%
cases:8.64%
controls:5.12%
75
541
1467
14872
37
195
1512
15280
—
—
7
35
1539
15410
32
184
1453
14811
115
685
1216
12701
Sprain and strain of shoulder joint
S43.4 [45607418]
S43.4 [45607418]
1.2e+00
—
—
—
—
1.5e+00
8.9e-01
cases:0.78%
controls:0.23%
—
—
—
—
—
—
—
—
cases:0.40%
controls:0.09%
cases:1.05%
controls:0.43%
12
36
1530
15377
—
—
—
—
6
13
1479
14982
14
58
1317
13328
Contusion of knee
S80.0 [45569633]
S80.0 [45569633]
4.8e-01
1.2e+00
—
—
—
5.5e-01
5.3e-01
cases:0.97%
controls:0.60%
cases:0.77%
controls:0.23%
—
—
—
—
—
—
cases:0.40%
controls:0.23%
cases:1.73%
controls:1.02%
15
93
1527
15320
12
36
1537
15439
—
—
—
6
35
1479
14960
23
137
1308
13249
lansoprazole; oral
A02BC03 [21600098]
A02BC03 [21600098]
5.6e-01
6.5e-01
—
—
—
3.6e-01
2.6e-01
cases:5.64%
controls:3.31%
cases:2.52%
controls:1.33%
—
—
—
—
—
—
cases:2.15%
controls:1.52%
cases:4.51%
controls:3.50%
87
510
1455
14903
39
206
1510
15269
—
—
—
32
228
1453
14767
60
469
1271
12917
enoxaparin; parenteral
B01AB05 [21600976]
B01AB05 [21600976]
7.1e-02
4.8e-01
—
—
1.1e+00
7.3e-01
4.7e-01
cases:3.50%
controls:3.27%
cases:1.74%
controls:1.09%
—
—
—
—
cases:0.45%
controls:0.16%
cases:1.89%
controls:0.91%
cases:4.81%
controls:3.06%
54
504
1488
14909
27
168
1522
15307
—
—
7
24
1539
15421
28
137
1457
14858
64
409
1267
12977
Bipolar affective disorder, unspecified
F31.9 [45571758]
F31.9 [45571758]
7.5e-01
1.4e+00
—
—
—
1.2e+00
1.2e+00
cases:0.71%
controls:0.34%
cases:0.58%
controls:0.14%
—
—
—
—
—
—
cases:0.54%
controls:0.16%
cases:1.20%
controls:0.37%
11
52
1531
15361
9
22
1540
15453
—
—
—
8
24
1477
14971
16
49
1315
13337
CT of paranasal sinuses and face area
DM1AD [2001301741]
DM1AD [2001301741]
1.2e+00
—
—
—
—
—
1.1e+00
cases:0.91%
controls:0.28%
—
—
—
—
—
—
—
—
—
—
cases:0.68%
controls:0.23%
14
43
1528
15370
—
—
—
—
—
9
31
1322
13355
Shoulder X-ray examination without contrast
NB1AA [2001307225]
NB1AA [2001307225]
1.2e+00
7.8e-01
—
—
—
1.6e+00
8.7e-01
cases:1.43%
controls:0.44%
cases:0.32%
controls:0.15%
—
—
—
—
—
—
cases:0.54%
controls:0.11%
cases:1.28%
controls:0.54%
22
68
1520
15345
5
23
1544
15452
—
—
—
8
17
1477
14978
17
72
1314
13314
LabWAS
↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
57
138
4.25
21.57
2.3
1.5
1.83
1.27
promille
1.62
39
114
967
7750
1.62
19.02
5.2
5.4
6.49
6.57
mmol/l
0.62
921
7289
516
3757
1.55
14.07
2.7
2.2
335.09
268.35
u/l
0.22
498
3603
827
6709
1.48
13.10
6.7
6.7
11.56
11.75
umol/l
0.10
801
6401
545
4116
1.49
12.12
3.1
2.7
58.01
60.34
u/l
0.17
519
3848
1145
10030
1.49
11.46
8.7
8.0
80.01
79.24
u/l
0.27
1107
9571
1474
13708
1.88
11.43
18.2
13.9
23.28
23.02
mg/l
0.11
1258
11086
678
5430
1.43
10.74
10.3
12.1
1.12
1.19
inr
3.82
573
4511
755
6201
1.41
10.19
3.0
2.8
—
—
estimate
—
0
0
934
8005
1.40
9.57
10.4
10.0
4.14
4.03
e9/l
0.71
816
6955
580
4588
1.41
9.54
4.0
3.4
23.81
64.49
ng/l
1.65
368
2886
982
8496
1.40
9.46
4.8
4.1
124.18
751.63
e6/l
0.82
17
113
429
3249
1.44
8.88
2.6
2.4
—
—
—
0
0
533
4199
1.40
8.82
3.7
3.3
270.69
64.30
e6/l
0.66
417
3161
286
2009
1.51
8.66
2.0
1.9
—
—
—
0
0
1443
13527
1.64
8.38
19.2
15.6
139.55
139.66
mmol/l
1.03
1415
13271
202
1330
1.59
8.14
2.3
2.5
32.08
73.80
u/l
0.61
168
1141
442
3418
1.40
8.01
4.7
4.3
92.54
91.36
%
0.52
430
3351
1107
9896
1.38
7.97
4.7
4.2
9.91
9.81
mm/h
0.11
1049
9351
1444
13567
1.62
7.96
19.4
15.7
3.95
3.96
mmol/l
0.22
1416
13279
191
1249
1.60
7.92
2.6
2.6
0.22
0.22
g/l
0.21
176
1172
292
2113
1.47
7.57
3.3
3.0
3.35
2.21
e6/l
1.05
157
1001
316
2324
1.45
7.52
2.5
1.9
1.58
1.45
%
2.29
277
2068
309
2263
1.45
7.52
3.2
2.8
0.73
0.90
e6/l
0.72
166
1145
138
847
1.69
7.34
2.1
1.8
0.34
0.32
mg/l
0.12
80
413
319
2372
1.43
7.12
3.4
3.7
170.11
651.06
ng/l
3.80
208
1660
26
81
3.25
6.98
2.8
4.1
152.50
150.80
umol/l
0.01
12
44
138
859
1.66
6.97
1.6
1.7
—
—
—
0
0
653
5467
1.33
6.89
5.3
5.5
36.10
36.63
g/l
1.61
622
5164
1350
12607
1.44
6.58
4.8
4.4
5.93
5.85
mmol/l
1.32
1254
11810
369
2850
1.38
6.56
2.8
2.6
5.78
5.95
e6/l
0.09
341
2591
425
3359
1.36
6.54
1.7
1.6
18.91
19.74
nmol/l
0.70
382
2912
587
4871
1.32
6.50
3.9
3.5
31.76
32.73
u/l
0.29
548
4626
1144
10415
1.34
6.43
3.6
3.4
—
—
—
0
0
455
3644
1.35
6.41
3.5
3.1
0.42
0.40
e6/l
0.07
336
2616
725
6230
1.30
6.09
7.0
7.8
1.21
1.21
mmol/l
0.30
643
5459
1513
14524
1.68
5.91
20.8
16.8
75.35
75.90
umol/l
0.25
1497
14383
283
2132
1.40
5.79
2.6
2.7
13.72
13.98
umol/l
0.20
257
1997
127
816
1.60
5.68
2.9
2.4
2921.47
6214.22
u/l
1.16
56
316
652
5563
1.29
5.66
6.6
7.4
1.21
1.21
mmol/l
0.37
604
5188
63
331
1.94
5.65
1.2
1.3
—
—
—
0
0
1568
15231
2.08
5.62
26.8
21.4
40.77
41.42
%
1.40
1557
15099
1568
15231
2.08
5.62
26.4
20.9
4.56
4.61
e12/l
2.68
1544
14936
1567
15220
2.06
5.58
26.4
21.0
257.55
252.73
e9/l
2.22
1547
14957
1568
15236
2.07
5.53
26.5
21.1
136.71
138.23
g/l
3.85
1557
15111
1568
15236
2.07
5.53
26.4
21.0
6.96
6.71
e9/l
4.40
1545
14935
1360
12807
1.40
5.51
16.2
12.7
90.37
89.10
ml/min/173m2
1.37
1249
11629
1567
15228
2.04
5.44
26.3
20.9
90.21
90.21
fl
0.03
1556
15107
623
5313
1.28
5.35
2.1
2.0
98.88
96.23
pmol/l
0.64
347
2947
32
132
2.45
5.22
1.7
1.7
—
—
—
0
0
205
1488
1.43
5.16
1.9
1.8
—
—
—
0
0
263
2007
1.37
4.94
2.6
2.6
2.36
2.37
g/l
0.02
240
1869
242
1825
1.38
4.89
2.7
2.7
23.44
23.75
%
0.11
221
1717
126
838
1.55
4.89
1.5
1.3
—
—
—
0
0
148
1023
1.49
4.80
2.1
3.3
66.03
70.82
e9/l
1.11
101
727
1499
14451
1.53
4.60
12.6
11.0
28.65
28.16
u/l
0.44
1465
14136
1098
10122
1.27
4.57
4.4
3.4
49.81
45.26
u/l
1.28
1054
9697
72
425
1.73
4.51
1.8
1.8
—
—
—
0
0
29
123
2.38
4.50
2.4
2.2
13.18
18.76
mg/l
0.99
17
54
213
1608
1.37
4.27
3.3
3.1
9.11
7.54
umol/l
0.40
180
1409
226
1723
1.36
4.26
1.8
1.7
1051.86
1154.37
nmol/l
1.05
172
1338
128
884
1.49
4.19
3.8
4.5
1.66
1.46
mmol/l
0.31
99
649
75
460
1.66
4.11
2.0
1.9
—
—
—
0
0
190
1419
1.38
4.07
4.4
4.3
31.60
30.87
%
0.36
124
1015
33
156
2.14
4.01
1.3
1.4
—
—
—
0
0
108
727
1.52
4.01
2.0
1.6
—
—
—
0
0
86
550
1.60
4.00
3.1
3.0
1.02
1.02
ratio
0.44
77
513
164
1203
1.40
3.91
3.3
4.1
4.97
4.72
kpa
0.74
164
1176
139
991
1.44
3.88
3.0
2.5
0.14
0.48
e6/l
2.20
132
941
409
3423
1.26
3.87
2.4
2.3
2.51
2.69
mg/l
1.20
359
2975
33
159
2.10
3.84
1.3
1.4
—
—
—
0
0
33
159
2.10
3.84
1.3
1.4
—
—
—
0
0
402
3366
1.26
3.78
2.6
2.8
338.17
343.67
umol/l
0.57
360
3050
523
4516
1.23
3.72
4.1
3.6
8.13
8.44
mmol/l
0.73
448
3936
31
149
2.10
3.64
1.3
1.4
—
—
—
0
0
31
149
2.10
3.64
1.3
1.4
—
—
—
0
0
209
1614
1.34
3.63
2.7
2.3
—
—
—
0
0
188
1429
1.36
3.62
2.0
1.9
—
—
—
0
0
31
150
2.09
3.58
1.3
1.4
—
—
—
0
0
488
4197
1.23
3.58
2.9
3.4
2.36
2.35
mmol/l
0.12
456
3866
229
1796
1.32
3.58
5.2
7.1
1.10
1.06
mmol/l
0.76
218
1691
96
647
1.51
3.57
1.6
1.4
—
—
—
0
0
678
6033
1.21
3.55
2.6
2.6
70.20
73.30
nmol/l
2.34
629
5598
11
26
4.25
3.50
1.3
1.2
—
—
—
0
0
180
1368
1.36
3.48
2.6
2.2
—
—
—
0
0
1320
12576
1.27
3.44
5.4
4.9
1.82
1.85
mu/l
0.40
1239
11855
179
1363
1.35
3.42
4.3
4.6
1.41
1.62
mmol/l
0.34
162
1158
1135
10640
1.23
3.40
4.3
4.1
14.39
14.57
pmol/l
1.90
1054
9881
71
453
1.59
3.38
2.6
2.4
1248.61
407.90
ug/l
0.58
64
427
313
2583
1.26
3.30
1.4
1.3
17.48
25.69
iu/ml
0.97
77
722
423
3616
1.23
3.24
1.9
1.7
—
—
—
0
0
366
3082
1.24
3.23
1.9
1.9
0.89
1.12
mg/l
1.52
281
2311
261
2116
1.28
3.18
2.4
2.7
162.90
115.73
ug/g
0.82
209
1714
801
7291
1.20
3.17
3.9
3.5
0.00
0.23
estimate
0.54
157
1376
127
926
1.40
3.17
4.2
5.0
24.13
23.97
mmol/l
0.26
127
921
266
2170
1.27
3.08
3.3
4.2
0.80
0.82
mmol/l
1.91
250
2082
797
7264
1.19
3.08
3.8
3.5
15.60
4.48
estimate
0.49
172
1467
42
240
1.77
3.03
1.4
1.4
14.87
18.48
u/l
0.41
31
201
442
3833
1.21
2.90
3.8
3.6
0.01
0.01
estimate
0.19
158
1364
786
7190
1.18
2.82
3.8
3.5
0.00
0.00
estimate
0.50
166
1468
89
626
1.45
2.74
4.2
5.2
24.87
24.62
mmol/l
0.32
84
599
1393
13439
1.27
2.74
5.2
5.1
2.77
2.77
mmol/l
0.03
1303
12777
57
367
1.57
2.67
1.4
2.5
0.20
0.90
g/l
2.16
45
331
1382
13331
1.26
2.65
4.8
4.6
4.62
4.65
mmol/l
0.42
1308
12726
74
507
1.48
2.62
1.4
2.2
1.40
1.45
g/l
0.17
61
453
59
386
1.55
2.59
1.3
1.3
—
—
—
0
0
292
2461
1.23
2.53
1.7
1.7
427.45
30267905.56
pmol/l
2.36
249
2131
56
365
1.55
2.51
1.6
2.4
9.77
10.42
g/l
0.52
49
337
32
180
1.79
2.48
1.1
1.2
—
22.75
—
0
8
133
1021
1.33
2.46
2.6
2.4
18.79
18.74
au/ml
0.00
14
124
301
2553
1.22
2.45
2.6
2.2
—
—
—
0
0
127
970
1.34
2.43
1.4
1.5
—
—
—
0
0
118
893
1.35
2.40
2.1
2.9
66.61
67.15
g/l
0.37
108
837
1374
13276
1.24
2.39
4.7
4.5
1.38
1.41
mmol/l
2.43
1294
12613
278
2345
1.22
2.39
1.4
1.3
7.66
10.33
u/ml
0.35
108
940
261
2196
1.22
2.30
2.8
2.9
2.45
2.43
mmol/l
1.15
234
1975
15
66
2.28
2.24
2.7
3.7
—
34.50
—
0
13
62
426
1.47
2.21
1.6
2.3
3.45
3.75
g/l
0.94
54
401
62
426
1.47
2.21
1.6
2.3
4.05
4.24
g/l
1.08
55
400
62
426
1.47
2.21
1.6
2.3
7.27
7.14
g/l
0.25
54
401
432
3826
1.18
2.18
4.2
4.3
6.60
9.17
mg/mmol
0.86
261
2526
169
1367
1.26
2.13
6.7
10.1
0.90
0.78
mmol/l
0.14
138
1141
428
3796
1.17
2.12
1.5
1.4
1.99
2.08
u/ml
0.04
112
1042
370
3243
1.18
2.11
3.6
3.5
1.02
1.02
kg/l
0.99
245
2120
29
168
1.74
2.08
1.3
1.1
—
—
—
0
0
30
176
1.72
2.06
1.0
1.1
—
—
—
0
0
13
56
2.33
2.05
2.8
2.3
15.16
16.84
umol/l
0.28
13
56
385
3396
1.18
2.03
1.7
1.5
2.35
2.27
g/l
0.34
244
2155
119
929
1.30
2.00
1.1
1.1
—
—
—
0
0
57
394
1.46
1.99
1.4
1.2
3.13
15.64
u/ml
—
7
56
317
2757
1.19
1.98
2.8
2.4
—
—
—
0
0
57
395
1.46
1.97
1.4
1.2
8.80
2.69
u/ml
—
5
32
752
6987
1.14
1.94
3.3
3.2
110.64
111.45
ug/l
0.02
700
6631
6
16
3.76
1.93
3.7
9.0
36.33
48.55
umol/l
—
6
11
149
1204
1.26
1.92
4.0
3.1
—
—
—
0
0
58
406
1.44
1.91
1.6
2.3
2.98
2.89
g/l
0.25
51
381
23
128
1.81
1.90
1.4
2.0
—
—
—
0
0
6
17
3.54
1.84
6.0
1.5
14.26
1.91
nmol/l
—
6
17
87
662
1.33
1.77
3.0
3.3
0.59
0.62
%
0.45
87
662
69
509
1.37
1.72
1.5
1.3
—
—
—
0
0
13
61
2.14
1.71
1.2
1.4
—
—
—
0
0
13
61
2.14
1.71
1.2
1.4
—
—
—
0
0
48
332
1.46
1.71
1.3
1.4
—
—
—
0
0
11
48
2.30
1.70
1.3
1.4
—
—
—
0
0
11
48
2.30
1.70
1.3
1.4
—
—
—
0
0
62
453
1.38
1.65
1.3
1.1
4.24
3.93
—
8
75
76
574
1.34
1.65
3.9
3.8
52.47
49.83
%
0.43
76
566
1277
12366
1.16
1.61
6.0
5.5
39.02
38.43
mmol/mol
1.05
1211
11795
1295
12561
1.16
1.56
4.1
3.9
1.34
1.31
mmol/l
0.67
1219
11865
166
1403
1.20
1.45
4.9
4.6
224.86
247.75
u/l
1.87
159
1334
46
328
1.41
1.44
1.3
2.4
0.21
0.02
g/l
0.44
40
302
5
16
3.13
1.44
1.8
1.1
—
—
—
0
0
67
510
1.33
1.41
1.7
1.6
0.04
0.22
iu/ml
0.90
19
76
45
321
1.41
1.41
1.4
2.5
0.00
0.00
g/l
-0.00
38
283
17
96
1.78
1.39
1.4
1.1
—
43.20
—
0
5
18
104
1.74
1.37
1.3
1.2
101.11
109.81
pmol/l
0.46
18
104
5
17
2.95
1.36
1.2
1.1
—
—
—
0
0
10
47
2.13
1.33
2.0
3.6
9.33
10.50
kpa
—
10
47
10
47
2.13
1.33
2.0
3.6
5.29
4.95
kpa
—
10
47
81
640
1.28
1.32
1.5
1.4
—
—
—
0
0
28
184
1.53
1.32
1.3
1.3
—
—
—
0
0
6
24
2.51
1.30
1.0
1.1
—
—
—
0
0
21
129
1.64
1.30
1.7
1.7
60.25
58.84
%
0.06
16
92
75
589
1.29
1.29
1.7
1.8
3.35
7.12
iu/ml
1.53
12
136
28
186
1.51
1.27
10.9
3.0
—
—
—
0
0
19
116
1.65
1.21
1.3
2.0
—
—
—
0
0
23
148
1.56
1.20
1.4
1.9
—
—
—
0
0
38
272
1.41
1.20
1.2
1.8
—
—
—
0
0
35
247
1.43
1.19
1.2
1.3
—
—
—
0
0
35
247
1.43
1.19
1.2
1.3
—
—
—
0
0
6
26
2.31
1.18
1.5
1.3
1.18
1.19
mmol/l
—
6
26
108
897
1.22
1.17
4.2
4.8
90.00
83.06
ng/l
0.34
97
816
46
343
1.35
1.15
1.3
1.6
13.15
15.29
e6/l
0.09
33
251
5
20
2.50
1.15
1.4
1.3
—
—
—
0
0
5
20
2.50
1.15
1.6
1.5
—
—
—
0
0
49
370
1.33
1.13
1.1
1.1
6.74
4.46
u/ml
0.30
30
202
57
441
1.30
1.12
1.1
1.1
4.71
1.96
u/ml
0.90
37
248
18
111
1.63
1.12
1.6
1.4
11450.50
2093.32
e6/l
0.69
12
71
19
119
1.60
1.12
1.3
1.1
—
68.00
—
0
7
142
1217
1.18
1.11
7.8
8.9
9.14
8.46
mmol/l
0.53
135
1178
49
372
1.33
1.10
1.2
1.1
—
—
—
0
0
5
21
2.38
1.09
1.2
1.1
—
—
—
0
0
8
41
1.96
1.09
1.3
1.4
106.12
89.71
nmol/24h
—
8
41
49
373
1.32
1.08
1.2
1.1
—
—
—
0
0
177
2016
0.86
1.08
2.0
1.9
3.75
3.63
ratio
0.54
140
1546
163
1417
1.17
1.08
2.2
2.1
362.44
377.66
nmol/l
0.43
152
1329
7
33
2.13
1.05
1.0
1.2
—
—
—
0
0
130
1512
0.85
1.04
1.7
1.7
3.64
3.49
mmol/l
0.70
84
1043
23
154
1.50
1.04
1.3
1.5
—
—
—
0
0
46
350
1.32
1.03
1.4
1.6
3118.67
504.48
e6/l
0.52
36
268
45
342
1.32
1.02
1.1
1.1
16.95
6.68
u/ml
1.07
25
171
16
99
1.62
1.00
1.7
1.4
25694.11
23813.43
e6/l
—
9
54
106
896
1.20
0.99
2.3
2.3
5.19
8.52
ug/l
1.84
94
815
10
54
1.86
0.96
1.4
2.7
—
45196.30
—
0
10
39
294
1.33
0.95
2.3
2.3
139.94
132.60
g/l
0.82
32
234
1256
12274
1.11
0.93
21.6
17.2
333.68
333.94
g/l
0.44
1249
12200
20
134
1.50
0.92
1.0
1.1
—
—
—
0
0
49
384
1.28
0.91
1.5
1.4
283.17
286.89
ug/g
0.04
28
223
34
253
1.35
0.90
4.9
3.5
23.88
27.17
mg/l
0.21
25
174
583
5523
1.09
0.88
3.7
3.3
0.03
0.03
estimate
0.04
136
1246
6
30
2.00
0.87
1.2
1.1
—
—
—
0
0
80
669
1.21
0.86
1.3
1.3
250.53
218.49
miu/ml
0.28
32
320
38
291
1.31
0.85
1.4
1.3
—
—
—
0
0
8
45
1.78
0.84
1.5
2.2
—
—
—
0
0
8
45
1.78
0.84
1.5
2.2
—
—
—
0
0
8
45
1.78
0.84
1.5
2.2
—
—
—
0
0
35
456
0.76
0.84
1.4
1.4
—
—
—
0
0
15
97
1.55
0.81
1.3
1.4
75.13
76.10
umol/l
0.08
15
97
8
47
1.71
0.80
1.4
1.8
—
—
—
0
0
44
348
1.27
0.79
2.8
3.2
2.74
2.32
index
0.12
23
197
0
24
0.00
0.79
0.0
1.0
—
—
—
0
0
103
890
1.17
0.78
3.0
3.6
4.71
4.68
pmol/l
0.06
94
805
18
123
1.47
0.77
1.6
1.5
29.24
33.45
g/l
0.77
18
110
103
893
1.16
0.76
3.9
4.0
1.22
1.23
mmol/l
0.18
85
773
35
271
1.30
0.74
3.1
2.9
1.81
1.53
mmol/l
0.28
35
262
65
542
1.21
0.74
1.6
1.7
12.84
9.51
u/ml
0.27
14
142
48
388
1.24
0.73
3.0
3.0
—
—
—
0
0
9
55
1.64
0.73
1.1
1.0
—
—
—
0
0
145
1293
1.13
0.73
5.7
6.0
—
—
—
0
0
21
151
1.40
0.71
1.1
1.1
—
—
—
0
0
16
109
1.47
0.71
2.9
2.7
—
—
—
0
0
67
565
1.19
0.69
3.0
2.4
67.36
56.94
u/ml
0.11
67
546
56
464
1.21
0.69
1.1
1.1
9.72
4.95
u/ml
0.94
37
279
16
110
1.46
0.68
1.2
1.2
—
—
—
0
0
18
127
1.42
0.68
1.2
1.4
3.78
3.58
u/ml
0.03
11
66
24
179
1.35
0.67
1.0
1.3
—
—
—
0
0
45
366
1.24
0.67
1.4
1.8
—
—
—
0
0
16
111
1.45
0.66
1.2
1.2
—
—
—
0
0
36
286
1.26
0.65
1.1
1.3
—
—
—
0
0
592
5676
1.07
0.63
1.9
1.9
1.43
1.41
mmol/l
0.18
491
4969
12
79
1.52
0.62
1.1
1.1
—
—
—
0
0
12
79
1.52
0.62
1.8
1.6
—
—
—
0
0
67
776
0.86
0.58
1.2
1.1
1.50
1.50
g/l
0.05
67
776
91
802
1.14
0.58
2.5
3.1
152.17
168.31
ng/l
0.20
83
715
1218
11970
1.07
0.58
21.4
17.1
13.52
13.40
%
2.41
1208
11832
8
54
1.48
0.57
4.0
3.5
0.69
1.28
%
—
8
54
21
158
1.33
0.57
1.0
1.1
—
—
—
0
0
116
1040
1.12
0.57
4.1
4.6
6.69
21.11
ug/l
1.02
92
849
43
356
1.21
0.56
1.6
1.7
—
—
—
0
0
67
579
1.16
0.56
2.0
1.8
—
—
—
0
0
32
257
1.25
0.55
1.7
1.6
—
—
—
0
0
36
438
0.82
0.54
3.0
3.8
1217.53
3090.78
u/ml
0.35
30
377
6
38
1.58
0.54
1.2
1.1
—
—
—
0
0
20
151
1.33
0.54
1.2
1.2
—
—
—
0
0
9
61
1.48
0.53
1.4
2.0
—
—
—
0
0
9
61
1.48
0.53
1.4
2.0
—
—
—
0
0
9
61
1.48
0.53
1.4
2.0
—
—
—
0
0
9
61
1.48
0.53
1.4
2.0
—
—
—
0
0
326
3080
1.07
0.53
3.3
3.3
1158.18
1125.57
ng/l
0.06
266
2558
64
737
0.86
0.53
1.2
1.1
0.66
0.68
ratio
—
9
62
15
108
1.39
0.53
1.4
1.7
—
—
—
0
0
15
108
1.39
0.53
1.4
1.7
—
—
—
0
0
15
108
1.39
0.53
1.4
1.7
—
—
—
0
0
6
39
1.54
0.53
1.0
1.1
—
—
—
0
0
6
39
1.54
0.53
1.0
1.1
—
—
—
0
0
19
143
1.33
0.52
1.0
1.1
—
—
—
0
0
40
332
1.21
0.52
1.1
1.0
0.19
0.30
u/ml
0.45
17
124
6
40
1.50
0.51
1.0
1.6
—
—
—
0
0
25
197
1.27
0.51
2.2
1.6
31.64
25.19
ng/l
0.45
25
197
9
65
1.39
0.50
1.9
1.6
—
—
—
0
0
9
65
1.39
0.50
1.7
1.8
1.44
3.84
u/field
—
9
53
13
92
1.42
0.50
1.2
1.3
—
—
—
0
0
463
4436
1.06
0.50
4.6
4.6
2.17
1.94
ug/l
0.27
420
4064
31
252
1.23
0.50
1.5
1.3
5.50
4.64
u/ml
0.15
20
114
7
45
1.56
0.49
1.0
1.4
—
—
—
0
0
7
45
1.56
0.49
1.3
1.6
—
—
—
0
0
19
145
1.31
0.49
1.0
1.1
13.38
6.74
iu/ml
—
6
34
7
47
1.49
0.47
2.0
2.5
—
—
—
0
0
58
504
1.16
0.47
1.2
1.1
2.48
2.92
u/ml
0.11
37
288
31
254
1.22
0.47
1.5
1.2
2.18
3.85
u/ml
0.75
11
94
7
49
1.43
0.46
1.0
1.0
32.27
48.38
iu/ml
—
7
49
120
1097
1.10
0.44
1.2
1.3
152.14
135.52
u/ml
0.16
45
419
98
887
1.11
0.44
1.4
1.5
19.89
21.87
iu/l
0.31
84
721
23
285
0.80
0.43
2.1
2.4
54.45
110.75
ug/min
0.89
14
175
11
78
1.41
0.43
1.8
2.8
6.15
8.06
mmol/l
2.92
11
78
5
31
1.61
0.43
1.2
1.1
—
—
—
0
0
28
230
1.22
0.42
1.3
1.9
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
30
360
0.83
0.42
2.3
3.9
0.35
0.36
iu/ml
0.05
16
193
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
8
57
1.41
0.42
1.1
1.3
106.88
108.96
%
—
8
57
5
33
1.52
0.41
1.0
1.8
—
—
—
0
0
0
17
0.00
0.40
0.0
1.1
—
26.03
—
0
12
0
17
0.00
0.40
0.0
1.1
—
1.35
—
0
17
5
34
1.47
0.40
1.0
1.3
—
—
—
0
0
253
2665
0.94
0.39
2.7
2.9
0.69
0.71
ug/l
0.12
150
1505
10
71
1.41
0.39
1.0
1.2
197.03
219.95
iu/ml
—
10
71
11
80
1.38
0.38
3.4
3.4
1624.00
670.96
u/ml
0.62
11
80
37
317
1.17
0.38
1.7
1.7
22360.26
13166.60
e6/l
0.31
27
224
35
299
1.17
0.37
1.5
1.3
—
—
—
0
0
8
113
0.71
0.37
2.4
1.7
—
—
—
0
0
54
478
1.13
0.36
1.6
1.9
0.85
2.04
ug/l
1.11
47
426
30
254
1.18
0.35
1.3
1.5
—
—
—
0
0
72
795
0.90
0.35
1.3
1.1
0.89
0.89
g/l
0.06
72
795
6
42
1.43
0.35
1.0
1.1
—
—
—
0
0
6
42
1.43
0.35
1.0
1.1
—
—
—
0
0
6
42
1.43
0.35
1.0
1.1
—
—
—
0
0
429
4149
1.05
0.34
3.5
2.9
0.02
0.03
estimate
0.14
138
1191
6
45
1.33
0.33
1.2
1.2
—
—
—
0
0
16
127
1.26
0.33
1.9
2.6
179.88
231.05
e6/l
0.88
16
108
15
118
1.27
0.33
1.5
1.6
—
—
—
0
0
213
2024
1.06
0.33
1.4
1.5
—
—
—
0
0
36
411
0.87
0.31
1.3
1.5
—
—
—
0
0
127
1189
1.07
0.31
3.5
2.8
10.33
10.61
g/l
0.36
121
1104
10
75
1.34
0.30
1.1
1.1
—
—
—
0
0
10
75
1.34
0.30
1.6
3.1
26.86
331.56
ug/l
—
10
68
50
448
1.12
0.30
1.1
1.1
1.15
1.23
u/ml
0.06
32
217
7
55
1.27
0.30
4.0
1.8
—
—
—
0
0
7
56
1.25
0.29
1.1
1.3
—
—
—
0
0
36
408
0.88
0.29
1.9
2.1
3.45
4.11
iu/l
0.29
14
174
8
62
1.29
0.28
5.0
1.9
71.38
118.99
ng/l
—
8
62
8
63
1.27
0.27
1.1
1.3
284.75
455.30
u/l
—
8
56
107
1002
1.07
0.27
2.8
2.5
69.18
74.20
ml/min/173m2
0.69
45
412
11
86
1.28
0.26
1.0
1.1
1719.45
1482.59
miu/ml
0.25
11
86
15
123
1.22
0.25
1.1
1.2
—
—
—
0
0
31
273
1.14
0.25
1.1
1.1
—
—
—
0
0
82
763
1.08
0.25
1.5
1.7
306.22
293.98
mu/l
0.19
76
697
74
686
1.08
0.24
1.5
1.6
9.69
7.46
u/l
1.15
57
535
29
255
1.14
0.24
2.8
2.6
6.05
7.28
umol/l
0.15
21
194
35
312
1.12
0.24
1.3
1.6
—
—
—
0
0
6
85
0.70
0.24
1.2
1.2
—
—
—
0
0
14
115
1.22
0.23
2.6
2.3
—
—
—
0
0
41
370
1.11
0.23
1.7
1.5
45.69
57.99
ug/l
1.81
41
370
11
88
1.25
0.22
2.7
2.2
2.45
1.72
u/field
0.16
11
57
39
352
1.11
0.22
1.4
1.7
—
—
—
0
0
15
125
1.20
0.22
1.1
1.2
—
—
—
0
0
13
107
1.22
0.21
1.8
2.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
5.1
—
414.10
—
0
10
0
10
0.00
0.21
0.0
5.7
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
0
12
0.00
0.21
0.0
3.8
—
—
—
0
0
35
316
1.11
0.20
1.5
1.7
—
—
—
0
0
14
117
1.20
0.20
4.6
3.8
—
—
—
0
0
0
14
0.00
0.20
0.0
4.7
—
133447.50
—
0
6
0
14
0.00
0.20
0.0
4.5
—
—
—
0
0
15
127
1.18
0.19
1.1
1.1
—
—
—
0
0
15
128
1.17
0.18
1.1
1.2
—
—
—
0
0
7
58
1.21
0.18
1.0
1.2
—
—
—
0
0
7
59
1.19
0.18
4.0
1.7
205.00
195.32
u/l
—
7
59
46
426
1.08
0.17
2.2
1.7
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
82
1.22
0.17
1.0
1.1
—
—
—
0
0
10
119
0.84
0.15
3.9
2.4
1.20
1.19
mmol/l
—
10
119
7
87
0.80
0.14
3.6
2.1
30.29
26.90
umol/l
—
7
81
11
93
1.18
0.14
2.8
1.5
13.26
6.50
ug/l
0.39
11
81
48
450
1.07
0.14
1.1
1.1
8.00
6.31
eliau/ml
—
5
69
28
256
1.10
0.14
1.3
1.6
—
—
—
0
0
26
237
1.10
0.14
3.0
3.7
11.56
8.37
pmol/l
0.84
26
237
17
151
1.13
0.13
1.4
1.4
173.22
175.88
pmol/l
0.03
17
151
32
296
1.08
0.13
2.5
3.8
1.12
3.57
ratio
0.95
14
166
56
530
1.06
0.13
1.7
1.5
0.95
0.95
ratio
0.01
32
334
56
530
1.06
0.13
1.7
1.5
1.33
1.23
ratio
0.26
32
334
56
530
1.06
0.13
1.7
1.5
1.10
1.16
ratio
0.22
32
334
9
108
0.83
0.13
3.0
3.1
679.67
1308.44
mg
—
9
108
24
219
1.10
0.12
3.5
3.1
7.20
7.33
mmol/l
0.09
24
212
13
148
0.88
0.12
1.2
1.3
—
88.17
—
0
6
15
133
1.13
0.12
1.1
1.1
—
—
—
0
0
27
249
1.09
0.12
1.1
1.1
—
—
—
0
0
35
327
1.07
0.11
2.4
4.1
65.39
46.82
mg/l
0.44
25
284
35
327
1.07
0.11
2.4
4.1
50.91
65.12
mg/l
0.28
25
283
105
1015
1.04
0.11
1.8
1.6
920.61
1002.25
mu/l
0.44
91
867
345
3503
0.98
0.11
3.6
3.9
21.75
21.39
%
0.14
153
1415
25
270
0.92
0.10
1.1
1.1
324.33
2005.46
iu/ml
—
6
66
29
271
1.07
0.09
1.4
1.6
—
—
—
0
0
36
381
0.94
0.09
1.2
1.5
—
17.43
—
0
7
16
145
1.10
0.09
1.6
1.7
—
—
—
0
0
21
194
1.08
0.09
1.0
1.1
—
—
—
0
0
166
1694
0.98
0.08
2.6
2.4
13.13
13.69
nmol/l
0.39
148
1575
6
57
1.05
0.08
1.0
1.0
—
—
—
0
0
70
676
1.04
0.08
1.9
1.8
—
—
—
0
0
61
633
0.96
0.08
2.1
1.8
6.67
4.76
mg/l
0.38
46
461
5
64
0.78
0.08
1.0
1.2
—
—
—
0
0
13
117
1.11
0.08
2.2
3.7
20.00
13.69
index
—
8
87
54
519
1.04
0.08
1.7
1.5
—
—
—
0
0
22
205
1.07
0.08
5.5
4.2
134.12
1513.40
u/ml
0.61
22
192
6
73
0.82
0.07
1.0
2.2
—
—
—
0
0
6
73
0.82
0.07
1.0
2.2
—
—
—
0
0
8
74
1.08
0.07
1.1
1.1
—
—
—
0
0
33
347
0.95
0.07
1.3
2.3
0.85
0.83
nmol/l
0.06
25
306
34
357
0.95
0.07
1.2
1.5
121.92
139.69
au/ml
0.41
12
104
9
85
1.06
0.07
1.9
2.1
99.00
145.81
nmol/l
—
9
75
49
472
1.04
0.07
1.7
1.6
—
—
—
0
0
8
92
0.87
0.06
1.1
1.7
—
—
—
0
0
8
92
0.87
0.06
1.1
1.2
—
—
—
0
0
68
660
1.03
0.06
1.6
1.5
—
—
—
0
0
56
579
0.97
0.06
1.8
1.6
49.82
61.18
ug/l
1.75
49
497
17
182
0.93
0.05
1.4
1.7
—
—
—
0
0
19
202
0.94
0.05
1.2
1.2
—
—
—
0
0
114
1120
1.02
0.05
1.4
1.3
372.30
321.83
u/ml
0.15
104
1044
18
170
1.06
0.04
1.7
1.4
0.58
0.58
nmol/l
0.02
18
164
24
249
0.96
0.02
1.8
1.6
—
—
—
0
0
15
144
1.04
0.00
1.1
1.2
—
296.00
—
0
5
19
196
0.97
0.00
1.4
1.6
—
—
—
0
0
21
204
1.03
0.00
2.5
3.1
23.11
22.71
nmol/l
0.06
21
195
24
244
0.98
0.00
1.4
1.3
12.25
44.75
u/l
1.87
24
208
11
111
0.99
0.00
1.2
2.1
—
756.51
—
0
21
43
428
1.00
0.00
1.2
1.3
243.75
228.99
u/ml
0.16
31
236
12
121
0.99
0.00
3.4
2.4
3.81
4.01
mmol/l
0.41
12
121
12
121
0.99
0.00
3.4
2.4
104.08
105.45
mmol/l
0.19
12
121
28
281
1.00
0.00
1.1
1.1
7.98
3.03
eliau/ml
—
10
126
18
183
0.98
0.00
1.2
1.8
—
—
—
0
0
34
335
1.02
0.00
1.2
1.1
33.10
14.17
au/ml
—
5
97
24
235
1.02
0.00
1.0
1.2
—
40.00
—
0
5
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
4.3
—
—
—
0
0
6
60
1.00
-0.00
1.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.7
—
1.59
—
0
8
6
67
0.90
-0.00
2.2
1.6
1.33
4.55
nmol/l
—
6
57
5
58
0.86
-0.00
1.2
1.2
92.20
107.04
%
—
5
49
7
78
0.90
-0.00
8.3
6.3
8.14
8.24
%
—
7
78
8
86
0.93
-0.00
1.4
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
7.9
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
5.8
—
0.24
—
0
5
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
61
0.98
-0.00
1.7
1.2
0.25
0.29
g/l
—
6
51
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
8
87
0.92
-0.00
1.9
3.8
0.50
0.91
index
—
8
87
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: ST19_BURN_CORROSION_WRIST_HAND – Burn and corrosion of wrist and hand
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).